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Construction of two recombinant luxI bacteriophage-based bioluminescent 
bioreporters was undertaken to develop detection and monitoring systems for 
Staphylococcus aureus and Salmonella spp. These systems take advantage of the high 
specificity of bacteriophage for their hosts and the Vibrio fischeri lux operon responsible 
for quorum sensing bioluminescence. The detection system is composed of two elements, 
a recombinant phage with luxI which is specific for the target pathogen, and an 
acylhomoserine lactone (AHL)-inducible bioreporter cell line carrying the reporter lux 
genes. The goal of this study was to construct Salmonella- and S. aureus-specific 
recombinant phages which contain luxI. 
 The luxI expression in S. aureus was controlled by cloning the gene into S. aureus 
under the control of a Gram-positive promoter and ribosomal binding site (RBS). The 
same construct was also placed into Escherichia coli and Bacillus subtilis for comparison 
purposes. Although light was produced by E. coli and B. subtilis, there was no light from 
S. aureus. The presence of luxI transcript was shown in all strains using real time qRT-
PCR. Western blotting detected LuxI only in E. coli but not in B. subtilis and S. aureus. 
After the construct RBS was shown to be effective, the codon utilization of luxI was 
adapted to S. aureus phage P68 genome to eliminate a possible codon preference 
problem. Optimization had no effect on S. aureus while it resulted in a significant 
decrease of light from E. coli and a non-significant increase in B. subtilis. Additional 
studies are needed to determine reason(s) for luxI expression problem in S. aureus. 
 Salmonella choleraesuis, which carries luxI under the control of Salmonella 
phage P22 promoter and a Gram-negative RBS, produced high levels of light. The luxI, 
 
 iv
under the control of the same promoter and RBS, was cloned into the phage P22 genome 
using homologous recombination. The recombinant phage P22luxI induced light from the 
bioreporter only when it was propagated using S. choleraesuis which harbored the 
homologous recombination plasmid. The bioluminescent bioreporter E. coli OHHLux 
was shown to produce light in the presence of P22luxI without the S. choleraesuis host. 
Bioluminescence tests showed P22luxI as the source of the problem. Escherichia coli 
OHHLux was shown not to be lysed by P22 or P22luxI and not to uptake the P22luxI 
genome during bioluminescence tests. P22luxI and S. choleraesuis in combination 
produced AHL by using an AHL bioreporter, Agrobacterium tumefaciens A136. Since A. 
tumefaciens A136 is not specific enough to use for quantification of AHL, another 
bioreporter was constructed by placing the E. coli OHHLux plasmid into Klebsiella 
strains. They produced light with P22luxI without the host like the previous bioreporter.  
Future studies should focus on constructing a bioreporter strain which does not produce 
light when mixed with P22luxI without its host. Optimization, and sensitivity and 
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INTRODUCTION AND GENERAL INFORMATION 
 
Various methods have been used to monitor the environment, agricultural 
products, food, fermentors, and wastewater treatment plants to detect pollutants and 
pathogens and also to observe biological processes for clinical and pharmaceutical 
purposes (1-15). Although these methods can be sensitive, specific, and powerful, they 
are usually costly, laborious, time-consuming, and need to be performed in special 
laboratories by trained personnel. Furthermore, chemical detection methods such as gas 
or high pressure liquid chromatography and mass and atomic absorption spectrometry do 
not take into account bioavailability; the interactions with other chemicals in mixtures 
and the effects on organisms (13-15). Frequently, pathogen detection methods cannot 
differentiate between dead and alive and/or living and viable but not culturable (VBNC) 
organisms and may have specificity and cross-contamination problems (1-12). These 
problems with the existing methods create a need for alternative systems.  
Bioluminescent bioreporters offer a good alternative. They are genetically 
engineered microbial organisms that react to the presence of specific analyte(s) by 
generating light (see reviews 13-22). Light-producing reporter genes are placed under the 
control of a promoter which is inducible only by the particular analyte. Bioreporters are 
integrated into biosensors, forming devices which are a combination of biological and 
electrical components so that the light produced can be measured to detect and quantify 
the target analyte. They provide a rapid, non-invasive, sensitive, and specific alternative 
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to existing methods. Bioluminescent bioreporters can be used to determine effects of 
chemicals on organisms and their bioavailability and to differentiate living pathogens 
from those which are dead or VBNC. 
 Bioluminescent bioreporters have been constructed previously in our lab for 
detection of naphthalene (23-27), salicylate (24, 25, 28, 29), polychlorinated biphenyls 
(30), benzene, toluene, ethylbenzene, and xylene (BTEX) (31), trichloroethylene (32), 
polycyclic aromatic hydrocarbons (33, 34), 2, 4-dichlorophenoxyacetic acid and 2,4-
dichlorophenol (35), phenol (36), and for toxicity monitoring in biological wastewater 
treatment systems (37). These systems used Vibrio fischeri lux genes as reporter genes.  
Integrated circuit luminometers have been developed to measure and record the light 
generated by bioreporters.  They are called bioluminescent bioreporter integrated circuits 
(BBICs) (38). The BBIC is composed of a photodetector and a signal processor which are 
contained in a 1cm3 area. While the photodetector captures light, the signal processor 
digitizes and transmits it to a data receiver. This is a mobile unit in a hand-held format. 
The bioluminescent bioreporter interfaced with the BBIC is an ideal system for 
monitoring of different environments for chemicals and pathogens. It is a small and 
portable self-sustained device which allows for remote sensing. Testing is performed by 
exposing the device to the sample with no requirement for trained personnel. It is a cheap 
and low power drain system. All these capabilities of the system make it suitable for 
continuous and remote monitoring of different environments in real-time for any analyte 
of interest.  
 Infectious diseases caused by the contamination of food and environment by 
bacterial pathogens have been on the rise recently (1, 39-43). An important route of 
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contamination is transfer of pathogens including Salmonella from animal and human 
feces to soil as a result of poorly treated sewage sludge applications on the land (39, 40, 
44-48). Pathogens are eventually transported to water from soil (39). Contaminated water 
may infect humans and animals or contaminate agricultural products (39, 40, 45, 49-52). 
Pathogens which become airborne after waste application and agricultural irrigation may 
also cause infections (50-53). Among them is Staphylococcus aureus which can be a 
lower human colon organism (53). Staphylococcus aureus and other opportunistic 
pathogens are also found on surfaces and as airborne in health care centers, causing 
nosocomial infections (43, 54-57). Therefore, there is a need for detection methods to 
monitor environments such as soil, water, and surfaces and agricultural products. Another 
environment that needs to be monitored for pathogens is within the spacecraft. 
Spacecrafts are especially susceptible to contamination due to use of reconditioned air 
and recycled water and the closed environment (58, 59). Opportunistic pathogens, 
including S. aureus, have been detected frequently in space flights from various surfaces 
of the craft and astronauts (58-60). This may pose serious health risks to the astronauts 
whose immune systems are weakened in space (58, 61). Contamination in spacecrafts 
may also lead to allergic reactions, food spoilage, release of toxins, infection of plants, 
and deterioration of structural materials (58, 62).  
 The aim of this study was to construct a bioluminescent bioreporter system for 
detection of bacterial pathogens in various environments by applying the same principles 
used for developing previous pollutant monitoring bioreporters. The system takes 
advantage of the high specificity of the bacteriophage for their hosts and V. fischeri 
quorum sensing lux system. Unlike previous bacteriophage-based bioluminescent 
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bioreporters, this system utilizes all components of the V. fischeri lux operon (see below). 
luxI is carried by the recombinant phage whose host is the target pathogen while the rest 
of the lux operon genes are inside a recombinant bioreporter cell line. The bioreporter 
cannot generate light without luxI-synthesized acylhomoserine lactones (AHLs). The 
recombinant phage and bioreporter are ultimately designed to be integrated in a BBIC 
(38). When the system is exposed to a sample contaminated with the target pathogen, 
AHL, the product of LuxI, is produced upon infection of pathogen by the recombinant 
phage. AHL diffuses into the bioreporter cell where it induces lux genes, which results in 
light production. Eventually, a BBIC will measure and transmit the signal obtained. The 
bioreporter cell was constructed previously and tested for Escherichia coli monitoring 
with successful results (63). This study aims to construct luxI recombinant phages that 
will be used for detecting S. aureus and Salmonella, separately. In the end, these will be 
self-sufficient and fully-automated systems without the need for addition of any 
exogenous substrates, use of laborious methods, and trained personnel. The mobile 
format does not require power or optic cables with transmission of data to a receiver, 
making them suitable for field use. They will be highly specific and sensitive devices, 
capable of monitoring various environmental samples and food for Salmonella and S. 
aureus continuously with remote sensing. 
 Chapter 2 provides information about the physiological, biochemical, and genetic 
aspects of quorum sensing and bioluminescence in V. fischeri, S. aureus, Bacillus 
subtilis, Salmonella, and E. coli. It includes a literature review for previous 
bioluminescent bioreporters for chemical and pathogen detection and describes details of 
the system developed for this work and difference from previous systems. General 
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information about the bacteriophage and contamination problems with Salmonella and S. 
aureus are also mentioned in this chapter. Chapters 3 and 6 discuss the details of the 
methods and experiments performed to develop appropriate vector and expression 
systems for bacteriophage-based bioluminescent bioreporters for monitoring S. aureus 
and Salmonella, respectively. Results obtained from these experiments are given in 
chapters 4 (S. aureus) and 7 (Salmonella). Chapters 5 and 8 discuss the S. aureus and 
Salmonella results, respectively, and present suggestions for their explanation.  
 Results obtained from this study point to some conclusions listed below: 
• Expression of V. fischeri luxI in S. aureus is problematic because of reasons other 
than the promoter and ribosomal binding site (RBS) compatibility. These reasons 
are unknown at the present time since there is no other study of V. fischeri luxI 
expression in S. aureus in the literature. They may include luxI mRNA or protein 
instability; or the presence of acylhomoserine lactonases or AHL antagonists in S. 
aureus. Further studies are needed to determine the cause of this problem. 
• Homologous recombination appears to be an efficient and significant mechanism 
used by Salmonella phage P22 frequently during the infection. 
• Recombinant Salmonella phage P22 may be infecting E. coli, Klebsiella 
pneumoniae, and Klebsiella oxytoca although the only host stated for wild-type 
P22 phage in the literature is Salmonella. However, the nature of this possible 
infection is not clear. It may be following a pseudolysogenic pathway. Further 
studies are required to determine the certainty and nature of possible infections of 
E. coli, K. pneumoniae, and K. oxytoca by P22. 
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• If further tests confirm infection of E. coli, K. pneumoniae, and K. oxytoca by 
P22, the recombinant phage P22luxI developed for Salmonella monitoring in this 
study may be used to test different bacterial strains (especially those belonging to 
enterobacteria) for P22 infection which does not lead to lysis. Also, principles 
used here to construct P22luxI can be applied to other phage strains for 
development of similar recombinant constructs which can be used for tests of 




















Quorum sensing, first described by Nealson and colleagues and Eberhard (64-67), 
is the production, release and subsequent detection of signal molecules called 
autoinducers by bacteria, indicative of population density. As the population of bacteria 
grows, cells secrete autoinducers into the environment. Therefore, the extracellular 
concentration of auotinducer is correlated with the population density. When the 
autoinducer reaches a critical threshold level, bacteria respond by altering gene 
expression. This allows bacteria to perform certain cell functions only when they reach a 
sufficiently large population, a quorum. Some of the functions controlled by quorum 
sensing are virulence, competence, biofilm formation, conjugation, antibiotic production, 
motility, sporulation and bioluminescence (68). 
There are three main classes of quorum sensing that use different types of 
autoinducer molecules: the LuxI/R systems of Gram-negative bacteria that utilize AHLs, 
the oligopeptide two-component systems of Gram-positive bacteria, and the autoinducer-
2 (AI-2) system widespread among Gram-negative and Gram-positive bacteria which use 
a furanosyl borate diester as the autoinducer. 
LuxI/R quorum sensing is common among α, β, and γ subclasses of 
Proteobacteria (69, 70). This system has two major components: a V. fischeri LuxI 
homologue that synthesizes the AHL autoinducer and a V. fischeri LuxR homologue that 
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binds AHL (69-76). The autoinducer diffuses into and out of the cell or is transported 
across the cell membrane. When its concentration reaches a threshold level, the LuxR 
type receptor protein binds AHL. The resulting complex controls expression of quorum-
sensing-regulated genes. LuxI/R systems have been identified in over 70 species of 
Gram-negative bacteria although there are no Gram-positive bacteria known that produce 
AHL (69, 73-75). 
Gram-positive bacteria use modified oligopeptides as autoinducers. Small linear 
or cyclic peptides are produced in the cytoplasm as precursors (72, 75). Later, they are 
modified and transported into the environment where they interact with the membrane-
bound two-component sensor kinase proteins. This interaction causes phosphorylation of 
the associated response regulator that changes expression of target genes. 
LuxI/R and oligopeptide two-component quorum sensing systems are used for 
intraspecies communication (73, 75). The autoinducer can be recognized only by the 
bacterial species that produces it. The structure of the autoinducer produced by each 
bacterial species is different from that of other species and receptors can only recognize 
their own cognate autoinducers. 
The AI-2-based quorum sensing is shared by both Gram-negative and -positive 
bacteria. It is a furanosyl borate diester produced by the luxS gene (72, 73). Homologues 
of luxS have been found in many species so this system has been implicated in 
interspecies communication (72, 77). However, the signaling mechanism has not been 
defined in most of the bacteria that carry luxS homologues and there are questions as to 




V. fischeri- Euprymna scolopes symbiosis 
Quorum sensing was first discovered and described in the bioluminescent marine 
bacteria V. fischeri and Vibrio harveyi (65-67). Most of the early quorum sensing 
research focused on V. fischeri which lives in a symbiotic relationship with the Hawaiian 
bobtail squid Eu. scolopes (78-80). Bacterial cells colonize the specialized light organ of 
the squid. Vibrio fischeri grow to very high cell densities (1010-1011 cells/ ml) in the 
nutrient-rich light organ (65, 81-85). When the autoinducer produced by the growing 
culture reaches a critical concentration inside the light organ, bioluminescence genes are 
induced for expression (86-88). Autoinducer concentrations inside the light organ can 
exceed 100 nM which is higher than the level required to induce bioluminescence with 
laboratory cultures (89). However, V. fischeri is found at low cell densities (a few 
cells/ml) in nutrient-limiting ocean conditions where autoinducer diffuses away and can 
not accumulate (82, 90). Therefore, the light organ is a primary niche in the ocean for V. 
fischeri to exist at high densities. Euprymna scolopes is a nocturnal animal that lives in 
the shallow sand flats (78, 79). It benefits from the symbiosis by using the light provided 
by V. fischeri to escape from its predators (78-80, 84, 85). In this strategy called 
counterillumination, the squid projects light downward to mask its shadow at night (79, 
82, 84, 85, 88). It can control the amount of light emitted by V. fischeri by opening and 
closing a shutter beneath the light organ. 
 
Bioluminescence reaction 
Luminescence created during V. fischeri cell growth is generated by the reaction 
of reduced flavomononucleotide (FMNH2), long-chain aliphatic aldehyde (RCHO), and 
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oxygen (91-96). This reaction produces oxidized flavomononucleotide (FMN), aliphatic 
acid (RCOOH) and water with the simultaneous release of excess free energy as blue-
green light at 490 nm that results in bioluminescence (91, 92, 97-99).  
FMNH2 + RCHO + O2             FMN + RCOOH + H2O + light (490 nm) 
luxA and luxB genes encode α and β subunits of the heterodimeric luciferase 
enzyme which catalyzes the reaction (86, 91, 92). The aldehyde substrate used by 
luciferase is converted from fatty acids by a multienzyme complex. The reductase, 
thioesterase and synthetase components of this fatty acid reductase complex are encoded 
by luxC, luxD and luxE genes, respectively (91, 92, 100, 101). luxG is thought to encode 
a flavin mononucleotide reductase which produces FMNH2 substrate for luciferase (92, 
102).  
 
Organization and regulation of lux genes 
Bioluminescence genes of V. fischeri are organized into two operons which are 
transcribed in opposite directions with a 150 bp-intergenic regulatory region between 
them (Figure 2-1). Structural genes, luxA, luxB, luxC, luxD, luxE, and luxG, and the 
regulator gene luxI, are located on the rightward luxICDABEG operon. The other operon 
consists of luxR whose product is the transcriptional activator of the luxICDABEG operon 
(86, 87, 95, 103-105). The LuxI protein is the autoinducer synthase and it produces an 
AHL, N-(3-oxohexanoyl)-L-homoserine lactone (OHHL) (86, 106, 107). The LuxR 
regulatory protein activates luxICDABEG operon transcription after binding the 





Figure 2-1. Vibrio fischeri Lux I/R quorum sensing system (64, 66, 67, 86, 87, 95, 103-











When V. fischeri cell density is low, the luxICDABEG operon is transcribed 
weakly (Figure 2-1). Therefore, the autoinducer level is low and almost no light is 
produced (66, 67, 108). Since OHHL can freely diffuse in and out of the cell, intracellular 
and extracellular concentrations become the same (109). As the cell density increases, it 
accumulates in the environment. When OHHL reaches a critical, threshold concentration 
(10 nM) it binds to the amino-terminal OHHL-binding domain of LuxR (66, 86, 87, 110-
112). The interaction induces a conformational change in the LuxR protein. This allows it 
to dimerise, which leads to unmasking of the DNA binding domain, carboxy-terminal 
(64, 112-118). The complex binds to the lux box which is a 20-bp inverted repeat 
sequence around 40 bp upstream of the luxICDABEG operon transcriptional start site 
(119-123). Binding stimulates expression of the lux cassette resulting in an exponential 
increase in both OHHL production and light generation (66, 108, 115, 124). While this 
creates a positive feedback loop on luxICDABEG transcription, it represses luxR 
expression (87, 125-128). Therefore, these loops keep light production under control at 
high population densities. 
 
Other regulators of V. fischeri bioluminescence 
Vibrio fischeri possesses two more signals that have a role in regulation of 
bioluminescence: N-octanoyl-L-homoserine lactone (C8-HSL) synthesized by AinS (129-
133) and AI-2, a furanosyl borate diester, produced by LuxS (134, 135) (Figure 2-2). C8-
HSL is sensed by AinR (129, 130) while AI-2 is sensed by LuxP and LuxQ (134, 135). 
These two signals stimulate bioluminescence by relieving the repression of LitR which is 





Figure 2-2. Ain S/R and Lux S/PQ quorum sensing systems in V. fischeri (129-140) (  









At low cell densities (<108 cells/ml) found in the ocean, luminescence is repressed 
through inhibition of LitR by LuxO (134, 136-138) (Figure 2-2). When C8-HSL 
accumulates to a threshold level that correlates with intermediate cell densities (108-109 
cells/ml) obtained in lab cultures and early stages of squid colonization, it induces 
bioluminescence partially by (i) activating a phosphorelay cascade that results in LuxO 
inactivation, and by (ii) binding LuxR (134, 138, 139). OHHL is at a low level to induce 
luminescence at this stage. C8-HSL binds its cognate receptor AinR to induce the cascade 
that inactivates LuxO through LuxU (134, 138, 139). This relieves repression of LitR and 
thus LitR stimulates expression of LuxR (136, 140). Binding of C8-HSL to LuxR causes 
a weak induction of luxICDABEG operon transcription. OHHL reaches significant 
amounts at high cell densities (>1010 cells/ml) achieved only inside the light organ of the 
squid and binds LuxR. This causes full induction of bioluminescence (138, 139). 
Although both C8-HSL and OHHL can induce bioluminescence by binding to 
LuxR, OHHL binding results in much higher light emission than C8-HSL binding does 
(Figure 2-2). Therefore, it acts as an antagonist of light induction by OHHL (131, 141). 
One role of C8-HSL may be to competitively inhibit premature activation of 
bioluminescence at low cell densities (131, 132). 
 
AHL synthesis and structure 
Quorum sensing autoinducer signals of Gram-negative bacteria are AHLs. AHLs 
are composed of an acyl side chain linked to a homoserine lactone ring with an amide 
bond. While all AHLs carry the same homoserine lactone, their acyl side chains differ in 
length and substitution (Figure 2-3, Table 2-1) (142-150). Acyl chains range from 4 to 14 
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carbons with either an oxo- or hydroxy- or no substituent at their third carbon atom. 
However, two AHLs with acyl chains up to 16 and 18 carbons have been found in 
Rhodobacter capsulatus and Sinorhizobium meliloti (151, 152). Acyl chains may also be 
saturated or unsaturated. 7,8-cis-N-(3-hydroxytetradecenoyl) homoserine lactone and 7,8-
cis-N-(tetradecenoyl) homoserine lactone produced by Rhizobium leguminosarum (153, 
154) and Rhodobacter sphaeroides (155), respectively, are two examples of AHL which 
carry acyl chains with double bonds. Most bacterial AHLs discovered carry an even 
number of carbons in their acyl chain. Pathogenic Gram-negative bacteria which do not 
produce AHL are Actinobacilus pleupneumoniae, E. coli, Haemophilus influenza, K. 
pneumoniae, Neiserria meningitides, Salmonella spp., Vibrio cholerae, Campylobacter 
jejuni, and Helicobacter pylori (156). 
 
 
Figure 2-3. Some examples of different AHL structures (see Table 2-1 for references) 
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Table 2-1. AHL types in various organisms  
 Organism LuxI/LuxR 
Homologue(s) 
 AHL Type References 
V. fischeri LuxI/LuxR- N-(3-oxohexanoyl)-L-
homoserine lactone  
(86, 87, 106) 
V. fischeri AinR/AinS N-(octanoyl)-L-










homoserine lactone  
(157, 158) 
A. tumefaciens TraI/TraR-TraM N-(3-oxooctanoyl)-L-
homoserine lactone  
(159-165) 
















homoserine lactone  
(145, 168) 
Erwinia carotovora ExpI/ExpR, 
CarI/CarR, HsII/? 
N-(3-oxohexanoyl)-L-





homoserine lactone  
(175, 176) 
E. chrysanthemi Unknown N-decanoyl)-L-
homoserine lactone  
(175) 
Erwinia stewartii EsaI/EsaR N-(3-oxohexanoyl)-L-
homoserine lactone  
(177) 
E. coli Unknown/SdiA Unknown (178-181) 











homoserine lactone  
(186-191) 














Table 2-1. Continued  
 Organism LuxI/LuxR 
Homologue(s) 
 AHL Type References 
R. leguminosarum RhiI/RhiR  N-hexanoyl-L-
homoserine lactone  
(153, 199, 
200) 
R. leguminosarum CinI/CinR N-(3-hydroxy-7-cis-
tetradecenoyl)-L-
homoserine lactone  
 (153, 154, 
199, 201, 
202) 
R. sphaeroides CerI/CerR 7,8-cis-N-
(tetradecanoyl)-L-








homoserine lactone  
(204, 205) 
Vibrio anguillarum VanI/VanR N-(3-oxodecanoyl)-L-

















homoserine lactone  
(213) 



















The LuxI protein and its homologues are responsible for synthesis of AHLs. 
LuxI-type proteins have the ability to produce AHLs in heterologous hosts as determined 
by studies on various bacteria transformed with luxI and its homologues (87, 159, 186, 
192, 213). This points to the fact that AHL substrates are from cellular pools of 
metabolites. The V. fischeri AHL was the first AHL discovered. It was identified as N-(3-
oxohexanoyl) homoserine lactone or OHHL (Figure 2-3, Table 2-1) (106). Vibrio fischeri 
crude extracts were shown to synthesize OHHL in the presence of S-adenosylmethionine 
(SAM) and 3-oxo-hexanoyl-CoA (124). Later studies found that SAM (107, 124, 159, 
215-219) and acyl-acyl carrier proteins (acyl-ACPs) (107, 159, 217-220) were substrates 
for LuxI-directed AHL synthesis. The homoserine lactone ring of AHL is derived from a 
common cellular amino acid substrate, SAM (221), while the acyl side chain is obtained 
from fatty acid biosynthesis metabolite, acyl-ACP. 3-oxohexanoyl-ACP is the specific 
acyl-ACP used for synthesis of OHHL. 
Synthesis of AHL starts with binding of SAM to the active site of the LuxI 
enzyme (Figure 2-4) (107, 218, 222). The acyl side chain of the appropriate acyl-ACP (3-
oxohexanoyl-ACP in the case of OHHL) forms an amide bond with SAM after a 
nucleophilic attack on the C1 position of the acyl-ACP by the amino nitrogen of SAM. 
Another nucleophilic attack, this time on the γ carbon of SAM by the SAM carboxylate 
oxygen, causes lactonization of the intermediate. This results in production of AHL and 
release of 5′-methylthioadenosine (MTA), a toxic byproduct. MTA is cleaved by Pfs, a 
nucleoside enzyme, into adenine and methylthioribose (MTR) which are not toxic (107, 



















LuxI and its homologues change from 194 to 226 amino acids in size (149). When 
their protein sequences are compared, <5% similarity is detected (223, 224). Although 
LuxI-type proteins produce AHL molecules with specific acyl side chains, the difference 
between protein sequences can not be used to determine the type of AHL synthesized by 
a particular sequence (223, 224). Comparison of protein sequences detected ten 
conserved amino acids with seven of them charged, mostly in the amino-terminal region 
(149, 225). Furthermore, mutational studies on LuxI-type proteins identified conserved 
charged residues in the amino-terminal half (LuxI residues 25-70) (225, 226). Most 
mutations resulted in production of nonfunctional LuxI proteins and five of the amino 
acids mutated are conserved in all LuxI-type proteins (LuxI Arg25, Glu44, Asp46, Asp49 
and Arg70) (226). These results suggest that highly conserved amino-terminal regions 
may be the parts responsible for functions consistent in all LuxI-type proteins while the 
carboxy-terminal regions may have roles in recognition of specific acyl side chains of 
acyl-ACPs (226). 
LuxI-type proteins synthesize specific AHLs which are used for intraspecies 
communication of bacterial species that produce them. Some species produces more than 
one type of AHL although only one acts as the main quorum sensing signal (107, 149, 
150, 152, 218). Secondary AHLs produced by LuxI-type proteins act as competitors of 
the main AHL signal (131, 141, 227, 228). These AHLs bind the LuxR-type protein in 
place of the main AHL without activating the protein. The specificity of the AHL 
molecule originates from its acyl side chain, so it has been suggested that recognition of 
the appropriate acyl-ACP by the LuxI-type protein creates this specificity in the 
production of AHL (149). Structural studies on EsaI in P. stewartii and LasI in P. 
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aeruginosa showed that the size of the cavity which interacts with the acyl side chain 
may be responsible for the selectivity of LuxI-type proteins for certain acyl-ACPs (222, 
229). The cavity of LasI which produces a longer AHL is larger than the cavity of EsaI 
which synthesizes a shorter AHL. However, the specificity in quorum-sensing systems is 
also provided by binding of LuxR-type proteins only to their cognate AHLs (230-232). 
Short-chain AHLs like OHHL of V. fischeri can freely diffuse across the cell 
membrane while long-chain AHLs (e.g., 12-carbon AHL of P. aeruginosa) need to be 
transported actively with efflux or influx pumps (109, 233, 234). Larger AHLs have 
higher hydrophobicity because of their longer hydrophobic acyl side chains, decreasing 
their permeability through cell membranes. Short-chain AHLs which usually contain a 3-
oxo- or 3-hydroxy group have low octanol/water partition coefficients (235). The 
presence of the hydrophilic homoserine lactone in the structure of AHLs in addition to 
the hydrophobic acyl side chain makes them capable of existing in both cell membrane 
and aqueous intracellular and extracellular media (236).  
 
Fatty acid biosynthesis (source of AHL acyl side chains) 
Fatty acids are produced by fatty acid biosynthesis (FAB) pathways which are 
divided into FAB I and FAB II. Type I pathway is found in mammals. It is a single 
protein with separate domains that catalyze different reactions of the pathway (237). 
Type II, or dissociated pathway, used by bacteria, plants, and parasites is composed of 
discrete proteins. Each protein catalyzes a single reaction in the pathway (238-241). 
Although different structurally, FAB I and FAB II are responsible for the same chemical 
reactions (242). FAB II pathway does not only produce fatty acids but also a variety of 
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cellular metabolism precursors. Fatty acids are components of membrane phospholipids 
(243-246). Intermediates of the FAB pathway are used in synthesis of lipoic acid, 
vitamins (247, 248), polysaccharides (249), adenylate cyclase, hemolysin (250), and 
quorum sensing AHL autoinducers (107, 159, 219).  
Gram-negative bacteria produce straight-chain saturated and unsaturated fatty 
acids at different lengths via FAB II pathway. The E. coli pathway is the most-studied 
type II system and serves as the model system for FAB II research in other organisms. 
The following is a summary of the E. coli straight-chain FAB reaction (241, 246, 251, 
252): 
Acetyl-CoA + 7 Malonyl-CoA + 14 NADPH + 14H          Palmitic acid + 7 CO2 +         
14 NADP + 6 H20 + 8 CoA 
The acyl carrier protein (ACP) is an important cofactor of this pathway that 
transfers the acyl side chain from enzyme to enzyme during FAB (241, 246, 253). 
Precursors for the pathway are provided by cellular acetyl-CoA supply (241). Individual 
steps of the pathway are explained below (see also Figure 2-5): 
1- The first reaction catalyzed by a multiunit enzyme complex, acetyl-CoA carboxylase 
(ACC), produces malonyl-CoA from acetyl-CoA and CO2 (254, 255). 
2- Malonyl-CoA:ACP transacylase (FabD) transfers the malonate group from malonyl-
CoA to ACP to form malonyl-ACP (241, 256). 
3- FAB starts with condensation of malonyl-ACP with acetyl-CoA. This reaction 
catalyzed by β-ketoacyl-ACP synthase III (FabH) releases β-ketobutyryl-ACP and CO2 




Figure 2-5. FAB II pathway (238, 241, 245, 251, 254-287) 
 
4- β-ketobutyryl-ACP enters the elongation cycle which is catalyzed by four enzymes. 
The acyl side chain is elongated by two carbons with each cycle.  
a- The keto group is reduced to a hydroxyl group by β-ketoacyl-ACP reductase 
(FabG) in the NADPH-dependent first reaction of the cycle (264, 265). 
b- The resulting β-hydroxyacyl-ACP is dehydrated by β-hydroxyacyl-ACP 
dehydratase (FabA or FabZ) to form an enoyl-ACP (266-270). 
c- The cycle is completed by production of an acyl-ACP after reduction of the 
double bond in enoyl-ACP by NADH-dependent enoyl-ACP reductase (FabI, 
FabK, or FabL) (271-274). 
5- The product formed is condensed with malonyl-ACP by β-ketoacyl-ACP synthase 
(KAS) I or II (FabB or FabF, respectively) to extend the acyl-ACP by two carbons. 




FAB II pathway can also synthesize unsaturated fatty acids (UFAs). FabA 
isomerizes trans-2-decenoyl-ACP to cis-3-decenoyl-ACP at the 10-carbon intermediate, 
preserving the double bond in the acyl chain (266, 267, 269, 270, 288-293). The cis-3-
decenoyl-ACP is elongated by FabB-catalyzed condensation with malonyl-ACP to form 
UFAs as final products (266, 279, 288, 290, 294-298).  
Genes encoding FAB II pathway enzymes are highly conserved among bacteria. 
Homologues of E. coli pathway genes can be identified in genomes of other species by a 
simple BLAST search (242, 299). However, there are some differences between the type 
II pathways of Gram-positive and -negative bacteria. Gram-positive bacteria make their 
UFAs by desaturation of saturated fatty acids (300-302). Furthermore, many Gram-
positive bacteria posses branched-chain fatty acids as the largest component of their fatty 
acid pool while most Gram-negative bacteria have mainly straight-chain fatty acids (252, 
303-305). Bacterial genera which have branched-chain fatty acids as the major fatty acid 
include Staphylococcus and Bacillus (252, 305). The percentage of fatty acids which are 
branched is 81% in S. aureus and 95% in B. subtilis (252). This percentage is lower than 
20% in E. coli and Salmonella which have straight-chain fatty acids in high amounts 
(252). Type II pathway is used for synthesis of all bacterial fatty acids. The determining 
factor for production of straight- or branched-chain fatty acids during type II pathway is 
substrate specificity of the elongation-condensing FabH enzyme (70, 238, 251, 252, 262, 
303, 306, 307). Although the amino acid sequence of the FabH active site is conserved 
among bacteria and all FabH enzymes have similar catalytic mechanisms, there are 
significant differences in substrate specificities of FabH from Gram-negative and -
positive bacteria. FabH from branched-chain fatty acid-synthesizing bacteria show broad 
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substrate specificity whereas FabH from bacteria with mostly straight-chain fatty acids 
are highly selective for acetyl-CoA (70, 238, 251, 252, 257, 259, 262, 263, 303, 305-
317). FabH with broad substrate specificity can use 2-to-6-carbon straight chain and 
branched-chain acyl-CoAs (70, 252, 303, 306, 307, 309-312, 314-318). Branched-chain 
fatty acids contain either iso- or anteiso-methyl branches (252, 303, 309-312, 318-320). 
α-ketoisocaproate, α-keto-β-methylvalerate, and α-ketoisovalerate act as precursors for 
synthesis of iso-odd, anteiso-odd, and iso-even fatty acids, respectively (252). 
Escherichia coli FabH which can not utilize substrates with chains longer than 4 
carbons and branched-chain CoAs especially prefers acetyl-CoA. Thus, E. coli can only 
synthesize straight-chain fatty acids (238, 251, 257-259, 261-263, 303, 304, 308, 317). 
There are two homologues of FabH in B. subtilis: FabH1 and FabH2.  B. subtilis 
FabH1 is 45% identical and 56% similar to E. coli FabH, and B. subtilis FabH2 is 38% 
identical and 48% similar to E. coli FabH. However, unlike E. coli FabH, B. subtilis 
FabH homologues exhibit high activity with 4-to-8-carbon straight-chain acyl-CoA and 
all branched-chain acyl-CoA substrates while they are less active with acetyl-CoA. B. 
subtilis FabH1 and FabH2 expression in E. coli lead to the production of 17-carbon 
branched-chain fatty acids (252, 303, 307, 309-312, 314, 315, 318-320). 
The S. aureus membrane is made of 80% branched-chain fatty acids (70, 252, 
316, 317). Staphylococcus aureus FabH can use 4-to-6-carbon straight- and branched-
chain acyl-CoA substrates to make both straight-chain and branched-chain fatty acids. 
The S. aureus FabH activity order for various acyl-CoA substrates was determined as 
follows: isobutyryl-CoA>hexanoyl-CoA>butyryl-CoA>isovaleryl-CoA>>acetyl-CoA. In 
contrast, E. coli FabH showed the lowest activity with the same substrates except for 
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acetyl-CoA. The S. aureus FabH amino acid sequence has 57, 40, and 34% identity with 
FabH proteins of B. subtilis, E. coli, and Mycobacterium tuberculosis, respectively. The 
crystal structure of S. aureus FabH is similar to the E. coli FabH structure; and amino 
acid sequences of S. aureus and E. coli FabH acyl chain binding pockets are the same. In 
spite of the similarity between structures and amino acid sequences of two FabH, their 
binding pocket sizes are different. Acetyl- or propionyl-CoA can fit into the small E. coli 
FabH pocket. The S. aureus FabH pocket, which is larger, can accept 4-to-6-carbon 
straight- and branched-chain acyl-CoA substrates while exhibiting low activity with 
shorter substrates (70, 252, 316, 317). Other enzymes of the FAB II pathway are not 
selective for straight- or branched-chain fatty acids. All can use both straight- and 
branched-chain acyl-ACPs (252, 303).  
There are two more isoforms of elongation condensing enzymes other than FabH 
in E. coli FAB II pathway: FabB and FabF. FabH catalyzes only the first condensation 
reaction between acetyl-CoA and malonyl-ACP, whereas FabB and FabF are responsible 
for elongation of the fatty acid by condensing acyl-ACP substrates with malonyl-ACP.  
FabB can catalyze condensations up to 10-carbon acyl-ACP while FabF can catalyze 
conversion of 16-carbon palmitoleic acid to 18-carbon cis-vaccenic acid. Amino acid 
sequences of FabB and FabF are 40% identical and do not have high sequence homology 
with FabH. FabB, FabF, and FabH have similar structures but there are significant 
differences between active sites of FabH and Fab/F. Gram-positive bacteria contain FabH 
and either FabB or FabF as isoforms of elongation condensing enzymes. FabB/F are 
highly conserved among bacteria, being essential enzymes for the FAB II pathway (238, 
245, 251, 257-261, 263, 275-287, 296-299, 303, 321-324). 
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There are two isoforms of elongation dehydratases in E. coli: FabA and FabZ. 
FabA not only acts as the dehydratase during the elongation cycle but also isomerizes 
trans-2- to cis-3- to add a double bond into the 10-carbon acyl-ACP to produce UFAs. 
FabA is essential for UFA synthesis in Gram-negative bacteria and found only in the γ 
subdivision of Proteobacteria. Unlike FabA, FabZ has a role in dehydration but not in 
isomerization. Gram-positive bacteria contain only the FabZ isoform of the dehydratase 
(266-270, 288-295, 299). 
FabI, FabK, and FabL are the three isoforms of bacterial enoyl-ACP reductases 
which regulate the rate of FAB. Each bacterial species has different isoform(s). FabI is 
found in E. coli and M. tuberculosis (271, 274, 325-331). Gram-positive Streptococcus 
pneumoniae, Enterococcus faecalis, Enterococcus faecium, and Gram-negative 
Pseudomonads have the FabK isoform (273, 299). Staphylococcus aureus contains only 
FabI, whereas B. subtilis posseses both FabI and FabL (272, 299, 332). Bacillus subtilis 
and S. aureus FabI are structurally very similar to E. coli FabI (272, 303, 332). 
Staphylococcus aureus FabI protein sequence is 48% identical to E. coli FabI sequence 
(332). Both have the same active sites and their substrate activities are highly similar 
(332). Staphylococcus aureus FabI which substituted E. coli FabI was shown to be 
functional (332). 
The rest of the FAB II enzymes are highly conserved among bacteria and have 
single isoforms. Domains of ACPs which transport the growing fatty acid chain from 
enzyme to enzyme during FAB can be exchanged between different organisms. Binding 
sites for FAB intermediates and enzymes are conserved among over a hundred ACP 
protein sequences. ACP proteins from different bacterial species are also structurally very 
 
 28
similar (242, 246, 253, 333-356). ACC catalyzes the first reaction of the fatty acid 
synthesis which is the rate-limiting step in the FAB II pathway (254, 255). The S. aureus 
and E. coli ACC structures show 52% sequence identity and both have a small, zinc-
binding region which has an acetyl-CoA binding site (255). The fabG and fabD genes are 
found in the genomes of all bacteria sequenced and their amino acid sequences are all 
highly similar (256, 264, 265, 299, 325-331, 357-360). 
Some FAB II pathway genes are clustered together in the E. coli genome in the 
order, fabH-fabD-fabG-acpP-fabF. The rest of the genes are dispersed throughout the 
chromosome. Salmonella typhimurium was determined to have the same cluster of genes 
in the identical order in a study (264). The sequence of the S. typhimurium cluster of fab 
genes was 85% identical to the E. coli cluster. Presumed protein sequences from the S. 
typhimurium cluster were found to contain the same number of residues and to have 90% 
identity to the E. coli cluster of Fab sequences. A 55-bp deletion in S. typhimurium acpP 
promoter region was the only difference between clusters of the two organisms. This 
deletion has been suggested to cause a difference in transcription of S. typhimurium acpP 
compared to E. coli acpP. Salmonella typhimurium and E. coli FAB II pathway proteins 
are interchangeable since they are identical (261, 264, 361). 
 
AHL substrate SAM 
SAM is synthesized from methionine and ATP by S-adenosylmethionine 
synthetase (ATP:L-methionine S-adenosyltransferase, EC 2.5.1.6) (362-387) which is 
encoded by the metK gene in E. coli (388-394) as shown below: 
ATP + Methionine + H2O        SAM + PPi + Pi 
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SAM levels in the cell are retained by a cycle of reactions which are a part of methionine 
biosynthesis metabolism (Figure 2-6) (395, 396). The cycle starts with a reaction where 
S-adenosylhomocysteine, which is created by SAM-dependent methylation reactions, is 
hydrolyzed to form adenosine and homocysteine. Homocysteine is converted to 
methionine using the methyl group from methyltetrahydrofolate by methionine synthase. 
Methionine synthase needs to be activated by SAM to mediate this reaction. Methionine 
and ATP are used to generate SAM in the final reaction of the cycle. 
SAM is the major methyl donor for a wide variety of biological reactions in both 
prokaryotic and eukaryotic cells (Figure 2-6) (363) and the second most used enzyme 
substrate after ATP (397). Molecules which are methylated by SAM include RNA (398) 
and DNA (389, 399, 400) for modulation of transcription and translation, norepinephrine 
for production of epinephrine (401), membrane phospholipids (401), and proteins (402). 
SAM is also the donor of the aminopropyl group for synthesis of polyamine (399, 403, 
404) and spermidine (405), and the amino donor for the synthesis of biotin (406). It is 
used in the activation of free radical enzymes (407) and endonucleases of E. coli type I 
restriction and modification systems (408-411). SAM has a role in generation of 
cyclopropane fatty acids from UFAs in E. coli (412) and acts as the corepressor of 
methionine biosynthesis in E. coli, S. typhimurium, and Gram-positive bacteria (221, 413-
417). Finally, the homoserine lactone ring for the quorum sensing AHL autoinducer 

















SAM synthetase protein sequence is highly conserved among organisms (Table 2-
2). The E. coli and B. subtilis enzyme sequences are 57% identical while B. subtilis 
protein sequence is 77% and 63% identical to the enzyme sequences of S. aureus and S. 
typhimurium, respectively (417, 418). Amino acid sequences of E. coli and human 
enzymes show 54% identity (362). Also, the active site residues of SAM synthetase are 
conserved in over 30 enzyme sequences reported, including the rat liver enzyme (363, 
368). However, various isoforms of the enzyme have kcat values different from one 
another up to 100-fold and the domain of the synthetase which covers the active site is 
the least conserved region in enzymes from different organisms (362). 
 
Quorum sensing in Gram-positive bacteria 
Gram-positive bacteria use modified oligopeptides instead of AHLs as quorum 
sensing signals (Figure 2-7). These peptides function by activating two component 
sensor/signal transduction systems. Examples of processes which are regulated by 
peptide-mediated quorum sensing in Gram-positive bacteria include virulence in S. 
aureus and competence and sporulation in B. subtilis (419-422). 
In S. aureus, quorum sensing is regulated by agr (accessory gene regulator). This 
system controls expression of virulence factors in a density-dependent manner (420, 423-
431). The agr system consists of two transcriptional units, RNAII and RNAIII which are 
controlled by promoters P2 and P3, respectively (Figure 2-8) (423, 424). RNAII unit 
encodes the sensor (agrC) and the response regulator (agrA) of a two-component signal 
transduction system and proteins (by the agrD and agrB genes) responsible for 
generation  of  the  autoinducing peptide  (AIP) of  quorum  sensing  (423, 424, 432-435).  
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Table 2-2. Gram-positive bacteria which carry SAM synthetase gene, metK (413, 416) 
B. subtilis Leuconostoc mesenteroides Clostridium botulinum 
Bacillus cereus Pediococcus pentosaceus Clostridium tetani 
Bacillus halodurans Lactococcus lactis Clostridium difficile 
Bacillus 
stearothermophilus 
Streptococcus agalactiae Thermoanaaerobacter 
tengcong. 
Oceanobacillus iheyensis Streptococcus mutans Streptomyces coelicolor 
S. aureus Streptococcus pneumoniae Thermobifida fusca 
L. monocytogenes Streptococcus pyogenes Chlorobium tepidum 
E. faecalis Streptococcus suis Chloroflexus aurantiacus 
Lactobacillus plantarum Streptococcus thermophilus Cytophaga hutchinsonii 
Lactobacillus casei Streptococcus uberis Thermotogales 
Lactobacillus delbrueckii Clostridium acetobutylicum Fusobacterium nucleatum 























RNAIII unit encodes δ-haemolysin and RNAIII transcript (423, 424, 427, 428, 446, 447). 
RNAII operon is expressed continuously at a low level. The agrD gene encodes a 
precursor protein (424, 448), which is exported into the extracellular environment by the 
action of the agrB product (449-451). AgrB cleaves the precursor during this transport 
forming the quorum sensing signal AIP which is a thiolactone-carrying octapeptide (424). 
AIP accumulates in the environment as cell numbers increase until reaching a threshold 
level during the transition stage from exponential to stationary growth (420). Then, AIP 
binds to the membrane-associated sensor protein, AgrC, which activates AgrC by 
autophosphorylation (423, 424, 452). Phosphate is transferred from AgrC to the 
cytoplasmic response regulator, AgrA (435). Phosphorylated AgrA activates RNAII and 
RNAIII operons (423, 424, 453). RNAII operon induction results in an autoinduction 
feedback loop, producing more AIP (423, 424). RNAIII transcript produced from RNAIII 
operon acts as the effector molecule for regulating the production of various S. aureus 
virulence factors (420, 427, 428, 430, 433, 447, 454-460).  
Staphylococcus aureus AIPs are 8-9 amino acids-long and all contain a 
thiolactone ring which is essential for signal activity (Figure 2-7) (432, 436-439). The 
ring is formed by a linkage between a central conserved cysteine residue and the C-
terminal carboxylic acid and is common to all AIPs. AIPs produced by different S. aureus 
strains vary in their amino acid sequence. S. aureus strains are categorized into four 
groups based on the AIP signal they produce. The AIP signal of each S. aureus group 
inhibits activation of agr systems in other S. aureus groups (424, 432, 436, 437, 461-
463). This interference is believed to help the S. aureus strain which activates its quorum 
sensing system in the host organism first to outcompete other strains. 
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Two quorum sensing signal peptides control competence and sporulation in B. 
subtilis (Figure 2-9). These peptides are released into the environment as the number of 
cells increases. The peptide ComX, which is obtained by ComQ processing, is the 
activator of two-component system ComP/ComA (440-443). Phosphorylated ComA 
induces expression of comS. ComS inhibits degradation of ComK which is responsible 
for activation of competence development genes (464-467). The other peptide signal is 
CSF (competence and sporulation factor) which is internalized by an ABC (ATP-binding 
cassette) transporter (441, 444, 445). At low concentrations, CSF stimulates competence 
by inhibiting ComA phosphatase RapC (444, 468-470). This increases the level of 
phosphorylated ComA, eventually leading to competence development. However, CSF at 
high concentrations promotes sporulation and inhibits ComS, which results in 
competence repression (444, 468, 471-473).  
 
 
Figure 2-9. B.subtilis quorum sensing (440-445, 464-473)( =Repression =Induction) 
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Bacillus species contain aiiA genes which encode AHL lactonases (474-476). 
AHL lactonases inactivate AHLs by hydrolyzing their lactone ring. Bacillus species, 
which use peptides as quorum sensing signals, are not affected by these enzymes. It has 
been suggested that Bacillus use AHL lactonases to interfere with AHL-mediated quorum 
sensing to compete with other bacteria. 
 
Quorum sensing in Salmonella and E. coli 
Salmonella typhimurium and E. coli produce an AI-2 molecule which is encoded 
by luxS when grown in the presence of glucose or another carbohydrate (Figure 2-10) 
(477, 478). AI-2 was identified as (2R, 4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran 
(R-THMF) in S. typhimurium (479). The S. typhimurium and E. coli luxS gene sequences 
show significant identity with V. harveyi luxS sequence (477). The only genes which are 
known to be regulated by LuxS in S. typhimurium form the lsr operon (LuxS-regulated) 
(480, 481). This operon encodes a sugar ABC transporter which is used to import AI-2 
into the cell in S. typhimurium and E. coli (480-482). AI-2 is produced and released into 
the environment where it accumulates during mid-exponential growth phase (478, 483). 
It is taken up by cells through the Lsr transporter during stationary growth (478, 480-
483). AI-2 is modified inside the cell, leading to loss of its activity (481, 482). The 
function of this system is not known. It has been hypothesized that S. typhimurium uses 
this process to interfere with quorum sensing of other AI-2-producing bacteria (74). 
Acidic pH and high osmolarity, which are similar to conditions found in a host, induce 
AI-2 production as well (484). Therefore, some researchers have suggested that AI-2 




Figure 2-10. S. typhimurium AI-2, R-THMF (479) 
 
Escherichia coli and S. typhimurium have a LuxR homologue, SdiA, (181, 485) 
but no LuxI homologue and do not produce AHLs (158, 486). SdiA promotes virulence 
genes, the rck operon, and other genes which provide resistance to host defense 
mechanisms in S. typhimurium (203, 487-489). This LuxR homologue also activates cell 
division genes (178, 179, 181), regulates virulence factors (490, 491), and increases 
resistance to xenobiotics (485, 492) in E. coli. SdiA does not sense AI-2s produced by E. 
coli and S. typhimurium but it responds to AHLs produced by other bacterial species 
(486, 493, 494). Some suggested that E. coli and S. typhimurium utilize SdiA to detect the 
presence of other bacteria (203, 486, 494), while others proposed that sensing other 
bacteria provide them with the information that they are inside a host (203). It is not clear 
whether SdiA and LuxS interact in S. typhimurium and E. coli (483, 484). 
 
Bacteriophage 
Bacteriophage or phage are viruses that infect bacteria and are highly specific for 
their hosts (495). Each phage can infect a certain species or strain(s) of a species. Phage 
particles or virions are composed of DNA or RNA genetic material and a protein or 
lipoprotein coat called the head or capsid (495). The number of bases found in phage 
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genomes varies from a few thousand to a few hundred thousand. Phage are obligate 
parasites that take over host cell machinery after infection to produce their own genetic 
material and proteins (495). They are found in very high numbers in the environments 
where their hosts occupy. When phage are outside a host, they can survive for long 
periods of time; but are susceptible to various chemical and physical agents such as UV 
light, sunlight, acidic pH, ascorbic acid, urea, detergents, alcohols, and heat (495). 
More than 95% of all known phage belong to the order Caudovirales or tailed 
phage. The phage of this group have one molecule of linear dsDNA and icosahedral 
heads of protein with no envelope (495-500). Heads have binary symmetry which is a 
combination of both cubic and helical symmetry. Isometric or elongated heads range 
from 45-170 nm in diameter. Elongated heads can reach up to 230 nm. The G+C content 
of their genome is similar to that of their host DNA. Genes of proteins with similar 
functions are found in clusters in the genome. This group of phage has tails which are 
composed of helical rows or stacked discs, and base plates, fibers, or spikes for 
adsorption to the host cell surface. There are three families in this group based on tail 
morphology: Siphoviridae, Myoviridae, and Podoviridae (495-500). Siphoviridae phage 
which make up to 61% of tailed phage have long and noncontractile tails of 65-570 x 7-
10 nm (495-500). Coliphage λ is the best-known phage in this family. Myoviridae form 
25% of tailed phage (495-500). Their tails are made up of a sheath and a central tube 
which form a double layer. They measure 80-455 x 16-20 nm and are contractile. T4 is 
the type species in this family. Finally, 15% are in Podoviridae family which carries 
short, noncontractile tails capable of extension during infection (495-500). Tails are 
around 20 x 8 nm. Coliphage T7 is a member of this family. 
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Phage are termed virulent or temperate depending on their life cycle. Virulent 
phage take over host cell machinery to reproduce after infection and then lyse the cell to 
release newly-formed phage particles (495, 496, 501-503). Virulent phage have various 
mechanisms to take control of host metabolism. These include degradation of the host 
genome, inhibition of host DNA replication, transcription, and translation, blocking the 
restriction system, and changing the host membrane (495, 496, 501-503). Only a limited 
number of phage genes are expressed during the lysogenic cycle. Temperate phage which 
form more than 50% of all tailed phage enter either the lytic or lysogenic cycle after 
infection depending on the physiological condition of the host cell (495, 496, 501-503). 
The presence of a poor medium, host cell starvation, low temperatures, and infection with 
more than one phage are some of the factors that induce the lysogenic cycle. The phage 
genome is inserted into the host chromosome or exists as a plasmid in the bacterial 
cytoplasm during the lysogenic cycle. Usually a specific integrase enzyme places the 
genome into a certain site at the chromosome. The phage genome is replicated together 
with the host cell chromosome. A phage in this state is called a prophage (495, 496, 501-
503). Prophage may remain in hosts for many generations. The prophage produce a 
repressor protein to suppress the expression of lytic cycle genes. However, some 
chemical and physical agents such as mitomycin C and UV light which damage host 
DNA or inhibit its replication can induce prophage to start the lytic cycle. Prophage 
usually prevent infection of their hosts by other phage in the same immunity group and 
also may provide them with virulence factors, restriction systems, and antimicrobial 
resistance (495, 496, 501-503). This process, in which prophage gene expression changes 
the host cell phenotype, is called lysogenic conversion. 
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There are five stages of the phage life cycle: adsorption, penetration, replication, 
assembly, and lysis. Phage first bind to receptors on the surface of bacteria (495, 501-
505). These can be lipopolysaccharide components or outer membrane proteins of Gram-
negative bacteria while phage of Gram-positive bacteria bind to teichoic acids, specific to 
each species, which are found inside the peptidoglycan layer. Some phage can recognize 
multiple types of receptors and others bind only to a single type. Phage use their tail 
fibers (adhesin regions) to interact with receptors (495, 501-505). Adhesin regions are 
specific to each phage species. This attachment between the adhesin and host receptor is 
responsible for host specificity of a phage. Penetration stage starts with degradation of the 
peptidoglycan layer of the host cell by a lysozyme released from the tail tip (495, 501-
505). Then the tail degrades or makes contact with the bacterial inner membrane, 
inducing release of phage DNA. The genome of the phage enters the bacterial cell after 
passing through the tail. The capsid is left outside the cell. Phage have various 
mechanisms to protect their genomes from degradation by bacterial nucleases and 
restriction enzymes (495, 501-505). Their genomes may carry an unusual nucleotide or 
lack restriction enzyme recognition sequences. Some phage inhibit host cell nucleases. 
The phage genome may circularize itself while other phage have proteins to protect the 
linear ends upon entering the host. The genome of most phage is circularized by 
recombination of redundant ends after DNA transfer. In case of the lysogenic cycle, the 
circularized genome is integrated into the host chromosome while the circular genome of 
the lytic cycle-phage replicates via theta mode. The phage genome becomes latent in the 
host until it is induced to enter the lytic cycle (495, 501-505). Large lytic phage have a 
totally different mechanism for DNA replication in which the linear genome is replicated 
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by the phage’s own DNA polymerase. Lytic cycle transcription starts with recognition of 
the strong phage promoters which induce early phage genes by bacterial RNA 
polymerase (495, 501-505). Products of these genes have roles in protection of the phage 
genome from host defense mechanisms, in decision between the lytic and lysogenic 
cycle, or in capturing host cell machinery. Then, middle genes are expressed with 
production of molecules which function in phage DNA replication. Lastly, late phage 
genes are transcribed, producing components of the capsid and tail, sigma proteins, RNA 
polymerase-related proteins, assembly factors, and lysis proteins. Phage may alter and 
use bacterial RNA polymerase and/or synthesize its own polymerase(s) for transcription 
(495, 501-505). Most phage form a linear concatemer of multiple genomes by a rolling-
circle replication mechanism. Virion assembly starts with packaging of DNA from the 
concatemer into the preformed capsid until the capsid is full or specific termination 
sequences are reached (495, 501-505). Assembly pathways for capsids, tails, and tail 
fibers are separate. The capsid filled with DNA attaches to the preformed tail, resulting in 
formation of a complete, infective virion. In the final lysis phase, holins produced by the 
phage aggregate to construct hole formations in the inner membrane which provide 
access to the peptidoglycan layer for endolysins (495, 501-505). Endolysins disrupt the 
peptidoglycan layer through which the virions are released. Lysis is a scheduled event 
which is under the control by the phage (495, 501-505). If the number of target bacteria 
in the environment is high, lysis happens earlier while it is delayed if bacterial cell 





Bacterial pathogens Salmonella and S. aureus 
Animal and human feces contain various bacterial pathogens such as 
Campylobacter, Salmonella, Shigella, Yersinia, Aeromonas, Pasteurella, Franciella, 
Leptospira, Vibrio, Escherichia, Legionella, Neisseria, Bacillus, Francisella, 
Burkholderia, Clostridium, and Brucella (39, 44, 45). Salmonella has been detected in 
high amounts in feces (46) and was isolated from 55% of treated sewage sludge samples 
in Sweden (47). Application of poorly treated human and animal wastes on land causes 
contamination of soil with these bacterial pathogens (39, 45, 48). Half of the seven 
million dry tonne sewage sludge produced annually is used for land application each year 
in USA (39, 45).  Treatment methods used in wastewater-treatment plants to produce 
sludge with reduced pathogen concentrations include composting, aerobic and anaerobic 
digestion, alkaline stabilization, conditioning, dewatering, and heat drying (39). 
Contamination of soil may also occur after utilization of human and animal wastes for 
land fertilization (39, 40). Pathogens which survive in soil for long periods of time may 
reach ground and surface water (39). Salmonella was shown to remain in soil alive for 20 
days and it is also resistant to freezing and drying (39). If contaminated water is used for 
irrigation and/or drinking, this results in a potential source of infection of animals and 
humans. Furthermore, contaminated soil could lead to transfer of these pathogens to food 
products (39, 40, 45, 49-52). Contaminated produce was the cause of 41% of outbreak 
cases from 1990 to 1998 in the USA (39, 40). There are more than 200 types of 
foodborne diseases. Seventy-six million cases and 5,000 deaths are caused by diseases 
transmitted by food each year in the USA (41). Salmonella is one of the main causative 
agents for foodborne diseases worldwide. Salmonella enterica and Campylobacter were 
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responsible for 70% of all cases between 1995 and 2001 in Finland (1, 42).  Additionally, 
salmonellosis leads to reactive arthritis and increases the fatality 3.1 times compared to 
controls (506, 507). Salmonella is also a Centers for Disease Control and Prevention 
(CDC) Category B bioterrorism threat agent.  
Pathogens can be dispersed into the air after use of wastes and wastewater for 
land application and agricultural irrigation (50-53) and may cause airborne diseases by 
being transferred to humans via winds. People who reside within 1 km of sewage sludge 
application regions were found to be highly infected by pathogens from application sites 
(53). One forth of all residents were infected with S. aureus which can be a lower human 
colon organism resistant to desiccation. This pathogen is an opportunistic pathogen which 
can infect irritated tissues (53). Staphylococcus aureus is also detected commonly in the 
air and surface samples from hospitals (54). It is thought to be an important causative 
agent for airborne nosocomial infections in hospitals (54). Besides, it has been suggested 
to cause late onset biomaterial infections as a result of exposure of these materials to 
contaminated air before an operation (54). The number of patients nosocomially infected 
by opportunistic pathogens in hospitals is more than 2 million with more than $4.5 billion 
cost each year in the USA (43). The major source of contamination in hospitals is various 
surfaces such as computer keyboards, faucet handles, and fabrics. Staphylococcus aureus, 
Enterococci, E. coli, Pseudomonas, and Enterobacter are the most common etiologic 
agents (43, 55). Staphylococcus aureus has been shown to survive on dry surfaces for 
long periods of time (56, 57). This pathogen is also known to commonly infect humans 
by contaminating recreational waters (508, 509). 
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Traditional, nucleic acid-based, and immunological bacterial pathogen detection 
methods 
Microscopy and culturing on selective media have been traditional methods to 
detect bacterial pathogens in various types of samples (see reviews 2-6). These methods 
are easy to perform and cheap. However, there are some problems with traditional 
detection methods. While the disadvantage of microscopy is that it can not be used to 
identify bacteria, there are several problems with culture methods as well (see reviews 2-
6). Some bacteria found in the environment are VBNC on general culture media. These 
include some pathogenic bacterial species such as H. pylori, Campylobacter, E. coli, V. 
cholerae, Vibrio spp., and Legionella pneumophila. Therefore, traditional culture 
methods may select for organisms which can grow fast and easily adapt to growth 
conditions. Also, bacteria isolated from the environment can be injured or stressed 
physically because of various environmental stressors such as nutrient deficiency, 
disinfectants, and UV light (see reviews 2-6). Enterobacteriaceae including Salmonella 
species, which are deficient or slow in lactose fermentation, have been shown to be 
underrepresented during traditional culturing methods. Therefore, VBNC and injured 
bacteria need to be enriched before detection using nonselective media under conditions 
without stress, which can take up to 8-24 h. Detection itself can take up to several days. 
These problems make culturing methods time-consuming and laborious, and also 
decrease the sensitivity.   
Various PCR-based methods are used for detection and identification of bacterial 
pathogens in environmental, clinical, and food samples (see reviews 1, 2-5, 7-9). Nested 
PCR, multiplex PCR, real time quantitative PCR, amplified ribosomal DNA restriction 
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analysis (ARDRA), ribosomal RNA intergenic spacer analysis (RISA), denaturing 
gradient gel electrophoresis (DGGE), amplified fragment length polymorphism (AFLP), 
enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR), 
the repetitive sequence-based polymerase chain reaction (rep-PCR), terminal restriction 
fragment length polymorphism (TRFLP), length heterogeneity PCR (LH-PCR), and 
ligase chain reaction (LCR)  are examples of PCR-based molecular detection methods. 
Some of these methods such as ARDRA, RISA, DGE, and TRFLP analyze sequences 
amplified from rRNA gene regions (see reviews 1, 2-5, 7-9). Unlike DNA-based PCR 
methods, rRNA-based PCR methods can determine viable cells because of the 
relationship between copy numbers and the metabolic activity of the cell.  
PCR-based techniques have various advantages over traditional methods such as 
rapidness and sensitivity with low detection limits (theoretically as low as one cell) (see 
reviews 1, 2-5, 7-9).  Identification range of these techniques includes VBNC, injured, 
and slow-growing bacteria as well as healthy cells. PCR-based methods do not require 
culturing of samples. However, these tests are not without limitations. Samples usually 
contain substrates which inhibit PCR, leading to false-negative results (see reviews 1, 2-
5, 7-9). This problem increases especially with concentrated samples since inhibitors are 
also concentrated during the process. DNA-specific PCR-based methods can not 
differentiate between viable and nonviable organisms. This may require an additional 
culturing step before PCR, increasing the testing time and eliminating detection of VBNC 
cells. Efficiency of these methods is limited to the specificity of the primers for the target 
organism and PCR conditions used. Also, primer target sequences need to be represented 
in the gene database (see reviews 1, 2-5, 7-9). If primers are not specific enough for the 
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target organism, cross-reactivity with other bacteria present in the sample may result. 
Contamination by exogenous DNA from test materials and reagents or carryover from a 
positive sample is another common problem. Since the sensitivity of PCR is very high, 
even very low amounts of contaminating DNA will be increased to detectable levels 
during PCR. Interpretation of results is not easy; false-positive results due to 
contamination or false-negative results which are caused by poorly-designed primers and 
assay conditions or PCR inhibition are always possible (see reviews 1, 2-5, 7-9). Some 
PCR-based assays are technically quite complex and need to be performed by well-
trained personnel, take long periods of time, and require expensive equipment. 
There are also hybridization assays which are used for bacterial pathogen 
detection. Fluorescent in situ hybridization (FISH) uses DNA probes which can hybridize 
with genus- or species-specific 16S rRNA sequences (see reviews 2-4, 7, 9). FISH has a 
high sensitivity and does not require culturing of the sample. This hybridization method 
can detect VBNC cells as well and can be used to quantify specific organisms. However, 
it may not detect injured cells, and bacterial debris and materials other than organisms 
found in the sample may nonspecifically bind probes and affect test results. Nucleic acid 
microarray is another type of hybridization assay based on DNA or RNA sequences (see 
reviews 2-4, 7, 9). It is quite specific and sensitive, being able to perform very high 
numbers of reactions at one time. Inhibition by substrates found in samples is a 
significant problem. Nucleic acid microarray detects VBNC, living, and dead cells 
without being able to distinguish between them. This technique is highly complex in 
terms of processing and data analysis, and costly, which makes it unsuitable to use as a 
routine detection method. Both types of hybridization assays can detect organisms whose 
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target sequence is already in the database, limiting the detection range of the test (see 
reviews 2-4, 7, 9). 
Immunological methods which are used commonly for pathogen detection take 
advantage of the specificity of an antibody for an antigen (see reviews 2, 6, 10-12). The 
antigen can be various types of molecules on the surface of the bacterial pathogen. Both 
monoclonal and polyclonal antibodies can be used (see reviews 2, 6, 10-12). The 
specificity of the assay can be adjusted to detect organisms at the family, genus, species, 
or serotype level. Some examples of immunological detection methods are ELISA 
(enzyme-linked immunosorbent assay), fluorescently labeled immunoassay, and enzyme 
immunoassay (see reviews 2, 6, 10-12). While immunological methods are easy to 
perform, rapid, sensitive, and suitable for automation, they do have some disadvantages. 
The detection limit is not as high as that of nucleic acid-based molecular methods 
because of the low affinity of the antibody for its antigen (see reviews 2, 6, 10-12). The 
detection limit of ELISA is between 103 and 105 colony forming units (cfu)/ml. The 
efficiency of immunological tests depends on the condition of the antigen in the 
environment. If the antigen is changed in the environment, the antibody can not bind it as 
effectively as it does under laboratory conditions (see reviews 2, 6, 10-12). There may 
also be cross-reaction problems with other organisms which may share some antigens 
with the target organism. The debris found in the environment may nonspecifically bind 
to antigens or antibodies, and thus may interfere with results (see reviews 2, 6, 10-12). In 




Various disadvantages of current techniques described previously create the need 
for alternative bacterial pathogen detection methods. Public health concerns demand 
rapid, sensitive, easy-to-perform, and cheap detection methods which can be automated 
for continuous and real-time monitoring of pathogens. 
 
Bioluminescent bioreporters 
Bioluminescent bioreporters are usually recombinant bacteria which are 
genetically engineered to emit light in the presence of a specific analyte (Figure 2-11) 
(see reviews 13-22). These bioreporters carry a construct, formed by placing reporter 
gene expression under the control of the promoter which is induced only by the target 
analyte. The construct can be in the form of a plasmid or can be integrated into the 
bacterial chromosome. The most common bioluminescence reporter genes are the lux 
genes of Photorhabdus luminescens, V. harveyi, or V. fischeri.  The reporter gene 
product, bioluminescence, is easily detected and measured by luminescence-measuring 
devices. The intensity of the response is correlated with the quantity of the analyte. The 
analyte to be detected can be an environmental pollutant, toxic chemicals in wastewaters, 
bacterial nutrients, and pathogens (Table 2-3). 
Bioluminescent bioreporters provide a very rapid, specific, and sensitive method 
of detection which is not invasive in organisms. Properties of a highly detectable 
bioluminescence signal make it ideal for construction of high-throughput, continuous and 




Figure 2-11. The bioluminescent bioreporter working mechanism (see reviews 13-22) 
(  = Induction) 
 
Table 2-3. Bioluminescent bioreporters constructed for detection of chemicals 
Chemical References 
Cadmium  510-513 
Nickel  514, 515 
Antimonite  516  
Lead  511 
Zn, Cu, and Cd, alone and in combination  517 
Metals in soils amended with sewage sludge  518  
Aluminum  519 
Arsenate  520, 521 
Arsenite  516, 520 
Arsenic  512 
Chromate  514, 521 
Copper  521, 522 
Iron  523 
Inorganic mercury  522, 524-530
Nitrate  531 
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Table 2-3. Continued 
Chemical References 
Zinc  532 
Heavy metals  533-535 
Metal salts  536  
Pentachlorophenol  510 
Dioxins  537 
Endocrine disruptors  538 
Polycyclic aromatic hydrocarbons (PAHs) naphthalene and salicylate  23-30, 33, 
539, 540 
Alkanes  541 
m-xylene 542 
4-chlorobenzoate  543 
Hydrocarbon  544 
Phenol  36, 545-547 
Phenolic compounds 548 
Organotin pollutants and their initial breakdown products (tributyltin, 
dibutyltin, triphenyltin and diphenyltin)  
549 
Biocides  550 
Bioavailable linear alkylbenzene sulfonate  551 
BTEX  31, 552 
Tetracyclines  553 
Polychlorinated biphenyls  30 
Pesticides 2,4-dichlorophenoxyacetic acid and 2,4-dichlorophenol  35 
Trichloroethane  32 
Organic solvents  536 
Hydrophobic pollutants  544 
Gas toxicants  554 
Ethanol  555, 556 
Benzene derivatives  557 
Wastewater toxicity  37, 558 
Various pollutants  536, 559-571
Oxidative stress chemicals  564, 572 
Cell membrane-damaging chemicals  571, 573 
DNA-damaging chemicals  565, 573 
Protein-damaging chemicals  560, 573 
PAH bioavailability  34 
Nitrogen bioavailability  574-576 
Phosphorus bioavailability  576, 577 
Iron bioavailability  578, 579 
Carbon bioavailability  576 




Bacteriophage-based bioluminescent bioreporters for bacterial pathogen detection 
High specificity of phage for their hosts makes them ideal candidates for specific 
bacterial pathogen detection (Table 2-4). Phage can be used to develop systems which 
identify bacteria with high sensitivity, selectivity, and rapidity. High amounts of phage 
can be produced in short times inexpensively while antibiotics are much more costly and 
slower to make. Furthermore, a phage-based system can detect living and VBNC cells 
unlike PCR- and antibiotic-based methods. However, a phage-based system can be 
practical, economical, and simple only if the phage can be screened quickly and easily. 
Also, the phage formed should be measured quantitatively to be able to determine the 
amount of the target organism. The combination of the phage-based detection with 
bioluminescence offers this system (see reviews 581-585). In such a system, the 
recombinant phage carries the bacterial lux or eukaryotic luc genes from a naturally-
luminescent organism. Since phage do not have transcriptional and translational 
machinery in the absence of a host, they can not produce light. When they infect the host 
which is the target organism to detect, lux genes are transferred into the host cell and 
expressed. In the presence of exogenous substrate, this results in generation of 
bioluminescence which can be readily measured, determining the presence and amount of 







Table 2-4. Bioluminescent bacteriophage-based bioreporters for bacterial pathogen 
detection (Det=Detection, Min=Minimum, Ref=References, NK=Not known) 






























































TM4  Fflux Culture 24 h 104-105 
cells  
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S. typhimurium P22  luxAB Soil, water, and 
sewage sludge  






























E. coli O157:H7  ФV10  V. harveyi 
luxAB 
















The bacteriophage-based bioluminescent bioreporter system developed in this work 
Previous bacteriophage-based bioluminescent bioreporters of bacterial pathogens 
(Table 2-4) have all used only the luciferase-coding genes (prokaryotic luxAB or 
eukaryotic Fflux), and thus could not function without addition of an inducer (aldehydes 
for prokaryotic and luciferin for eukaryotic systems) which is necessary for light 
generation. Therefore, these were not self-sufficient techniques which are required for 
construction of automated, high-throughput methods to monitor pathogens continuously. 
Also, such methods prevent optimization of bioreporter response since inducer 
concentration and addition time will be changed for each assay. Research of the present 
study aims to construct S. aureus- and Salmonella- monitoring systems which have the 
advantages but not the disadvantages of previous methods. The system will be composed 
of two elements: S. aureus- or Salmonella-specific recombinant phage which has the luxI 
gene from V. fischeri and a bioreporter cell line which is an E. coli strain with the V. 
fischeri luxR gene, promoter site (Plux), and luxCDABE cassette (Figure 2-12). The system 
is not capable of producing light in the absence of the phage host organism. Since the 
phage itself is metabolically inactive, luxI can not be expressed. Light will not be emitted 
without the AHL autoinducer, synthesized by the luxI gene product. When there is the 
target organism which is the host of the luxI+ phage in the environment, it will be 
infected by the phage. This will result in transfer of the phage genome carrying luxI into 
the host cell and its subsequent expression. The LuxI protein formed in the target 
pathogen will synthesize AHL which can freely diffuse across the cell membrane. AHL 





Figure 2-12. The bacteriophage-based bioluminescent bioreporter system for pathogen 
monitoring developed in this work 
 
  The bioreporter cell line was already constructed and tested for E. coli detection 
using a λ phage engineered to carry V. fischeri luxI gene in our lab (63). The system 
could detect 108 cfu/ml and as low as 1 cfu/ml in 1.5 h and 10.3 hours, respectively, in 
culture. When the system was tested with spiked lettuce leaves, 108 cfu/ml and 130 
cfu/ml were detected in 2.6 and 22.4 hours, respectively. The aim of this research is to 
construct luxI-carrying recombinant phage, one specific for S. aureus and one specific for 
Salmonella. Each of phage will be used in combination with the bioreporter cell line 
which has the other genes of the lux operon. Ultimately, these two autonomous systems 
are aimed to be used for applications that will monitor S. aureus and Salmonella 
separately in a continuous and totally automated format in real time. The recombinant 
phage and the bioreporter cell will be fixed on a BBIC which contains a photodetector 
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and a signal processor (38). The BBIC will measure light generated after exposure to the 
target pathogen in the environment. The value determined will be digitized and 
transmitted to a data receiver. The system will be portable with no requirement for power 
and optic cables, which is suitable for field detection. It will be able to be used easily by 




MATERIALS AND METHODS 
CONSTRUCTION OF S. AUREUS BIOREPORTER 
 
Bacterial strains, plasmids, and bacteriophage 
Bacterial strains, plasmids, and bacteriophage used in this study are shown in 
Tables 3-1, 3-2, and 3-3, respectively. 
 
Growth and storage conditions 
Escherichia coli, B. subtilis, and S. aureus strains were grown in LB (Luria-
Bertani broth; 10 g tryptone, 5 g yeast extract, 10 g NaCl, pH 7.5) at 37oC at 220 rpm 
overnight unless stated otherwise. Media were sterilized by autoclaving at 121°C and 15 
psi for 20 min. Agar plates were prepared by adding 15 g/L of agar into the medium 











Table 3-1. Bacterial strains used in this study. 
Species Strain Description and/or Genotype Reference and/or 
Source 
V. fischeri  NCMB 1281 Type strain ATCC 7744, 602 
E. coli  DH5α General cloning, blue/white 
screening without IPTG; F- 
φ80lacZ∆M15 ∆(lacZYA-
argF)U169 recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 
thi-1 gyrA96 relA1 
Invitrogen, Carlsbad, 
CA  
E. coli  TOP10 Chemically competent cloning 
strain, blue/white screening 
without IPTG; F- mcrA ∆ (mrr-
hsdRMS-mcrBC) 
Ф80lacZ∆M15 ∆lacX74 recA1 
araD139 ∆(ara-leu)7697 galU 
galK rpsL (StrR) endA1 nupG  
Invitrogen, Carlsbad, 
CA  
E. coli  RoLux OHHL bioluminescent 
bioreporter, phage λ sensitive; 
STBL4 (EZ::TN luxRoCDABE) 
603 
E. coli  OHHLux OHHL bioluminescent 
bioreporter, phage λ resistant; 
EZ::TN pMOD (Epicentre 
Biotechnologies, Madison, WI)-











E. coli  K12 XL10-
GOLD 
Cloning of 0602285pPCR-




B. subtilis BD170 pUB110, Kanr, Neor ATCC 37015 
S. aureus  SA113 Restriction deficient mutant 
from strain NCTC 8325 
ATCC 35556 
S. aureus  RN4220  Restriction deficient strain 
which accepts DNA from E. coli
Dr. Richard Novick, 
New York Un. 
S. aureus  CDC 85  Host of phage Ф85 ATCC27708, 605, 606
S. aureus  Twort Host of phage Twort Felix d'Herelle Center, 
Canada, 606, 607 
S. aureus  RN451 Host of phage P68 Dr. John Iandolo, Un. 
of Oklahoma , 608 
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Table 3-2. Plasmids used in this study. 
Plasmid Description Function Reference 
and/or 
Source 
pCR2.1 3929 bp, LacZα, MCS, 
pUC origin, Kanr, Ampr 
Overnight TA 





pCR2.1-TOPO 3931 bp, LacZα, MCS, 
pUC origin, Kanr, Ampr 







pCR2.1-luxI #13 4537 bp, luxI CDS with 
S. aureus RBS carrying 5′ 
BamHI and 3′ KpnI sites 
Cloning of luxI CDS 
under the control of 




4354 bp, phage Ф85 X8 
promoter with 5′ NotI and 
3′ SalI sites 
Cloning of  S. 
aureus phage Ф85 
X8 promoter  
This work 




Source of rrnB 
ribosomal terminator 
T1T2 of pKK223-3 
Lab stock 
pCR2.1-T1T2 #9 4367 bp, T1T2 with 5′ 
SacI and 3′ ClaI sites 
Cloning of  rrnB 
ribosomal terminator 





8227 bp, Gram-negative 
kanr with 5′ HindIII-NotI 
and 3′ HindIII sites (x2) 
in pYES2.1/V5-His-
TOPO yeast expression 
cloning plasmid 
(Invitrogen, Carlsbad, 
CA), pMB1 ori, Ampr , 
Kanr 
Source of Gram-
negative kanr of  
Invitrogen, 






2545 bp, MCS, 2X 
mosaic ends (MEs) for 








pMOD-2-kanr #2 3763 bp, Gram-negative 
pCR2.1 kanr with 5′ 










Table 3-2. Continued  





4356 bp, kanr-luxI CDS 
under the control of S. 
aureus RBS with 5′ 
BamHI and 3′ KpnI sites 
Cloning of luxI CDS 
under the control of 






4747 bp, kanr-S. aureus 
RBS-luxI CDS-T1T2 with 
5′ SacI and 3′ ClaI sites 
Cloning of rrnB 
ribosomal terminator 
T1T2 of pKK223-3 
into pMOD-2-kanr-
luxI #6 after luxI 






(also referred to as 
pMO-L #7 in text 
and tables)* 
5231 bp, kanr-S. aureus 
phage Ф85 X8 promoter 
with 5′ NotI and 3′ SalI 
sites-S. aureus RBS-luxI 
CDS-T1T2 between MEs 
in EZ::TN pMOD-
2<MCS> 
Cloning of kanr-S. 











left arm promoter PL-V. 






pMK4 5575 bp, MCS, lacZ, 












(also referred to as 
pMK-L #13.3 in 
text and tables)* 
6674 bp, pMK4-S. aureus 
phage Ф85 X8 promoter-
S. aureus RBS-luxI CDS, 
pUC9 ori, pC194 ori, 
Ampr, Camr 
Testing OHHL 
production from luxI 
CDS under the 
control of S. aureus 
RBS and phage Ф85 
X8 promoter 
This work 
pCR2.1-luxI #30  4539 bp, S. aureus RBS-
luxI CDS with 5′ SalI and 
3′ BamHI sites 
Addition of 5′ SalI 
and 3′ BamHI sites 
to S. aureus RBS-
luxI CDS for 




Table 3-2. Continued  
Plasmid Description Function Reference 
and/or 
Source 
pHPS9 5700 bp, MCS, cat-
86::lacZα, L. lactis 
promoter P59, Gram 
positive ori rep60 from 
pTA1060, Gram-negative 









(also referred to as 
pHP-L #7 in text 
and tables)* 
5684 bp, S. aureus RBS-
luxI CDS under the 
control of L. lactis 
promoter P59, Gram 
positive ori rep60 from 
pTA1060, Gram-negative 
ori from pUC , Emr, Camr
Testing OHHL 
production from luxI 
CDS under the 
control of S. aureus 
RBS and L. lactis 
promoter P59 
This work 
pCR2.1-kanR #10 4719 bp, S. aureus RBS-
kanr CDS from pDG148-
Stu with 5′ SalI and 3′ 
BamHI sites 
Cloning of kanr 
CDS from pDG148-
Stu under the control 
of S. aureus RBS 
used for luxI 




(also referred to as 
pHP-K #4 in text 
and tables)* 
5862 bp, S. aureus RBS-
pDG148-Stu kanr CDS 
under the control of L. 
lactis promoter P59, 
Gram positive ori rep60 
from pTA1060, Gram-




P59 efficiency by 
placing S. aureus 
RBS-kanr CDS from 
pDG148-Stu under 
its control into 
pHPS9 
This work 
pCR2.1-luxI #3 4525 bp, luxI CDS with 
5′ and 3′ StuI sites 
Addition of 5′ and 3′ 
StuI sites to luxI 
CDS for insertion 
into pDG148-Stu 
This work 
pDG148-Stu 8272 bp, Pspac (hybrid 
promoter of B. subtilis 
phage SPO-1/lac operator 
regulated by the IPTG-
inducible LacI repressor), 
a Gram-positive RBS, 
lacI, E. coli Ampr, E. coli 
or B. subtilis Kanr, E. coli 











Table 3-2. Continued  






(also referred to as 
pDG-L #28 in text 
and tables)*  
8854 bp, Pspac-the 
Gram-positive RBS-luxI-
lacI, Ampr, Kanr, Bler 
Testing OHHL 
production from luxI 
under the control of 
Gram-positive 
inducible promoter 
Pspac and RBS of 
pDG148-Stu 
This work 
pHPS9-sht #7 5000 bp, MCS, lacZα, L. 
lactis promoter P59, 
Gram positive ori rep60 
from pTA1060, Gram-
negative ori from pUC , 
Emr, Camr 
Shortening pHPS9 





(also referred to as 
pHP-PL #9 in text 
and tables)* 








carries luxI under 
the control of Pspac 
and RBS of 
pDG148-Stu for 
transfer into S. 
aureus instead of 
longer pDG148-Stu-





4704 bp, kanr CDS from 
pDG148-Stu with 5′ and 
3′ StuI sites 
Addition of 5′ and 3′ 
StuI sites to S. 





9017 bp, Pspac-the 
Gram-positive RBS-S. 
aureus kanr CDS from 
pDG148-Stu-lacI, Ampr, 
Kanr, Bler 
Cloning of S. aureus 
kanr CDS from 
pDG148-Stu into 
pDG148-Stu under 











Table 3-2. Continued  






(also referred to as 
pHP-PK #31 in text 
and tables)*  
7419 bp, pHPS9-sht #7 
carrying Pspac-Gram 
positive RBS-S. aureus 
kanr CDS from pDG148-




luxI-lacI #9 (or 
pHP-PL #9) RBS 
efficiency by 
replacing luxI with 
S. aureus kanr CDS 
This work 
pUB110 4548 bp, Kanr, Neor S. aureus natural 
plasmid used as a 






3462 bp, optimized luxI 
CDS with 5′ and 3′ StuI 
sites, f1 (+) ori, Col E1 
ori, Ampr  
Cloning of luxI CDS 
whose codon usage 
was adapted to the 
codon bias of S. 









8857 bp, Pspac-the 
Gram-positive RBS-
optimized luxI-lacI, 
Ampr, Kanr, Bler 
Cloning of 
optimized luxI CDS 
under the control of 
the Gram-positive 





(also referred to as 
pHP-POL #5 in 
text and tables)* 
7259 bp, pHPS9-sht #7 
carrying Pspac-Gram 
positive RBS-optimized 
luxI-lacI fragment from 
pDG148-Stu-optluxI #16 
Testing OHHL 
production from luxI 
whose codon usage 
was optimized for S. 
aureus phage P68 
This work 







Table 3-3. Bacteriophage used in this study. 
Phage Host Description Reference and/or 
Source 
Ф85 S. aureus CDC 
85 (ATCC 
27708) 
Temperate, serogroup B, 




Twort S. aureus Twort Myoviridae, 90 nm diameter, 203 
nm tail, virulent, single linear ds 
DNA genome (130,706 bp) 
Felix d'Herelle 
Center, Canada, 606, 
607 
P68 S. aureus RN451 Podoviridae,75 nm diameter, 
short/non-contractile tail (40 nm), 
virulent, single linear ds DNA 
genome (18,227 bp) 
Felix d'Herelle 
Center, Canada, 608, 
GenBank AF513033 
 
Molecular biology techniques 
 All molecular biology techniques were performed using protocols from Molecular 
Cloning: A Laboratory Manual (612) unless stated otherwise. All procedures which were 
carried out with kits followed manufacturer’s instructions. All restriction enzymes were 
provided by Promega (Madison, WI). Electrophoresis was done using TBE buffer which 
contained 0.045 M Tris-Borate and 0.001 M EDTA, pH 8.0. All PCR reactions were 
performed using PCR Ready-To-Go beads (Amersham Biosciences, Buckinghamshire, 
England) following manufacturer’s instructions on a PTC-225 DNA Engine Tetrad 
Peltier Thermal Cycler (MJ Research, Inc., Waltham, MA). All primers were obtained 
from Sigma Genosys (The Woodlands, TX) or Operon Biotechnologies, Inc. (Huntsville, 
AL). A list of primers is given in Table 3-4. Primers, arrived lyophilized, were suspended 
in sterile dH2O to make a stock solution with 1 nmol/µl concentration. The stock solution 
was diluted to a working solution of 5 pmol/µl concentration using sterile dH2O. All PCR 
and sequencing reactions were carried out using working solutions. DNA quantifications 




Table 3-4. List of primers used in this study. 
















GTCGACCTGAATTCGGTAACGATG This work 
T1T2SacI 
forward 
GAGCTCAAGAGTTTGTAGAAACGC This work 
T1T2ClaI 
reverse  
















GGATCCTCAAAATGGTATGCGTTTTG This work 
luxIStuI 
forward 
AGGCCTATGACTATAATGATAAAAA This work 
luxIStuI 
reverse 
AGGCCTTTAATTTAAGACTGCTT This work 
LuxI-qRT 
forward 
GCAATTCCATCGGAGGAGTA Dr. Michael Allen, 




AAACGCCAGCATCCACTTAC Dr. Michael Allen, 


















Sequencing reactions were done by the Molecular Biology Resource Facility at 
The University of Tennessee, Knoxville with an ABI Prism 3100 Genetic Analyzer and a 
3730 DNA Analyzer (Applied Biosystems, Foster City, CA). M13 reverse and forward 
primers (Invitrogen, Carlsbad, CA) were used for sequencing reactions of genes which 
were cloned into pCR2.1-TOPO or pCR2.1 (Invitrogen, Carlsbad, CA). Sequencing for 
genes cloned into other plasmids was done using primers which were used for cloning. 
 
Preparation of chemically competent cells of E. coli DH5α 
 One ml of overnight culture of E. coli DH5α was inoculated into 100 ml of fresh 
LB and was grown at 37oC at 220 rpm until reaching an OD600 of ~0.4. It was put into ice 
for at least 15 min. The ice-cold culture was centrifuged at 10,000 x g for 5 min at 4oC. 
The pellet was resuspended gently in 50 ml ice-cold wash buffer (5 mM Tris-HCL pH 
7.6, 10 mM MgCl2, 50 mM NaCl), centrifuged, and resuspended as before. After another 
centrifugation, the pellet was dissolved in 25 ml ice-cold calcium buffer (10 mM Tris-
HCL pH 7.6, 10 mM MgCl2, 100 mM CaCl2) and stored on ice for 30 min. Cells were 
centrifuged as before and then resuspended in 4 ml ice-cold storage buffer (43 ml calcium 
buffer, 7 ml glycerol). Finally, cells were stored at -80oC in 100 µl aliquots up to 3 
months. 
 
Chemical transformation of E. coli DH5α 
 The chemically competent cell aliquot (100 µl) was thawed on ice. One µl of 
plasmid or 5 µl ligation reaction was added into the cell suspension, mixed by tapping on 
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the bottom of the tube, and then stored on ice for 30 min. After incubation, the 
suspension was heat shocked for 30 sec at 37oC followed by storage on ice for 5 min. LB 
(150 µl) was added into the tube. Then it was shaken at 37oC for 1 h. Dilutions of the cell 
suspension were plated onto selective LB plates which were incubated at 37oC overnight. 
 
Electroporation of S. aureus 
 The method of Schenk and Laddaga (613) was used for preparation of electrically 
competent cells and electroporation of S. aureus. Briefly, the cultures at mid-log phase 
were washed with dH20 once and with 10% glycerol twice at room temperature. After 
incubation at room temperature for 15 min, they were resuspended in 10% glycerol. 
Then, cells were centrifuged, resuspended in 10% glycerol, and stored at -80oC in 60 µl 
aliquots. Electroporation was performed by mixing 60 µl electrocompetent cells with 1 µl 
DNA in a 1-mm gap electroporation cuvette. Cells and DNA were electroporated at 20oC, 
100 ohms resistance, 25 µF capacitance (optimum time constant of 2.5 ms), and 2.3 kV.  
 
Electroporation of B. subtilis 
 The B. subtilis electroporation protocol 0010a (BTX ID #1361) which was 
prepared using the method of Stephenson and Jarrett (614) as suggested by the Electro 
Cell Manipulator ECM 600 Manual (BTX Applications, Holliston, MA) was followed for 
preparation of electrically competent cells and electroporation of B. subtilis strains. 
Briefly, the mid-log phase cultures were washed with sterile ice-cold dH20 three times 
and resuspended in 30% glycerol, and stored at -80oC in 100 µl aliquots. Electroporation 
was performed by mixing 100 µl electrocompetent cells with 1 µl DNA in a 2-mm gap 
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electroporation cuvette. Cells and DNA were electroporated at 4oC, 150 ohms resistance, 
25 µF capacitance (optimum time constant of 6.5-8 ms), and 2.5 kV. 
 
Plasmid purification using rapid boiling mini-prep method 
 One ml of an overnight culture was centrifuged at 10,000 x g for 5 min at room 
temperature in a microcentrifuge. The pellet was resuspended in 40 µl of STET buffer 
(50 mM EDTA, 50 mM Tris pH 8.0, 5% Triton, 8% sucrose). Four µl of freshly prepared 
lysozyme solution (10 mg/ml in 20% sucrose, 50 mM Tris pH 8.0) were added to the 
suspension. The tube was placed in a boiling water bath for 1 min, and centrifuged at 
14,000 x g for 10 min at room temperature. The pellet was removed with a sterile 
toothpick and then 150 µl of 0.3 M KAc, pH 8.0 and 500 µl ice-cold ethanol were added 
to the supernatant. After mixing by inversion, the solution was stored on ice for 10 min, 
centrifuged at 14,000 x g for 15 min at 4°C, and the supernatant was discarded. The DNA 
pellet was washed with 500 µl of 70% ethanol. The pellet was dried at room temperature, 
resuspended in enzyme digestion buffer, and used for digestion. 
 
Purification of V. fischeri genome 
A colony of V. fischeri strain ATCC 7774 was placed into 100 µl of sterile dH20 
in a sterile 1.5 ml Eppendorf tube, boiled for 10 min, and then centrifuged at 14,000 x g 
for 5 min in a tabletop centrifuge at 4oC. The supernatant containing genomic DNA was 





luxI cloning from V. fischeri genome 
luxI gene was amplified from purified V. fischeri genome using luxIBamHI 
forward and luxIKpnI reverse primers. The RBS of V. fischeri luxI gene was changed into 
a typical S. aureus RBS (615) during amplification by including the S. aureus RBS in the 
luxIBamHI forward primer. The RBS change is shown below: 
               AGGGAGGTTGGT           changed to            GAGGAGGAGTTGGT 
 
          V. fischeri RBS  Spacer between                         S. aureus RBS  S. aureus spacer  
                                     the RBS and the                                                 of 7 bps between 
                                     coding sequence                                                 the RBS and the  
                                                                                                                coding sequence 
 
The PCR conditions were 94oC for 5 min followed by 39 cycles of 94oC for 30 sec, 56oC 
for 30 sec, and 72oC for 1 min, and then 72oC for 10 min extension time. Fifteen µl of the 
PCR reaction were run on a 1% agarose gel with ethidium bromide (EtBr) in 0.5xTBE 
(Tris-Borate EDTA) to verify PCR product size. After confirmation, the PCR product 
was cloned into a TA cloning vector pCR2.1 (Invitrogen, Carlsbad, CA) according to 
manufacturer’s instructions. Plasmids were purified from overnight cultures of selected 
transformant colonies using the rapid boiling mini-prep method (see above). They were 
screened for the presence of PCR product by EcoRI (Promega, Madison, WI) restriction 
analysis. Plasmids of selected transformants, which are positive for the insert, were 
purified with Wizard Plus Midi-Preps DNA Purification Systems (Promega, Madison, 
WI) according to manufacturer’s instructions and sequenced. After sequence 





X8 promoter cloning from S. aureus phage Ф85 genome 
The genome of S. aureus phage Ф85 was isolated using Wizard Lambda Phage 
DNA Purification System (Promega, Madison, WI) following manufacturer’s instructions 
and used as a template for amplifying the X8 promoter sequence (605). The PCR was 
performed with prom85NotI forward and prom85SalI reverse primers under the 
following conditions: 94oC for 5 min, then 35 cycles of 94oC for 30 sec, 52oC for 30 sec, 
and 72oC for 30 sec, followed by 72oC for 15 min. To verify the PCR product size, 15 µl 
of the reaction were electrophoresed on a 1% agarose gel with EtBr in 0.5xTBE. Then, 
the product was integrated into the TA cloning vector pCR2.1 (Invitrogen, Carlsbad, 
CA). Transformant colonies were screened with EcoRI restriction analysis as described 
previously. Transformants pCR2.1-phage85prom #2 and #8 were sequenced. Sequencing 
results of both constructs were the same. There were some differences between promoter 
sequences obtained and the sequence described by Carbonelli et al. (605) (Table 3-5). 
Since differences were outside the putative promoter area determined by Carbonelli et al. 
(605), studies were continued with plasmid pCR2.1-phage85prom #8. Table 3-5 shows 
these differences and the putative promoter region with the motifs determined by 








Table 3-5. The pairing of the phage Ф85 X8 promoter sequence used (top) and the X8 
sequence described by Carbonelli et al. (605) (bottom). Differences between sequences 




























                                                                  -54                      -44 
ATTTGTGTCATCCTCCATAAAAATTTTATTGTTTAAT 
ATTTGTGTCATCCTCCATAAAAATTTTATTGTTTAAT 









T1T2 transcription termination site cloning 
The rrnB ribosomal terminator T1T2 of pKK223-3 plasmid (Pharmacia, Uppsala, 
Sweden) which was cloned into a pMOD-1 vector (Epicentre Biotechnologies, Madison, 
WI) previously in our lab was amplified using T1T2SacI forward and T1T2ClaI reverse 
primers. The PCR protocol was as follows: 94oC for 5 min followed by 35 cycles of 94oC 
for 30 sec, 43oC for 30 sec, and 72oC for 1 min, and then a final step of 72oC for 15 min. 
Size confirmation and cloning of PCR product and restriction analysis of constructs 
(except for ClaI/SacI digestion instead of EcoRI digestion) were performed as described 
previously. The transformant pCR2.1-T1T2 #9 was chosen after sequence confirmation. 
 
Construction of pMOD-2-kanr-prom-luxI-T1T2 #7 (or pMO-L #7) plasmid 
pMOD-2-kanr-prom-luxI-T1T2 #7 (or pMO-L #7) plasmid was constructed to 
clone kanr-S. aureus phage Ф85 X8 promoter-S. aureus RBS-luxI CDS-T1T2 fragment 
into S. aureus phage Twort genome using transposition since phage genome was not 
sequenced at that point. The fragment to be transposed was placed in between two ME 
sites which are recognized by the EZ::TN transposase (Invitrogen, Carlsbad, CA). 
kanr gene was cloned into EZ::TN pMOD-2<MCS> plasmid (Epicentre 
Biotechnologies, Madison, WI). The source of the gene was pYES2.1/V5-His-TOPO 
plasmid (Invitrogen, Carlsbad, CA) carrying two copies of kanr from TA cloning vector 
pCR2.1 (Invitrogen, Carlsbad, CA). This plasmid was constructed in our lab previously 
(lab stock). The pYES2.1/V5-His-TOPO-kanr and pMOD-2 plasmids were digested with 
HindIII (Promega, Madison, WI) at 37oC for 105 min according to manufacturer 
instructions. The pMOD-2 digest was purified using QIAquick Gel Extraction Kit 
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(Qiagen Inc., Valencia, CA) following the manufacturer protocol. Then, it was 
dephosphorylated with calf intestine alkaline phosphatase (CIAP; Promega, Madison, 
WI) at 37oC according to manufacturer’s procedure. Digested and dephosphorylated 
pMOD-2 and digested pYES2.1/V5-His-TOPO-kanr plasmids were run on a 1% agarose 
gel with EtBr in 0.5XTBE for 90 min. DNA bands of pMOD-2 and kanr were screened 
under UV light, excised from the gel, and purified with QIAquick Gel Extraction Kit 
(Qiagen Inc., Valencia, CA). Concentrations of pMOD-2 plasmid and kanr insert purified 
from the gel were measured as 33 ng/µl and 2 ng/µl, respectively. The ligation reaction 
set after this contained 5.1 ng pMOD-2 vector, 24 ng kanr insert, 1x ligase buffer, and 1 
unit T4 DNA ligase (Promega, Madison, WI). The reaction was incubated at 16oC 
overnight. Five µl of the ligation reaction were chemically transformed into E. coli 
DH5α. Plasmids from overnight cultures of selected transformant colonies were purified 
using rapid boiling mini-prep method (see above) and screened with HindIII digestion 
(Promega, Madison, WI) for the presence of the kanr insert. Plasmids from selected 
transformants with the insert were purified using Wizard Plus Midi-Preps DNA 
Purification Systems (Promega, Madison, WI) according to manufacturer’s instructions 
and sequenced. The transformant carrying the correct kanr sequence in the correct 
orientation was selected and named pMOD-2-kanr #2. 
 To integrate luxI into pMOD-2-kanr #2 vector, pCR2.1-luxI #13 and pMOD-2-
kanr #2 were digested with KpnI and BamHI in the presence of 1X multicore buffer 
(Promega, Madison, WI) following manufacturer instructions. After digestion, pMOD-2-
kanr #2 was purified from the solution by QIAquick Gel Extraction Kit (Qiagen Inc., 
Valencia, CA) and dephosphorylated with CIAP. Then pMOD-2-kanr #2 and KpnI and 
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BamHI-digested pCR2.1-luxI #13 were run on a gel and screened as described 
previously. The pMOD-2-kanr #2 and luxI bands were purified using QIAquick Gel 
Extraction Kit (Qiagen Inc., Valencia, CA). For ligation of luxI into the pMOD-2-kanr #2 
vector, 100 ng vector and 167.34 ng insert were mixed in the presence of 1X buffer and 
one unit T4 DNA ligase (Promega, Madison, WI). After overnight incubation at 16oC, E. 
coli DH5α cells were transformed with the reaction. Transformants obtained were 
screened as described previously using KpnI and BamHI. Transformant pMOD-2-kanr-
luxI #6 was chosen for further experiments after sequencing. 
 The rRNB ribosomal terminator T1T2 cut out of pCR2.1-T1T2 #9 was integrated 
into pMOD-2-kanr-luxI #6 in the same way as described previously. ClaI and SacI were 
used in the presence of buffer E (Promega, Madison, WI) for digestion of plasmids and 
for restriction analysis. Final DNA concentrations for ligation reaction were 293 ng 
pMOD-2-kanr-luxI #6 and 28 ng T1T2. The selected construct was named pMOD-2-kanr-
luxI-T1T2 #2. 
 The X8 promoter sequence (605) of phage Ф85 was cloned from pCR2.1-
phage85prom #8 into pMOD-2-kanr-luxI-T1T2 #2 using the same methods described 
previously. SalI and NotI (Promega, Madison, WI) were used for digestion of plasmids 
which were ligated while restriction analysis was performed with SalI and PstI (Promega, 
Madison, WI). Concentrations of pMOD-2-kanr-luxI-T1T2 #2 vector and X8 promoter 
insert were 196 ng and 176.37 ng, respectively, in the ligation reaction. The construct 
pMOD-2-kanr-prom-luxI-T1T2 #7 (or pMO-L #7; see Table A in the appendix for a 
















Bioluminescent and fluorescent detection of OHHL from pMO-L #7 in E. coli  
 Bacterial cultures were prepared by growing strains overnight in LB with 
antibiotics at 37oC and 220 rpm. Strains were OHHL bioreporters, RoLux and E. coli 
MT102 with pJBA132; positive and negative controls, E. coli strains carrying pCR2.1-
TOPO PL-luxI and pMOD-2-kanr #2, respectively; and E. coli harboring pMO-L #7. 
Overnight cultures of controls and pMO-L #7-carrying E. coli were diluted 100 times in 
fresh LB without antibiotics and grown at 37oC and 220 rpm until they reached mid-
exponential growth (OD600=0.5-0.7). Supernatants were collected and used for the 
experiment after cultures were centrifuged at 10,000 x g for 20 min. Pellets of bioreporter 
overnight cultures were resuspended in the same volume of fresh LB after centrifugation 
at 10,000 x g for 20 min. Resuspended cells were diluted to OD600=0.1 with fresh LB 
containing antibiotics to use for the experimental setup. One hundred µl of the 
supernatant from the strain to be tested for OHHL production was combined with 100 µl 
of the bioreporter in a well of a Costar 96-well black microtiter plate with a clear bottom 
(Corning Inc. Life Sciences, Lowell, MA) in triplicate. Bioluminescence, fluorescence, 
and absorbance were measured at 28oC overnight with a Wallac Victor2 1420 Multilabel 
Counter (PerkinElmer Life and Analytical Sciences, Waltham, MA). A diagram of the 
methodology is shown in Figure 3-2. The protocol consisted of a cycle of shaking for 10 
sec, absorbance measurement at 450 nm, shaking for 10 sec, bioluminescence 
measurement (CPS), shaking for 10 sec, fluorescence measurement (GFP), and 
incubation for 20 min. Bioluminescence and fluorescence values were normalized by 
dividing CPS and GFP values by OD450 values of bioreporters. Then, the average of 





Figure 3-2. Methodology for bioluminescent and fluorescent OHHL measurement from 
bacterial strains that carry luxI. 
 
Construction of pMK4-prom-luxI #13.3 (or pMK-L #13.3) 
 pMK4 is a Gram-positive and -negative shuttle vector. luxI CDS was cloned into 
pMK4 under the control of S. aureus RBS and phage Ф85 X8 promoter to test OHHL 
production from luxI inside S. aureus.  
To clone the phage Ф85 X8 promoter sequence (605) and the luxI gene from 
pMO-L #7 into pMK4, both plasmids were digested with HaeII (Promega, Madison, WI) 
at 37oC according to manufacturer’s instructions. pMK4 digest (5.6 µg) was purified with 
QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA) and then dephosphorylated 
with CIAP (Promega, Madison, WI). This was followed by another purification step with 
QIAquick Gel Extraction Kit this time from the dephosphorylation solution. The 
remaining portion of pMK4 digest (620 ng) and 3 µg pMO-L #7 digest were run on a 
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0.4% agarose gel with EtBr in 0.5xTBE. The gel was screened using UV illumination to 
detect whether pMK4 digestion was successful and to determine the pMO-L #7 digestion 
products based on size. The DNA band which contained the promoter and luxI genes 
from pMO-L #7 were excised from the gel and purified using the QIAquick Gel 
Extraction Kit (Qiagen Inc., Valencia, CA). The promoter and luxI genes were integrated 
into dephosphorylated and purified pMK4 plasmid in a ligation reaction with 742 ng 
insert and 277 ng vector in the presence of one unit T4 DNA Ligase (Promega, Madison, 
WI). The reaction was incubated at 16oC overnight and then transformed into chemically 
competent E. coli DH5α. Plasmids obtained from transformants were screened with 
HaeII/XbaI, SmaI, PstI, HaeII, HindIII, SacI/XbaI, NotI/SacI, PvuII/SacI, and XbaI/NotI 
(Promega, Madison, WI) digestions and sequenced in the same manner described 
previously. Two copies of the promoter and luxI genes were integrated into pMK4. To 
eliminate one of the copies, the selected construct was digested with SacI (Promega, 
Madison, WI) and the digest was run on the gel as described previously. The DNA band 
which included pMK4 with one copy of the promoter and luxI was purified from the gel 
and ligated onto itself in the presence of T4 DNA Ligase (Promega, Madison, WI). After 
transformation, screening with KpnI (Promega, Madison, WI) digestion, and sequencing 
(following protocols described previously), the construct which carried one copy of the 
promoter and luxI in pMK4 was selected and named pMK4-prom-luxI #13.3 (or pMK-L 
#13.3; see Table A in the appendix for a complete list of alternative names used for 
plasmids). A construction scheme and a diagram of the plasmid are shown in Figures 3-3 





Figure 3-3. Construction of pMK4-prom-luxI #13.3 (or pMK-L #13.3). lacZ of pMK4 
was exchanged with two copies of the fragment that contained partial kanr, X8 promoter, 
luxI, and partial T1T2 from pMO-L #7 (steps 1 and 2). One of the copies was removed in 













Transfer of pMK-L #13.3 into B. subtilis and S. aureus 
 pMK-L #13.3 was electroporated into electrically competent B. subtilis cells. 
Plasmids were purified from overnight cultures of resulting transformants in LB with the 
antibiotic using Wizard Plus Midi-Preps DNA Purification Systems (Promega, Madison, 
WI). Plasmids were screened for the presence of pMK-L #13.3 by XbaI (Promega, 
Madison, WI) restriction analysis at 37oC. Digests were run on a 0.3% agarose gel with 
EtBr in 0.5xTBE. The B. subtilis transformants which carry pMK-L #13.3 were detected 
based on digest size after screening the gel with UV illumination. 
The plasmid of the selected B. subtilis transformant was used to electoroporate 
electrically competent cells of S. aureus SA113 strain. Plasmids were purified from 
transformants using MasterPure Gram Positive DNA Purification Kit (Epicentre 
Biotechnologies, Madison, WI) and digested with XbaI (Promega, Madison, WI) at 37oC. 
They were run on a 0.4% agarose gel with EtBr in 0.5xTBE. The S. aureus SA113 cell 
containing pMK-L #13.3 was determined by screening the gel with UV light and tested 
for OHHL production. 
 
Bioluminescent detection of OHHL from pMK-L #13.3 in S. aureus using Wallac 
1450 Microbeta Plus Liquid Scintillation Counter 
Bioluminescent bioreporter RoLux, negative control (E. coli carrying pMO-L #7), 
positive control (E. coli with pCR2.1-TOPO PL-luxI), and S. aureus harboring pMK-L 
#13.3 were grown overnight in LB with antibiotics at 37oC and 220 rpm. Overnight 
cultures except for the bioreporter culture were inoculated into fresh LB without 
antibiotics (100 µl culture into 10 ml LB), and grown at 37oC with 220 rpm until their 
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OD600 reached 0.5-0.7. Then, cells were centrifuged at 10,000 x g for 20 min and 
supernatants were collected. The bioreporter overnight culture cells, after being washed 
with LB twice, were resuspended in LB with the antibiotic, diluted to OD600=0.1 with 
antibiotic-containing LB, and used for the assay. A Costar 24-well black microtiter plate 
with a black bottom (Corning Inc. Life Sciences, Lowell, MA) was used to combine 100 
µl supernatant of the strain to be tested for OHHL production, 100 µl of the bioreporter 
resuspension, and 100 µl LB with the antibiotic in each well. Each sample was prepared 
in triplicate. Bioluminescence values were measured with a Wallac 1450 Microbeta Plus 
Liquid Scintillation Counter (PerkinElmer Life and Analytical Sciences, Waltham, MA). 
The methodology is shown in Figure 3-2. The protocol was repetition of bioluminescence 
measurement (CPS) followed by incubation for 20 min which carried on overnight at 
28oC. Average CPS measurement in triplicate was calculated for each sample. 
Bioluminescence versus time charts were constructed using these average values. 
 
Fluorescent detection of OHHL from pMK-L #13.3 in S. aureus using Wallac 
Victor2 1420 Multilabel Counter 
 Experimental conditions and strains used were the same as described previously 
with several exceptions. The fluorescent bioreporter E. coli MT102 with pJBA132 which 
was diluted to OD600 = 0.1 with LB was used instead of RoLux. The supernatant (100 µl) 
of the strain to be tested for OHHL production and 100 µl of the bioreporter resuspension 
were mixed in each well of the 96-well black microtiter plate with a clear bottom. The 
negative control was the fluorescent bioreporter, 100 µl of which was combined with 100 
µl dH20 in the microtiter well. Wallac Victor2 1420 Multilabel Counter recorded the 
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fluorescence and absorbance measurements where a cycle of shaking for 10 sec, 
absorbance measurement at 450 nm, shaking for 20 sec, fluorescence measurement 
(GFP), and incubation for 20 min was repeated overnight at 28oC. Fluorescence 
measurements were normalized by dividing GFP by OD450 values. The average of 
normalized fluorescence values in triplicate were calculated and used for construction of 
charts. 
 
Construction of the pHPS9-luxI #7 (or pHP-L #7) plasmid 
luxI CDS was placed into pHPS9 under the control of S. aureus RBS and L. lactis 
promoter P59 to control luxI OHHL production in S. aureus. To integrate luxI into Gram-
positive and -negative shuttle expression vector pHPS9, SalI and BamHI sites were added 
to the 5′ and 3′ ends of luxI, respectively. For this, luxI was amplified from the V. fischeri 
genome using luxISalI forward and luxIBamHI reverse primers. This process also added 
the luxI RBS region used for construction of pMO-L #7 to the sequence. Conditions for 
PCR included a step of 94oC for 5 min followed by 35 cycles of 94oC for 30 sec, 48oC for 
30 sec, and 72oC for 40 sec, and a final step of 72oC for 15 min. Cloning of the PCR 
product into the TOPO TA cloning vector pCR2.1 (Invitrogen, Carlsbad, CA) and 
screening of transformants (with EcoRI digestion) were performed as described 
previously. The construct pCR2.1-luxI #30 was selected. 
pCR2.1-luxI #30 and pHPS9 were digested with SalI/BamHI (Promega, Madison, 
WI) in a reaction with 1x buffer D at 37oC. Digests were run on a 0.5% agarose gel with 
EtBr in 0.5xTBE. After screening gel with UV light, DNA bands to be purified were 
determined based on size. To clone luxI under the control of the P59 promoter in place of 
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cat-86 in pHPS9, the larger size pHPS9 fragment was purified leaving the smaller band 
in the gel after digestion with SalI/BamHI, which removed the cat-86 gene. Also, the luxI 
fragment cut out of pCR2.1-luxI #30 was purified from the gel using QIAquick Gel 
Extraction Kit (Qiagen Inc., Valencia, CA). DNA Ligation Kit Ver.2.1 (Takara Bio Inc., 
Shiga, Japan) was used to ligate 528 ng of purified luxI fragment to 502 ng of the purified 
pHPS9 fragment following manufacturer instructions. The reaction was incubated 
overnight at 16oC. Then 9 µl of the reaction were mixed with one µl Solution III of DNA 
Ligation Kit Ver.2.1 (Takara Bio Inc., Shiga, Japan) to increase transformation 
efficiency. The mixture was chemically transformed into E. coli DH5α. Transformants 
were screened as described previously with SalI/BamHI digestion followed by 
sequencing. The construct chosen was named pHPS9-luxI #7 (or pHP-L #7; see Table A 
in the appendix for a complete list of alternative names used for plasmids) (Figure 3-5). 
 
Transfer of pHP-L #7 into S. aureus 
pHP-L #7 was electroporated into electrically competent S. aureus RN4220 cells. 
Plasmids from overnight transformant cultures were purified using the Plasmid Midi Kit 
(Qiagen Inc., Valencia, CA) following the protocol suggested by the manufacturer for 
Staphylococcus spp. plasmid purification. They were screened for the presence of luxI 
insert by SalI/BamHI digestion at 37oC followed by electrophoresis with a 0.5% agarose 
gel with EtBr in 0.5xTBE. The S. aureus RN4220 transformant which carried pHP-L #7 
was selected after screening the gel for the insert with UV illumination. The selected 
plasmid was sequenced to confirm results. Staphylococcus aureus RNN4220 strain 





Figure 3-5. Construction of pHPS9-luxI #7 (or pHP-L #7). cat-86 of pHPS9 was 












Fluorescent detection of OHHL from pHP-L #7 in E. coli and S. aureus using 
Wallac Victor2 1420 Multilabel Counter 
Two different negative controls were used for these assays, a bioreporter alone 
mixed with dH2O which replaced the sample supernatant for E. coli with pCR2.1-TOPO 
PL-luxI (positive control), and E. coli carrying pHP-L #7. The bioluminescent detection 
bioreporter was RoLux and the fluorescent detection bioreporter was E. coli MT102 with 
pJBA132. For S. aureus with pHP-L #7, the wild type S. aureus RN4220 strain was used 
as the negative control. Strains were grown overnight in LB with antibiotics at 37oC. 
Overnight cultures, except for bioreporter strain cultures, were reinoculated into fresh LB 
without antibiotics (100 µl culture into 10 ml LB), and grown at 37oC until they reached 
mid-log phase (OD600= 0.5-0.6 for E. coli and 0.6-1.5 for S. aureus). Supernatants 
collected after centrifugation at 10,000 x g for 15 min were passed through 0.22 µm 
filters and used for assays. Overnight cultures of bioreporters, washed with LB, were 
diluted to OD600 = 0.1 with LB containing antibiotics. Each assay was carried out in a 
Costar 96-well black microtiter plate with a clear bottom (Corning Inc. Life Sciences, 
Lowell, MA). For samples which were tested for OHHL production, the positive control, 
and the S. aureus negative control, 100 µl of supernatant of each strain were mixed with 
100 µl bioreporter dilution in a well while 100 µl dH2O combined with 100 µl bioreporter 
solution was used as the negative control for E. coli strains (Figure 3-2). Each was 
prepared in triplicate. Fluorescence and absorbance from samples were monitored by a 
Wallac Victor2 1420 Multilabel Counter. The protocol consisted of shaking for 10 sec, 
absorbance measurement at 450 nm, shaking for 20 sec, fluorescence measurement 
(GFP), and incubation for 20 min. This cycle was repeated overnight at 28oC. 
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Measurements were normalized by dividing GFP by OD450 values, averages were 
calculated, and used for bioluminescence or fluorescence versus time charts. 
 
Bioluminescent detection of OHHL from pHP-L #7 in E. coli and S. aureus using 
Wallac 1450 Microbeta Plus Liquid Scintillation Counter 
 Experiments were completed in the same way as described previously with the 
following exceptions. A Costar 96-well black microtiter plate with a black bottom 
(Corning Inc. Life Sciences, Lowell, MA) was used in measurements made by a Wallac 
1450 Microbeta Plus Liquid Scintillation Counter (PerkinElmer Life and Analytical 
Sciences, Waltham, MA). The bioluminescence measurement (CPS) following 
incubation for 20 min repeated overnight was the experimental protocol. Assays 1, 2, and 
5 were done at 28oC while assays 3 and 4 were performed at 30oC. The average of CPS 
measurements was calculated for each sample to construct charts.  
 
Detection of OHHL from pHP-L #7 in E. coli and S. aureus using Liquid 
Chromatography Mass Spectrometry (LCMS) 
 Overnight cultures of E. coli and S. aureus harboring pHP-L #7 were diluted 100 
times in fresh LB with antibiotics. These 100 ml cultures were grown at 37oC with 220 
rpm in 500 ml flasks for 24 h. Twenty ml of each 24 hour-culture were completed to 200 
ml by adding fresh LB with antibiotics. These 200ml-cultures were incubated at 37oC 
with 220 rpm in one liter flasks. Fifty ml samples from each culture were collected after 
incubations of 2 (the time0 sample) and 24 h (the time24 sample). These samples were 
used for OHHL extraction. 
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 To extract OHHL from cultures, each 50 ml sample was mixed with 50 ml ethyl 
acetate in a 125 ml separation funnel and shaken manually for 30 min with frequent 
ventilations. The mixture was allowed to stand for 10 min for separation. The top layer, 
which is OHHL-containing ethyl acetate, was collected in a 250 ml flask. The bottom 
layer of medium and cells were left in the funnel. Fresh ethyl acetate (50 ml) was added 
to this and shaken manually for another 30 min with frequent ventilations. After 
separation, the top layer was transferred to the flask which contained the first top layer 
collected and the bottom layer was discarded. Ethyl acetate was evaporated. The OHHL 
that remained in the flask was dissolved in 6 ml methanol and transferred to a 10 ml vial. 
Methanol was evaporated by exposing the solution to nitrogen gas. The OHHL that 
remained in the tube was stored at -20oC until it was used for LCMS analysis. Each 
OHHL sample was brought to room temperature and dissolved in 500 µl methanol just 
before analysis. The standard was a synthetic OHHL solution (Sigma-Aldrich Co., St. 
Louis, MO) dissolved in dH20 (1 mg/ml). The instrument and equipment used for OHHL 
detection were LCQ Deca XPplus LCMS and Ace 3 C18 column (Advanced 
Chromatography Technologies, Aberdeen, Scotland) #ACE-111-1046 with dimensions of 
10 cmx4.6 mm Id. Four scans were done within a mass range of 100-350 for MS. APCI 
was used for MS with the following specifications: source heater temperature of 300oC, 
sheath gas flow rate of 35 arb, aux/sweep gas flow rate of 10 arb, discharge current of 5 
µA, capillary temperature of 250o C, capillary voltage of 17 V, and tube lens offset of 20 




Table 3-6. LCMS conditions used to detect OHHL from the standard (OHHL in dH20) 
and pHP-L #7 in E. coli and S. aureus. 
Minute Water% Methanol% Flow rate (µl/minute) 
0 80 20 200 
1 80 20 200 
21 30 70 200 
24 30 70 200 
 
Construction of pHPS9-kanR #4 (or pHP-K #4) 
 kanr coding sequence (CDS) from pDG148-Stu was cloned into the pHPS9 
plasmid under the control of the pHPS9 promoter P59 and the RBS which was used for 
luxI expression in the pHP-L #7 construct. This was done to determine the pHPS9 
promoter P59 efficiency by placing a gene other than luxI under its control.  kanr CDS 
was amplified using kanRSalI forward and kanRBamHI reverse primers from pDG148-
Stu. The PCR protocol consisted of a step of 94oC for 5 min, 35 cycles of 94oC for 30 
sec, 55oC for 30 sec, and 72oC for 50 sec, and finally a step of 72oC for 15 min. The PCR 
product screening and cloning into the TOPO TA cloning vector pCR2.1 (Invitrogen, 
Carlsbad, CA) were carried out as described previously. Transformants were screened 
with EcoRI restriction analysis and sequenced. The clone selected was named pCR2.1-
kanR #10. 
 pHPS9 and pCR2.1-kanR #10 were cut with SalI and BamHI (Promega, Madison, 
WI) at 37oC in the presence of 1X buffer D. Digests were run on a 0.5% agarose gel with 
EtBr in 0.5XTBE. The gel was screened under UV illumination to detect DNA fragments 
to be used based on size. Digestion of the pHPS9 plasmid resulted in two fragments, the 
region between SalI and BamHI sites which is mostly the cat-86 gene and the remaining 
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part of the plasmid. The goal was to replace the region between SalI and BamHI sites 
with kanr. Therefore, the pHPS9 portion without the cat-86 gene was cut out of the gel 
and purified using the QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA). kanr 
from the digested pCR2.1-kanR #10 was purified from the gel in the same way. kanr (54 
ng) was integrated into 81 ng pHPS9 which was purified from the gel using one unit T4 
DNA Ligase (Promega, Madison, WI). After overnight incubation at 16oC, 4 µl of the 
solution were transformed into chemically competent E. coli TOP10 cells (Invitrogen, 
Carlsbad, CA). Transformants obtained were screened with SalI/BamHI restriction 
analysis and sequenced as explained above. The selected transformant was called pHPS9-
kanR #4 (or pHP-K #4; see Table A in the appendix for a complete list of alternative 
names used for plasmids) (Figure 3-6). 
 
Transfer of pHP-K #4 into S. aureus 
pHP-K #4 was electroporated into electrically competent S. aureus RN4220 cells. 
Staphylococcus aureus transformants were screened using SalI/BamHI digestion. The S. 
aureus transformant which carried the construct was tested for kanamycin resistance. 
 
Detection and analysis of kanamycin resistance provided by pHP-K #4 in E. coli and 
S. aureus 
 Cultures of E. coli and S. aureus with pHP-K #4 were plated onto LB plates 
containing kanamycin concentrations in the range of 2.5-70 µg/ml. Results were 
compared to kanamycin resistance patterns provided by the other plasmids and constructs 




Figure 3-6. Construction of pHPS9-kanR #4 (or pHP-K #4). cat-86 was exchanged with 
kanr  from pDG148-Stu, which placed kanr under the control of Gram-positive P59. 
 
Construction of pDG148-Stu-luxI #28 (or pDG-L #28) 
 The luxI CDS was cloned into a Gram-positive and -negative shuttle expression 
vector, pDG148-Stu, under the control of the plasmid’s Gram-positive promoter and 
RBS. pDG148-Stu promoter is a hybrid promoter of the B. subtilis phage SPO-1 and the 
lac operator, Pspac, which is regulated by the IPTG-inducible LacI repressor. 
First, luxI CDS was amplified from pMO-L #7 using luxIStuI forward and 
luxIStuI reverse primers to add StuI enzyme sites to the 5′ and 3′ ends of the gene. The 
PCR protocol consisted of a first step of 94oC for 5 min followed by 35 cycles of 94oC 
for 30 sec, 42oC for 30 sec, and 72oC for 42 sec, and a final step of 72oC for 15 min. PCR 
product screening and cloning into the TOPO TA cloning vector pCR2.1 (Invitrogen, 
 
 91
Carlsbad, CA); and transformant screening with EcoRI digestion and sequencing were 
performed as described previously. The construct pCR2.1-luxI #3 was selected for further 
cloning. 
pCR2.1-luxI #3 and pDG148-Stu were digested with StuI enzyme (Promega, 
Madison, WI) at 37oC. pCR2.1-luxI #3 digest (8080 ng) and an aliquot of pDG148-Stu 
digest (601 ng) were run on a 0.5% agarose gel with EtBr in 0.5xTBE. UV illumination 
of the gel showed the resulting DNA fragments, confirming the digestion of pDG148-Stu 
and spotting the luxI bands from pCR2.1-luxI #3. luxI bands were cut out of the gel and 
purified with QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA) to use for 
ligation. The portion of the pDG148-Stu digest which was not run on the gel was purified 
the same way for ligation. luxI (221 ng) integration into pDG148-Stu (50 ng) was done 
using the DNA Ligation Kit<Mighty Mix> (Takara Bio Inc., Shiga, Japan). The ligation 
reaction was transformed into chemically competent E. coli TOP10 cells (Invitrogen, 
Carlsbad, CA). Transformants were screened with EcoRI/BamHI restriction analysis and 
sequenced. The transformant which was chosen was called pDG148-Stu-luxI #28 (or 
pDG-L #28; see Table A in the appendix for a complete list of alternative names used for 
plasmids) (Figure 3-7). 
 
Transfer of pDG-L #28 into S. aureus 
 Attempts to electroporate pDG-L #28 into electrically competent S. aureus 






Figure 3-7. Construction of pDG148-Stu-luxI #28 (or pDG-L #28). luxI was placed under 
the control of Gram-positive Pspac and RBS. 
 
Construction of pHPS9-sht-Pspac-luxI-lacI #9 (or pHP-PL #9) 
 pDG148-Stu which is 8.3 kb and pDG-L #28 which is 8.85 kb could not be 
electroporated into S. aureus RN4220. A smaller construct was formed to electroporate 
luxI under the control of Pspac and RBS of pDG148-Stu into S. aureus more easily.  
 First, a smaller version of the pHPS9 plasmid was created. For this, pHPS9 was 
first digested with PstI (Promega, Madison, WI) and run on a 0.5% agarose gel with EtBr 
in 0.5xTBE. The digestion produced two fragments: the 0.7 kb-region between two PstI 
sites which contained cat-86 and the remaining part of the plasmid which is 5 kb. The 5-
kb fragment of the plasmid was purified from the gel using QIAquick Gel Extraction Kit 
(Qiagen Inc., Valencia, CA) after UV light screening. This fragment (360 ng) was 
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religated onto itself using DNA Ligation Kit Ver.2.1 (Takara Bio Inc., Shiga, Japan). The 
ligation reaction was transformed into chemically competent E. coli TOP10 cells 
(Invitrogen, Carlsbad, CA). Transformants were screened with PstI (Promega, Madison, 
WI) digestion as described previously. The transformant selected was named pHPS9-sht 
#7. This process shortened the plasmid from 5.7 kb to 5 kb. 
To clone pDG-L #28 region between EcoRI and BamHI sites which contained 
Pspac, RBS, luxI, and lacI into pHPS9-sht #7, both plasmids were digested with EcoRI 
and BamHI in the presence of 1x buffer E (Promega, Madison, WI) at 37oC. Digests were 
run on a 0.5% agarose gel with EtBr in 0.5xTBE. DNA bands on the gel which contained 
digested-pHPS9 and the pDG-L #28 fragment of Pspac, RBS, luxI, and lacI were spotted 
based on size using UV illumination. They were cut out of the gel and purified with 
QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA). Two ligation reactions were 
set up using DNA Ligation Kit Ver.2.1 (Takara Bio Inc., Shiga, Japan): the reaction with 
the vector:insert ratio of 1:5 (82 ng pHPS9-sht #7:190 ng Pspac, RBS, luxI, and lacI) and 
the reaction with the vector:insert ratio of 1:10 (41 ng pHPS9-sht #7:190 ng Pspac, RBS, 
luxI, and lacI). Reactions were transformed into chemically competent E. coli TOP10 
cells (Invitrogen, Carlsbad, CA). Transformants obtained were screened with PstI 
digestion and sequenced as described previously. Based on these results, the construct 
pHPS9-sht-Pspac-luxI-lacI #9 (or pHP-PL #9; see Table A in the appendix for a complete 
list of alternative names used for plasmids) was selected. A construction scheme for the 
plasmid is shown in Figure 3-8. The size of the plasmid which carries luxI under the 
control of pDG148-Stu promoter Pspac and RBS was decreased from 8854 bp to 7256 bp 




Figure 3-8. Construction of pHPS9-sht-Pspac-luxI-lacI #9 (or pHP-PL #9). Pspac, RBS, luxI, and lacI from pDG-L #28 (or 
pDG148-Stu-luxI #28) were inserted into pHPS9-sht #7, which resulted in construction of a smaller plasmid with luxI under the 




Transfer of pHP-PL #9 into B. subtilis and S. aureus 
pHP-PL #9 was electroporated into electrically competent B. subtilis and S. 
aureus RN4220 cells. Plasmids of B. subtilis transformant overnight cultures were 
purified using Wizard Plus Midi-Preps DNA Purification Systems (Promega, Madison, 
WI) according to manufacturer instructions. Instructions suggested by the manufacturer 
for Wizard Plus Midi-Preps DNA Purification Systems (Promega, Madison, WI) were 
modified to purify plasmids from transformant S. aureus overnight cultures. Cells of each 
S. aureus transformant culture were suspended in 1/10 volume with the suspension buffer 
of the kit. Fifty µl (for every 10 ml of the overnight culture) lysostaphin enzyme solution 
(0.5 mg/ml) which is capable of specifically degrading S. aureus cell walls were added 
into the resuspended culture. The solution was incubated at 37oC for 17 min. The 
remainder of the protocol was carried out as suggested by the manufacturer. Plasmids 
were screened with PstI/BamHI restriction analysis for both B. subtilis and S. aureus and 
also sequenced for S. aureus as described previously. The selected B. subtilis and S. 
aureus transformants which carried pHP-PL #9 were tested for OHHL production. 
 
Bioluminescent and fluorescent detection of OHHL from pDG-L #28 in E. coli and 
pHP-PL #9 in E. coli, B. subtilis, and S. aureus using Wallac Victor2 1420 Multilabel 
and 1450 Microbeta Plus Liquid Scintillation Counters 
 For OHHL detection from pDG-L #28 in E. coli, the strain itself, bioluminescent 
bioreporter E. coli OHHLux, and fluorescent bioreporter E. coli MT102 with pJBA132 
were grown overnight in LB with antibiotics at 37oC. The overnight culture of E. coli 
harboring pDG-L #28 (100 µl) was inoculated into fresh LB without antibiotic (10 ml) 
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and grown at 37oC until mid-log phase (OD600 = 0.86). To induce the Pspac promoter of 
pDG-L #28, the culture was divided into 3 tubes with 3.2 ml in each, following 
procedures described by Joseph et al. (611).  The control tube contained no IPTG while 
0.5 mM IPTG was added into one tube and 2 mM IPTG was added into the other. 
Cultures continued to grow at 37oC for 2 h. After this, supernatants were collected, 
passed through 0.22 µm filters, and used for the experimental set-up. Overnight cultures 
of bioreporters were washed with LB, diluted to OD600= 0.1 in fresh LB containing 
antibiotics, and used for the experiment. A Costar 96-well black microtiter plate with a 
clear bottom (Corning Inc. Life Sciences, Lowell, MA) was used for Wallac Victor2 
1420 Multilabel Counter (PerkinElmer Life and Analytical Sciences, Waltham, MA) 
measurements and a Costar 96-well black microtiter plate with a black bottom (Corning 
Inc. Life Sciences, Lowell, MA) was used for Wallac 1450 Microbeta Plus Liquid 
Scintillation Counter (PerkinElmer Life and Analytical Sciences, Waltham, MA) 
measurements. Each sample was prepared by combining 100 µl supernatant with 100 µl 
bioreporter dilution in triplicate (Figure 3-2). Negative controls contained 100 µl 
bioreporter dilution (E. coli OHHLux or E. coli MT102 with pJBA132) combined with 
100 µl dH2O instead of the supernatant, each in triplicate. Wallac Victor2 1420 
Multilabel Counter measurements of fluorescence and absorbance followed a protocol of 
shaking for 10 sec, absorbance measurement at 450 nm, shaking for 20 sec, fluorescence 
measurement (GFP), and incubation for 20 min. The protocol was repeated overnight at 
28oC. Fluorescence data obtained were normalized by dividing GFP values by OD450 
values. The mean of normalized values for triplicate measurements of each sample was 
used for construction of the graphs. Wallac 1450 Microbeta Plus Liquid Scintillation 
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Counter protocol consisted of bioluminescence measurement (CPS) every 20 min of 
incubation repeated overnight at 28oC. Charts were prepared using the mean of each 
sample’s triplicate measurement versus time. 
 OHHL detection from pHP-PL #9 in B. subtilis and S. aureus was performed 
assertively in the same way with a few differences. The negative control for S. aureus 
with pHP-PL #9 was the wild type S. aureus strain RN4220 whose supernatant was 
combined with the bioreporter dilution for measurements. Cultures from which 
supernatants were collected were grown to mid-log phase with OD600= 0.62 for the 
positive control, 1.1 for the negative control S. aureus RN4220, 1 for S. aureus carrying 
pHP-PL #9, and 0.57 for B. subtilis harboring pHP-PL #9. The IPTG concentrations used 
for promoter Pspac induction were 2 and 3 mM. Incubation continued for 1 h after IPTG 
addition. 
 OHHL production from pHP-PL #9 in E. coli, B. subtilis and S. aureus was 
determined with bioluminescent and fluorescent measurements using the Overnight 
Express Autoinduction System 1 (Novagen, Darmstadt, Germany) instead of IPTG to 
induce the promoter Pspac. The Overnight Express Autoinduction System provided 
optimized media components to combine with a glucose-free complex medium, such as 
LB. The resulting medium allowed bacteria to reach high cell densities and then induced 
protein expression by its lactose component. It was developed to induce protein 
expression, without IPTG and needs to be used with IPTG-inducible hosts. Escherichia 
coli, B. subtilis and S. aureus containing pHP-PL #9 and S. aureus RN4220 as the 
negative control for plasmid-carrying S. aureus were grown in Overnight Express 
Autoinduction System 1 medium without antibiotics at 37oC overnight as suggested by 
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the manufacturer with the exception of 260 rpm shaking instead of 300 rpm. Supernatants 
of overnight cultures were collected, filtered through 0.22 µm filters and used for the 
experiment. Overnight cultures of bioluminescent and fluorescent bioreporters in LB with 
antibiotics were diluted to OD600= 0.1 in fresh LB with antibiotics and used. Negative 
controls for B. subtilis and E. coli strains were bioreporters combined with dH20 instead 
of supernatants. The remainder of the experiment was carried out as described previously. 
 
The luxI transcript detection from pHP-PL #9 and pDG-L #28 using real-time 
quantitative reverse transcriptase PCR 
 Real-time quantitative reverse transcriptase PCR (qRT-PCR) was used to test the 
efficiency of Pspac promoter in E. coli, B. subtilis and S. aureus by detecting the luxI 
transcript. Overnight cultures of E. coli, B. subtilis and S. aureus containing pHP-PL #9, 
E. coli with pDG-L #28, and the wild type S. aureus RN4220 (negative control) were 
diluted (1:100) into fresh LB with antibiotics and grown at 37oC until mid-log phase. The 
RNAprotect Bacteria Reagent (Qiagen Inc., Valencia, CA) was added to cultures. RNA 
from cultures was extracted using the RNeasy kit (Qiagen Inc., Valencia, CA) and the 
RNase-Free DNase Set (Qiagen Inc., Valencia, CA) which provided on-column DNase 
digestion. Protocols were carried out as suggested by the manufacturer with several 
modifications. Disruption of E. coli and B. subtilis cell walls was done by incubating 
cells with lysozyme for 30 min; while S. aureus was incubated with lysostaphin (7.5 
ng/ml culture) for 45 min and then with lysozyme for 15 min. The extracted RNA was 
quantified using the Quant-iT RiboGreen RNA Assay Kit (Molecular Probes-Invitrogen, 
Carlsbad, CA) and The Versafluor Fluorometer (Bio-Rad, Hercules, CA). Quantified 
 
 99
DNA was subjected to real-time qRT-PCR using QuantiTect Probe RT-PCR reagents 
(Qiagen Inc., Valencia, CA) in an Opticon DNA Engine (MJ Research, Inc., Waltham, 
MA) thermocycler with fluorescence detector. LuxI-qRT forward and reverse primers 
and LuxI-q5′P probe with a 5′ fluorophore, FAM, and a 3′ quencher, BHQ (black hole 
quencher) were used for reactions. The LuxI-q5′P probe sequence from 5′ to 3′ is 
CAGTATCATCACAAGCATAAATATA TTCTGCATT. Each sample was prepared in 
triplicate with an additional reaction which lacked the reverse transcriptase to control 
DNA contamination. The same amount of RNA (125 ng) was used for each reaction. 
Reactions were placed into a 96-well microtiter plate and measured. The protocol for 
real-time qRT-PCR followed these steps: 50oC RT reaction for 30 min, 95oC RT 
inactivation for 15 min, and then 45 cycles of 95oC denaturation for 15 sec, 58oC 
annealing/extension for 30 sec, and a fluorescence measurement. Baseline start and end 
cycles were 3 and 7, respectively. Data were analyzed using Opticon Monitor Analysis 
Software Version 1.08. 
 
luxI translation product detection from pHP-PL #9 and pDG-L #28 using SDS-
PAGE and Western Blotting 
The presence of LuxI protein in E. coli, B. subtilis and S. aureus harboring pHP-
PL #9, and E. coli carrying pDG-L #28 was tested by Sodium Dodecyl Sulfate-
Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Western Blotting. Pellets from 
mid-log phase cultures (20 ml each) of experimental strains and wild type S. aureus 
RN4220 (negative control) were subjected to protein extraction. Soluble and insoluble 
proteins of samples were extracted using the B-PER Bacterial Protein Extraction Reagent 
 
 100
(Pierce, Rockford, IL) with the midi-scale protocol supplied by the manufacturer. 
Incubation time for B. subtilis soluble protein extraction was changed from 10 min to 26 
min. Also, S. aureus soluble protein extraction was performed with 50 mg lysostaphin 
and the B-PER reagent at 37oC for 25 min. The whole protocol was carried out in the 
presence of Halt Protease Inhibitor Cocktail, EDTA Free (Pierce, Rockford, IL) as 
suggested by the manufacturer. 
Since B. subtilis soluble protein yield was low with B-PER Bacterial Protein 
Extraction Reagent (Pierce, Rockford, IL), the extraction was repeated using a French 
Press. The pellet of a 500 ml mid-log phase culture of B. subtilis harboring pHP-PL #9 
was dissolved in 50 ml lysis buffer (50 mM Tris pH 8.0, 5 mM EDTA, 200 mM NaCl, 1 
mM PMSF). After homogenization with a glass homogenizer, the solution was lysed by a 
French Press using three cycles at 16,000 psi. The supernatant of the cell lysate was used 
as the soluble protein fraction. 
 SDS-PAGE was used to check protein yields from extractions. Extracts were 
loaded into wells of a Criterion Precast Gel, 12.5% Tris-HCL, 1 mm, 12+2 comb, 45 µl 
(Bio-Rad, Hercules, CA). The gel was run at 200 V for about 1 h in a Criterion vertical 
electrophoresis cell (Bio-Rad, Hercules, CA). Proteins on the gel were stained using 
GelCode Blue Stain Reagent (Pierce, Rockford, IL) following instructions of the 
manufacturer. 
 To detect the LuxI protein, Western Blotting was performed using the LuxI 
antibody from rabbit antisera (Genemed Synthesis Inc., San Francisco, CA; Lot No: 
31465 Antiserum; ID: Antibody Rabbit #1423) which targets the LuxI sequence, 
AVGKNSSKINNSASEITM. Another SDS-PAGE was done for Western Blotting. After 
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the SDS-PAGE, proteins were transferred from the unstained gel onto a Sequi-Blot 
PVDF Membrane (0.2 µm; Bio-Rad, Hercules, CA) using the EBU-4000 Semi-Dry 
Blotter System (C.B.S. Scientific Co., Del Mar, CA) which was run at 200 mA for 1 h. 
The membrane was blocked in 10% milk blocking solution (in 1X TTBS; 20mM Tris-
HCL pH 7.6, 150 mM NaCl, 0.1% Tween 20) for 2 h at room temperature with gentle 
shaking. After blocking, it was incubated with the LuxI antibody (100-250X diluted) in 
2.5% milk (in 1X TTBS) overnight at 4oC without shaking. The membrane was washed 
in 1X TTBS for 30 min at room temperature with gentle shaking by changing the buffer 
every 10 min. This was followed by incubation of the membrane with the secondary 
antibody (2800-3000X diluted) in 1X TTBS for 2 h at RT with gentle shaking. 
ImmunoPure Goat Anti-Rabbit IgG, (H+L), Alkaline Phosphatase Conjugated (Pierce, 
Rockford, IL) was used as the secondary antibody. The membrane was washed as before. 
Color development was carried out using the Alkaline Phosphatase Conjugate Substrate 
Kit (Bio-Rad, Hercules, CA) as suggested by the manufacturer. The membrane was 
incubated with color development solution for 7 min at room temperature with gentle 
shaking. The reaction was stopped by washing the membrane in dH2O for 10-25 min at 
room temperature with gentle shaking. 
 
Construction of pHPS9-sht-Pspac-kanR-lacI #31 (or pHP-PK #31) 
 The RBS efficiency of the construct pHP-PL #9 in S. aureus which produces the 
luxI transcript but not the LuxI protein and light was tested by replacing the luxI CDS 
with the CDS of a S. aureus-native gene, kanr. 
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 kanr CDS with the 5′ and 3′ StuI enzyme sites was placed into TOPO TA cloning 
vector pCR2.1 (Invitrogen, Carlsbad, CA) after PCR using the kanRStuI forward and 
reverse primers and pDG148-Stu as the template. PCR conditions were a first step of 
94oC for 5 min, then 35 cycles of 94oC for 30 sec, 58oC for 30 sec, and 72oC for 47 sec, 
and a final step of 72oC for 15 min. Transformant screening with EcoRI restriction 
analysis and sequencing were done as described previously. The construct was named 
pCR2.1-kanRStuI #12. 
 kanr CDS did not directly replace luxI CDS in pHP-PL #9 construct since StuI 
enzyme was found not only at the 5′ and 3′ ends of luxI. kanr CDS was first integrated 
into pDG148-Stu. pCR2.1-kanRStuI #12 and pDG148-Stu were digested with StuI 
(Promega, Madison, WI) at 37oC. All of the pCR2.1-kanRStuI #12 digest (9.45 µg) and 
975 ng of the pDG148-Stu digest were run on a 0.5% agarose gel with EtBr in 0.5xTBE. 
Digestion products were screened on the gel with UV light to detect kanr fragments and 
to verify digestion of pDG148-Stu. kanr fragments were cut out of the gel and purified 
using QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA). The part of the 
pDG148-Stu digest which was not run on the gel (1.17 µg) was purified using the same 
kit after digestion. Purified kanr (331.5 ng) and pDG148-Stu (122 ng) were ligated using 
the DNA Ligation Kit<Mighty Mix> (Takara Bio Inc., Shiga, Japan) at 16oC overnight. 
The reaction was transformed into chemically competent E. coli TOP10 cells (Invitrogen, 
Carlsbad, CA). Transformants were screened with EcoRI/BamHI restriction analysis and 
sequenced. The construct determined that contained the correct insert in the correct 
orientation was selected and called pDG148-Stu-kanR #8. 
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 The region of pDG148-Stu-kanR #8 which contained Pspac, RBS, kanr, and lacI 
was inserted into pHPS9-sht #7. For this, both plasmids were digested with EcoRI and 
BamHI in the presence of 1x buffer E (Promega, Madison, WI) at 37oC and run on a 
0.5% agarose gel with EtBr in 0.5xTBE. UV illumination screening showed digestion 
products based on size. The digested pHPS9-sht #7 and the fragment containing Pspac, 
RBS, kanr, and lacI were cut out of the gel and purified with QIAquick Gel Extraction 
Kit (Qiagen Inc., Valencia, CA). The ligation reaction was carried out with 40 ng pHPS9-
sht #7 and 296 ng insert of Pspac, RBS, kanr, and lacI using the DNA Ligation 
Kit<Mighty Mix> (Takara Bio Inc., Shiga, Japan). After overnight incubation at 16oC, 
the reaction was transformed into chemically competent E. coli TOP10 cells (Invitrogen, 
Carlsbad, CA). The construct pHPS9-sht-Pspac-kanR-lacI #31 (or pHP-PK #31; see 
Table A in the appendix for a complete list of alternative names used for plasmids) was 
selected after screening of transformants with PstI digestion and sequencing (Figure 3-9). 
 
Transfer of pHP-PK #31 and pUB110 into S. aureus 
 pHP-PK #31 and pUB110 (for comparison) were electroporated into electrically 
competent S. aureus RN4220 cells. Plasmids of the transformants were purified as 
described previously with the exception that the incubation time with lysostaphin was 
decreased from 17 min to 10 min. pUB110 plasmid purifications were run on a 0.5% 
agarose gel with EtBr in 0.5xTBE. The gel was screened with UV light to detect plasmids 
based on size. pHP-PK #31 purifications were sequenced to determine S. aureus 
transformants which harbored the plasmid. Selected S. aureus transformants which 




Figure 3-9. Construction of pHPS9-sht-Pspac-kanR-lacI #31 (or pHP-PK #31). Pspac, RBS, kanr, and lacI were inserted into 






Detection and analysis of kanamycin resistance provided by pHP-PK #31 in S. 
aureus 
 Cultures of S. aureus with pHP-PK #31 and pUB110 were streaked onto LB 
plates containing different concentrations of kanamycin. Kanamycin resistance patterns 
were compared to those of the other plasmids and constructs which have the kanr gene 
under the control of various promoters and RBSs in S. aureus and one another. 
 
luxI CDS codon optimization for adaptation to the codon bias of S. aureus phage 
P68 
The presence of luxI transcript was shown in S. aureus with pHP-PL #9 while the 
LuxI protein was not detected using LuxI antibody. Also, the RBS of the construct was 
demonstrated to work after replacing the luxI CDS with S. aureus-native kanr CDS. 
Therefore, to determine if the codon preference is a problem for luxI translation in S. 
aureus, the luxI CDS codon usage was adapted to the codon bias of S. aureus phage P68. 
The reason for not adapting luxI codons to the codon bias of S. aureus strain RN4220 
which was used for pHP-PL #9 expression was that its genome is not sequenced yet. P68 
is the phage which was planned to clone the luxI gene into for the construction of the 
recombinant phage for monitoring S. aureus. Phage P68 was also shown to carry genes 
most of which have high translation efficiency (616).  
Codon optimization using the GeneOptimizer software and synthesis of the 
optimized gene were carried out by GENEART (Regensburg, Germany). During the 
process, the company avoided regions of very high (> 80%) or very low (< 30%) GC 
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content and cis-acting sequence motifs such as internal TATA-boxes, chi-sites and 
ribosomal entry sites, AT-rich or GC-rich sequence stretches, and repeat sequences and 
RNA secondary structures. Two negatively cis-acting motifs, one consensus TATA box 
and one -35 box, were found and corrected. Optimization increased the codon adaptation 
index (CAI) value from 0.62 to 0.98 (1 being the best score) which shows a high and 
stable degree of expression for the gene. Average GC content of luxI decreased from 33% 
to 27% after the optimization. Figures 3-10, 3-11, and 3-12 show details of the 
optimization process as reported by GENEART (Regensburg, Germany). Figure 3-13 




Figure 3-10. Codon quality distribution plots provided by GENEART (Regensburg, 
Germany) for (A) non-optimized and (B) optimized luxI for adaptation to the codon bias 
of S. aureus phage P68. The X-axis shows the quality class and the Y-axis shows the 







Figure 3-11. Codon quality plots provided by GENEART (Regensburg, Germany) for 
(A) non-optimized and (B) optimized luxI for adaptation to the codon bias of S. aureus 
phage P68. The X-axis shows the codon position and the Y-axis shows the quality. A 
quality value of 100 represents the most-used codon for P68 gene expression. 
 
 
Figure 3-12. GC content plots provided by GENEART (Regensburg, Germany) for (A) 
non-optimized and (B) optimized luxI for adaptation to the codon bias of S. aureus phage 






Figure 3-13. The pairing of non-optimized (top sequence) and optimized (bottom 
sequence) luxI for adaptation to the codon bias of S. aureus phage P68. (Vertical lines 
show identical bases and dots show non-identical bases.) 
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Construction of pHPS9-sht-Pspac-optluxI-lacI #5 (or pHP-POL #5) 
Optimized luxI was synthesized by assembling synthetic oligonucleotides by 
GENEART (Regensburg, Germany) as follows: The gene was cloned into pPCR-Script 
(ampR) at the KpnI and SacI restriction sites into E. coli K12 XL10-GOLD. The plasmid 
was purified with Pure Yield Plasmid Midiprep (Promega, Madison, WI) and confirmed 
the sequence of luxI by sequencing. A map of the plasmid which was provided by 
GENEART (Regensburg, Germany) is shown in Figure 3-14. 
 The luxI gene integrated into plasmid pPCR-Script (0602285pPCR-Script) was 
transformed into chemically competent E. coli TOP10 cells (Invitrogen, Carlsbad, CA). 
Resulting transformants were screened with KpnI/SacI restriction analysis and sequenced. 
The transformant carrying the plasmid was selected for further experiments. 
 
 
Figure 3-14. luxI, optimized for adaptation to the codon bias of S. aureus phage P68, in 
pPCR-Script (provided by GENEART, Regensburg, Germany) 
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Optimized luxI was first cloned into pDG148-Stu instead of directly replacing 
luxI in pHP-PL #9 which has more than two sites for StuI, used for luxI cloning. 
0602285pPCR-Script and pDG148-Stu were digested with StuI (Promega, Madison, WI) 
at 37oC. While pDG148-Stu was directly purified from the reaction after digestion, the 
0602285pPCR-Script digest was run on a 0.5% agarose gel with EtBr in 0.5XTBE. The 
gel was screened using a UV light to spot luxI bands based on size. luxI was cut out of the 
gel and purified. QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA) was used for 
all purifications. The ligation reaction containing 69 ng digested pDG148-Stu and 290 ng 
luxI was carried out using DNA Ligation Kit<Mighty Mix> (Takara Bio Inc., Shiga, 
Japan). After the overnight incubation at 16oC, reactions were transformed into 
chemically competent E. coli TOP10 cells (Invitrogen, Carlsbad, CA). Transformants 
were screened using EcoRI/BamHI digestion and sequenced. The construct carrying the 
correct insert at the correct orientation was named pDG148-Stu-optluxI #16. 
 The fragment of Pspac, RBS, optimized luxI, and lacI was cloned from pDG148-
Stu-optluxI #16 into pHPS9-sht #7. For this, pHPS9-sht #7 and pDG148-Stu-optluxI #16 
were cut with EcoRI and BamHI in the presence of 1X buffer E (Promega, Madison, WI) 
at 37oC and then run on a 0.5% agarose gel with EtBr in 0.5xTBE. The fragment of 
Pspac, RBS, optimized luxI, and lacI and digested pHPS9-sht #7 which were spotted 
with UV illumination were cut out of the gel and purified using QIAquick Gel Extraction 
Kit (Qiagen Inc., Valencia, CA). The ligation was performed with the DNA Ligation 
Kit<Mighty Mix> (Takara Bio Inc., Shiga, Japan) at 16oC overnight. Two reactions were 
prepared, one with 86 ng pHPS9-sht #7 and 400 ng fragment of Pspac, RBS, kanr, and 
lacI using 1:10 ratio of vector to insert and the other with 150 ng pHPS9-sht #7 and 346 
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ng fragment using 1:5 ratio. Transformants obtained after transfer of reactions into 
chemically competent E. coli TOP10 cells (Invitrogen, Carlsbad, CA) were screened with 
PstI digestion and sequencing. The construct selected was called pHPS9-sht-Pspac-
optluxI-lacI #5 (or pHP-POL #5; see Table A in the appendix for a complete list of 
alternative names used for plasmids). The construction of the plasmid was done in the 
same way as shown in Figure 3-8. 
 
Transfer of pHP-POL #5 into B. subtilis and S. aureus 
 pHP-POL #5 was electroporated into electrically competent B. subtilis and S. 
aureus RN4220 cells. Plasmids were purified from transformants as before. Plasmids 
from B. subtilis were screened with PstI/BamHI restriction analysis while S. aureus 
plasmids were screened with both PstI/BamHI digestion and sequencing. Transformants 
which carried plasmids were tested for OHHL production. 
 
Bioluminescent and fluorescent detection of OHHL from pHP-POL #5 in E. coli, B. 
subtilis, and S. aureus using Wallac Victor2 1420 Multilabel and 1450 Microbeta 
Plus Liquid Scintillation Counters 
 Escherichia coli, B. subtilis, and S. aureus strains carrying pHP-POL #5, wild 
type S. aureus RN4220 (negative control for S. aureus), E. coli harboring pCR2.1-TOPO 
PL-luxI (positive control), bioluminescent bioreporter E. coli OHHLux, and fluorescent 
bioreporter E. coli MT102 with pJBA132 were grown overnight in LB with antibiotics at 
37oC. Bioreporter cultures were washed with LB, diluted to OD600= 0.1 in LB with 
antibiotics and used for the assay. Cultures of other strains were diluted 100X in fresh LB 
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without antibiotics and grown at 37oC until mid-log phase (OD600= 0.55 for positive 
control, 0.95 for S. aureus negative control, 0.88 for E. coli sample, 1.6 for B. subtilis 
sample, and 0.75 for S. aureus sample). Supernatants were collected, passed through 0.22 
µm filters and used for the assay. Each sample was prepared in triplicate by mixing 100 
µl of supernatant with 100 µl of bioreporter dilution in Costar 96-well black microtiter 
plates (Corning Inc. Life Sciences, Lowell, MA). Plates with clear and black bottoms 
were used for Wallac Victor2 1420 Multilabel and Wallac 1450 Microbeta Plus Liquid 
Scintillation Counters (PerkinElmer Life and Analytical Sciences, Waltham, MA), 
respectively (Figure 3-2). Supernatant of S. aureus RN4220 was combined with 
bioreporter solution and used as the negative control for S. aureus sample. The 
bioreporter dilution (E. coli OHHLux or E. coli MT102 with pJBA132) mixed with dH2O 
instead of supernatant was used as the negative control for E. coli and B. subtilis samples. 
All controls were in triplicate. The protocol followed by Wallac Victor2 1420 Multilabel 
Counter contained shaking for 10 sec, absorbance measurement at 450 nm, shaking for 
20 sec, fluorescence measurement (GFP), and incubation for 20 min which was repeated 
overnight at 28oC.  Fluorescence measurements were normalized by dividing GFP values 
by OD450 values. The mean of triplicate measurements for each sample was calculated to 
construct charts. Wallac 1450 Microbeta Plus Liquid Scintillation Counter protocol was 
bioluminescence measurement (CPS) followed by 20 min incubation continued 
repeatedly overnight at 28oC. Charts for these measurements were prepared using mean 





Invitro packaging of S. aureus phage P68 genome 
Staphylococcus aureus phage P68 was selected for the construction of 
recombinant phage carrying luxI. Before cloning of luxI into the phage genome, the 
phage genome alone was used for packaging to develop a method. P68 genome (0.8-1 
µg) which was purified using Wizard Lambda Preps DNA Purification System (Promega, 
Madison, WI) was packaged invitro with MaxPlax Lambda Packaging Extracts 
(Epicentre Biotechnologies, Madison, WI). The packaging reaction (50-140 µl) was 
placed onto an LB plate with top agar (LB, 0.5% agar) containing S. aureus RN451 
overnight culture (20 µl). The plate was incubated overnight at 37oC. The area of lysis 
obtained the next day was scraped off and mixed with one ml LB in a sterile tube. The 
solution was kept at room temperature for 1.5 h and then vortexed. The supernatant 
collected after the centrifugation at 8,000 x g for 10 min was passed through a 0.22 µm-
filter, and tested for infectivity by pouring 600 µl of the solution mixed with top agar 
(LB, 0.5% agar) and S. aureus RN451 overnight culture (15 µl) onto an LB plate. Lysis 
was obtained on the plate after overnight incubation at 37oC. The remainder of the phage 
solution was stored at 4oC. 
 
Statistical calculations 
Bioluminescence and fluorescence values were normalized by dividing the CPS 
and GFP values obtained, respectively, by absorbance values at OD450 of the bioreporter 
culture measured at the same time point where available. The average of triplicate 
measurements was calculated for each time point. Normalized values were used if the 
absorbance of the bioreporter culture was measured. Error bars were generated by 
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calculating the standard deviation (SD) of triplicate bioluminescence or fluorescence 
values at each time point as follows: The average of triplicate measurements (normalized 
where available) for a time point was subtracted from each measurement (normalized 
where available) at that time point. The squares of the differences were calculated. The 
average of all three squared differences was determined. The square root of the value 
found was used as the standard deviation for the average value at each time point. 
Significance levels were determined by comparing average bioluminescence or 
fluorescence values of a sample to those of the negative control using Student’s t-test (P 
< 0.05). Maximum induction value of a sample for an assay was calculated by dividing 
the highest amount of light obtained from the sample during the assay by the amount of 





CONSTRUCTION OF S. AUREUS BIOREPORTER 
 
Bioluminescent and fluorescent detection of OHHL from pMO-L #7 in E. coli 
 The kanr-S. aureus phage Ф85 X8 promoter-S. aureus RBS-luxI CDS-T1T2  
fragment was placed into EZ::TN pMOD-2<MCS> plasmid (Epicentre Biotechnologies, 
Madison, WI) in between two MEs. MEs are sites which are recognized by the EZ::TN 
transposase (Epicentre Biotechnologies, Madison, WI) for transposition to occur. The 
aim was to clone luxI under the control of the S. aureus phage Ф85 X8 promoter and S. 
aureus RBS into the S. aureus phage Twort genome randomly using transposition since 
the Twort genome sequence was not known at the time. 
OHHL production by pMO-L #7 in E. coli was determined by bioluminescence 
and fluorescence measurements at 28oC overnight on a Wallac Victor2 1420 Multilabel 
Counter (PerkinElmer Life and Analytical Sciences, Waltham, MA). Bioluminescent and 
fluorescent OHHL bioreporters were RoLux and E. coli MT102 with pJBA132, 
respectively. The E. coli strains carrying pCR2.1-TOPO PL-luxI and pMOD-2-kanr #2 
were used as positive and negative controls, respectively. Each measurement represents 
the average of triplicate samples. Results (Figure 4-1) showed no OHHL production by 
pMO-L #7 in E. coli. Bioluminescence and fluorescence values were not significantly 
different from those of the negative control. The positive control produced 






































Figure 4-1 (A). Bioluminescent OHHL detection from pMO-L #7 (or pMOD-2-kanr-
prom-luxI-T1T2 #7) in E. coli at 28oC using bioreporter RoLux and Wallac Victor2 1420 




































Figure 4-1 (B). Fluorescent OHHL detection from pMO-L #7 (or pMOD-2-kanr-prom-
luxI-T1T2 #7) in E. coli at 28oC using bioreporter E. coli MT102 with pJBA132 and 
Wallac Victor2 1420 Multilabel Counter. Results represent the mean fluorescence values 










Bioluminescent and fluorescent detection of OHHL from pMK-L #13.3 in S. aureus 
pMK-L #13.3 was constructed to test OHHL production from luxI CDS under the 
control of S. aureus RBS and phage Ф85 X8 promoter inside S. aureus. pMK4 is a Gram-
positive and -negative shuttle vector so construction using it can be transferred into a S. 
aureus strain. 
Bioluminescent detection of OHHL from pMK-L #13.3 in S. aureus was done 
using RoLux as the bioreporter, E. coli with pMO-L #7 as the negative control, and E. 
coli with pCR2.1-TOPO PL-luxI as the positive control. The fluorescent detection 
bioreporter was E. coli MT102 with pJBA132 and the positive control was E. coli with 
pCR2.1-TOPO PL-luxI. The bioreporter itself was used as the negative control in the 
presence of dH20 replacing the sample supernatant in fluorescence measurements. 
Samples were set up in a 24-well black microtiter plate with a black bottom for 
fluorescent detection and in a 96-well black microtiter plate with a clear bottom for 
bioluminescent detection in triplicate. Bioluminescence measurements taken at 28oC 
were collected with a Wallac 1450 Microbeta Plus Liquid Scintillation Counter 
(PerkinElmer Life and Analytical Sciences, Waltham, MA). Fluorescence and absorbance 
data were measured with a Wallac Victor2 1420 Multilabel Counter (PerkinElmer Life 
and Analytical Sciences, Waltham, MA) at 28oC. Bioluminescence charts represent CPS 
values versus time, while fluorescence charts show GFP per absorbance values versus 
time. Results are shown in Figure 4-2. While positive control bioluminescence and 
fluorescence measurements reached ~19,000 and ~34,000 units, respectively, the pMK-L 
#13.3 plasmid-carrying S. aureus produced values which were not significantly different 
































Figure 4-2 (A). Bioluminescent OHHL detection from pMK-L #13.3 (or pMK4-prom-
luxI #13.3) in S. aureus at 28oC using bioreporter RoLux and Wallac 1450 Microbeta 
Plus Liquid Scintillation Counter. Results represent the mean bioluminescence values 












































Figure 4-2 (B). Fluorescent OHHL detection from pMK-L #13.3 (or pMK4-prom-luxI 
#13.3) in S. aureus at 28oC using bioreporter E. coli MT102 with pJBA132 and Wallac 













Bioluminescent and fluorescent detection of OHHL from pHP-L #7 in E. coli and S. 
aureus using Wallac Victor2 1420 Multilabel and Wallac 1450 Microbeta Plus 
Liquid Scintillation Counters 
 The efficiency of L. lactis promoter P59 from pHPS9 was tested for expression of 
luxI CDS under the control of S. aureus RBS by detecting OHHL produced from pHP-L 
#7 in E. coli and S. aureus. 
The positive control used for all experiments was E. coli harboring pCR2.1-
TOPO PL-luxI. The negative control for E. coli strains was the bioreporter used for the 
assay, RoLux for bioluminescence and E. coli MT102 carrying pJBA132 for 
fluorescence, while it was the wild type S. aureus RN4220 strain for S. aureus with pHP-
L #7. Each sample was prepared in triplicate and measured with Wallac Victor2 1420 
Multilabel and Wallac 1450 Microbeta Plus Liquid Scintillation Counters. Values from 
the Wallac Victor2 1420 Multilabel Counter were divided by the absorbance values to 
construct the graphs. Data from the Wallac 1450 Microbeta Plus Liquid Scintillation 
Counter were used directly since this device has no capability to measure absorbance. 
Each CPS or GFP value represents the average of triplicate measurements.  
Five assays were performed to detect OHHL from pHP-L #7 in E. coli and S. 
aureus where the bioluminescence and fluorescence were measured with the Wallac 
Victor2 1420 Multilabel Counter and only bioluminescence was measured with the 
Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Therefore, three sets of data 
were obtained from five different assays. There was no bioluminescence or fluorescence 
 
 122
obtained from the pHP-L #7 plasmid in S. aureus in any of the assays. The levels of light 
obtained were not significantly different from those produced by the S. aureus negative 
control. The pHP-L #7 plasmid in E. coli produced bioluminescence and fluorescence in 
varying amounts in all assays performed.  
A summary of these results and the positive control results as a comparison are 
presented in Table 4-1. The highest induction of the bioluminescent or fluorescent 
bioreporter obtained with E. coli with pHP-L #7 in each assay changed from 1.5 to 17.4 
times, compared to values obtained with the negative control. Induction values for the 
positive control were between 4.9 and 296.5. These values were acquired in a time period 
of 4.5-17.5 hours for both strains.  
A bioluminescence graph formed by measurements from assay 2 by the Wallac 
1450 Microbeta Plus Liquid Scintillation Counter and a fluorescence graph constructed 
from assay 2 measurements by the Wallac Victor2 1420 Multilabel Counter are shown as 












Table 4-1. A summary of assays for bioluminescent and fluorescent OHHL detection 
from pHP-L #7 in E. coli and positive control. The table shows maximum induction (MI; 
the highest amount of light from a sample divided by the negative control value at the 
same time point) value for each assay. RoLux and E. coli MT102 carrying pJBA132 were 
used as bioluminescent and fluorescent bioreporters, respectively. (T = Time period in h 
to obtain MI, Wallac 1450 = Wallac 1450 Microbeta Plus Liquid Scintillation Counter, 
Wallac Victor2 = Wallac Victor2 1420 Multilabel Counter) 
 pHP-L #7 in E. coli Positive control 
 MI T MI T 
Wallac 1450 Bioluminescence     
Assay 1 6.5X 8.5 7X 8.5 
Assay 2 13X 6 26X 14 
Assay 3 1.8X 8 5X 7.5 
Assay 4 1.9X 10 5X 7.5 
Assay 5 2.3X 7 297X 7 
Wallac Victor2 Bioluminescence     
Assay 1 4.3X 10 4.9X 8 
Assay 2 17.4X 13.5 9X 13 
Assay 3 4.6X 8 23.6X 9.5 
Assay 4 3.5X 10.5 22.3X 9.5 
Assay 5 2X 7.5 185X 7.5 
Wallac Victor2 Fluorescence     
Assay 1 4X 16.5 4.9X 12.5 
Assay 2 10X 17.5 22.4X 17.5 
Assay 3 2.8X 15.5 17.5X 15.5 
Assay 4 3X 4.5 9X 4.5 





























pHSP9-luxI #7 in E. coli





Figure 4-3 (A). Bioluminescent OHHL detection from pHP-L #7 (or pHPS9-luxI #7) in 
E. coli and S. aureus at 28oC using the bioreporter RoLux and Wallac 1450 Microbeta 
Plus Liquid Scintillation Counter. Results represent the mean bioluminescence values 


































PHPS9-luxI #7 in E. coli





Figure 4-3 (B). Fluorescent OHHL detection from pHP-L #7 (or pHPS9-luxI #7) in E. 
coli and S. aureus at 28oC using the bioreporter E. coli MT102 with pJBA132 and Wallac 
Victor2 1420 Multilabel Counter. Results represent the mean fluorescence values (n=3) ± 











Detection of OHHL from pHP-L #7 in E. coli and S. aureus using LCMS 
 There was generation of light from pHP-L #7 in E. coli while there was not any 
from pHP-L #7 in S. aureus. To determine if the problem is at OHHL or LuxI synthase 
production level, OHHL production from E. coli and S. aureus harboring pHP-L #7 was 
detected with LCMS. Synthetic OHHL (Sigma-Aldrich Co., St. Louis, MO) dissolved in 
sterile dH20 (1 mg/ml) was used as the standard. Cultures were grown at 37oC with 220 
rpm. Samples collected after 2 h (time0) and 24 h (time24) were used to detect OHHL. 
The method was LCQ Deca XPplus LCMS utilizing Ace 3 C18 column (Advanced 
Chromatography Technologies, Aberdeen, Scotland) #ACE-111-1046. There was no 
OHHL produced by S. aureus carrying pHP-L #7 (Figure 4-6). While it is probable that 
E. coli with pHP-L #7 produced OHHL, this was not certain because the retention time 
(RT) of E. coli sample OHHL (13.45) (Figure 4-5) is not the same as the standard OHHL 
RT (13.60) (Figure 4-4). Peaks at 213.9 and 214.0 m/Z in the standard and E. coli spectra, 
respectively, represent OHHL in samples (Figures 4-4 and 4-5). The E. coli and S. aureus 
spectra were prepared with time24 samples and the standard spectrum was constructed 





Figure 4-4. (A) The LC chromatogram and (B) mass/charge spectrum of the peak shown 







Figure 4-5. (A) The LC chromatogram and (B) mass/charge spectrum of the peak 
(marked with an arrow) in LC chromatogram to detect OHHL molecule in 24 h-culture of 







Figure 4-6. (A) The LC chromatogram and (B) mass/charge spectrum of the peak 
(marked with an arrow) in LC chromatogram to detect OHHL molecule in 24 h-culture of 












Detection and analysis of kanamycin resistance provided by pHP-K #4 in E. coli and 
S. aureus 
 Since pHP-L #7 produced OHHL in E. coli but not in S. aureus as shown by 
bioluminescence, fluorescence and LCMS tests, the efficiency of the construct promoter 
P59 which controls the luxI expression was tested. kanr was put in place of luxI into the 
construct to function as a bioreporter. The E. coli and S. aureus cultures with pHP-K #4 
were streaked onto LB plates containing different concentrations of kanamycin. Results 
were compared to kanamycin resistance patterns provided by other plasmids and 
constructs which contained the kanr gene under the control of different promoters and 
RBSs (Table 4-2). Compared to other plasmids, pHP-K #4 provided less resistance to 
kanamycin in S. aureus. On the other hand, the kanamycin resistance level from E. coli 
with pHP-K #4 was higher than those from other plasmids in E. coli. 
 
Table 4-2. Kanamycin resistance patterns provided by pHP-K #4 in E. coli and S. aureus. 
Patterns were compared to those of other constructs which contained kanr under the 
control of different promoters and RBSs. (R=Resistant, S=Sensitive, ND=Not 
determined, *=please see below for the construction of plasmid.) 
 Kanamycin concentration (µg/ml) 
 2.5 5 10 15 20 35 45 50 70 
pHP-K #4 in S. aureus R R R R S S S S S 
Wild type S. aureus RN4220 R R S S S S S S S 
pUB110 in S. aureus R R R R R R S S S 
pHP-PK #31 in S. aureus* R R R R R R R R R 
pHP-K #4 in E. coli  R R R R R ND ND ND ND
pHP-PK #31 in E. coli* R R R ND S S S S S 




These results are consistent with bioluminescent, fluorescent, and LCMS OHHL 
detection results from pHP-L #7 in E. coli and S. aureus. While the E. coli strain 
produced OHHL whose production is catalyzed by the product of luxI under the P59 
control, S. aureus strain did not. However, these results can not show with certainty that 
the P59 promoter of pHPS9 does not work efficiently because promoters and RBSs 
which control kanr expression and copy numbers of plasmids are different. The problem 
may be with the promoter, the RBS, or the copy number of pHPS9. Nevertheless, the 
results exhibit that the expression of a gene under the same conditions used for 
expression of luxI in pHP-L #7 construct is not efficient compared to conditions provided 
by other plasmids. 
 
Bioluminescent and fluorescent detection of OHHL from pDG-L #28 in E. coli and 
pHP-PL #9 in E. coli, B. subtilis, and S. aureus using Wallac Victor2 1420 Multilabel 
and 1450 Microbeta Plus Liquid Scintillation Counters 
  pDG-L #28 was formed by placing luxI CDS under the control of the Gram-
positive promoter and RBS of pDG148-Stu which is a Gram-positive and -negative 
expression shuttle vector. The promoter of the vector, Pspac, is a hybrid of the B. subtilis 
phage SPO-1 promoter and the lac operator which is regulated by the IPTG-inducible 
LacI repressor. Although the plasmid was transformed into E. coli, it could not be 
electroporated into S. aureus. To be able to clone luxI, which is under the control 
pDG148-Stu Pspac and RBS with lacI into S. aureus, these fragments were transferred 
into pHPS9-sht #7 (a 5 kb, shortened version of pHPS9). The resulting plasmid pHP-PL 
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#9 which is 7,256 bp was smaller than pDG-L #28 which is 8,854 bp. pHP-PL #9 could 
be electroporated into S. aureus and B. subtilis.  
The OHHL from pDG-L #28 in E. coli and pHP-PL #9 in B. subtilis and S. aureus 
was measured using bioluminescent bioreporter E. coli OHHLux, and fluorescent 
bioreporter E. coli MT102 with pJBA132. The negative control for E. coli and B. subtilis 
strains was the bioreporter alone combined with dH2O instead of the sample supernatant. 
The negative control for S. aureus sample was the wild type S. aureus strain RN4220 
supernatant combined with the bioreporter. The IPTG induction of light from plasmids 
was tested using 0.5 and 2 mM IPTG with E. coli containing pDG-L #28 and 2 and 3 mM 
IPTG with B. subtilis and S. aureus carrying pHP-PL #9.  
Bioluminescent and fluorescent values obtained with IPTG-induced strains were 
not significantly different from values obtained without IPTG (Figures 4-7 through 4-9). 
IPTG does not seem to have an inducing effect on light production. However, pDG-L #28 
in E. coli and pHP-PL #9 in B. subtilis were able to produce OHHL in the absence of 
IPTG as shown by the bioluminescence (Figures 4-7 (A) and 4-8 (A)) and fluorescence 
levels (Figures 4-7 (B) and 4-8 (B)) obtained. There was no bioluminescent or fluorescent 
OHHL detection from pHP-PL #9 in S. aureus (Figure 4-9). Bioluminescence and 
fluorescence detected from pDG-L #28 in E. coli were very high compared to those 
produced by pHP-PL #9 in B. subtilis. A comparison of the two systems is shown in 
Table 4-3. The maximum amount of light from pDG-L #28 in E. coli was 604 
(bioluminescent) and 20 (fluorescent) times higher than those from the negative control, 
while the highest light levels from pHP-PL #9 in B. subtilis were only ~3 

























pDG148-Stu-luxI #28-E. coli-2 mM IPTG
pDG148-Stu-luxI #28-E. coli-0.5 mM IPTG
pDG148-Stu-luxI #28-E. coli-no IPTG
negative control
 
Figure 4-7 (A). Bioluminescent OHHL detection from pDG-L #28 (or pDG148-Stu-luxI 
#28) in E. coli at 28oC with and without IPTG using the bioreporter E. coli OHHLux and 
Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Results represent the mean 

































pDG148-Stu-luxI #28-E. coli-2 mM IPTG
pDG148-Stu-luxI #28-E. coli-0.5 mM IPTG
pDG148-Stu-luxI #28-E. coli-no IPTG
negative control
 
Figure 4-7 (B). Fluorescent OHHL detection from pDG-L #28 (or pDG148-Stu-luxI #28) 
in E. coli at 28oC with and without IPTG using the bioreporter E. coli MT102 with 
pJBA132 and Wallac Victor2 1420 Multilabel Counter. Results represent the mean 






























pHPS9-sht-Pspac-luxI-lacI #9-B. subtilis-3 mM IPTG
pHPS9-sht-Pspac-luxI-lacI #9-B. subtilis-2 mM IPTG
pHPS9-sht-Pspac-luxI-lacI #9-B. subtilis-no IPTG
negative control
 
Figure 4-8 (A). Bioluminescent OHHL detection from pHP-PL #9 (or pHPS9-sht-Pspac-
luxI-lacI #9) in B. subtilis at 28oC with and without IPTG using the bioreporter E. coli 
OHHLux and Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Results 

































pHPS9-sht-Pspac-luxI-lacI #9-B. subtilis-3 mM IPTG
pHPS9-sht-Pspac-luxI-lacI #9-B. subtilis-2 mM IPTG
pHPS9-sht-Pspac-luxI-lacI #9-B. subtilis-no IPTG
negative control
 
Figure 4-8 (B). Fluorescent OHHL detection from pHP-PL #9 (or pHPS9-sht-Pspac-luxI-
lacI #9) in B. subtilis at 28oC with and without IPTG using the bioreporter E. coli MT102 
with pJBA132 and Wallac Victor2 1420 Multilabel Counter. Results represent the mean 
























pHPS9-sht-Pspac-luxI-lacI #9-S. aureus-3 mM IPTG
pHPS9-sht-Pspac-luxI-lacI #9-S. aureus-2 mM IPTG
pHPS9-sht-Pspac-luxI-lacI #9-S. aureus-no IPTG
negative control
 
Figure 4-9 (A). Bioluminescent OHHL detection from pHP-PL #9 (or pHPS9-sht-Pspac-
luxI-lacI #9) in S. aureus at 28oC with and without IPTG using the bioreporter E. coli 
OHHLux and Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Results 


































0) pHPS9-sht-Pspac-luxI-lacI #9-S. aureus-3 mM IPTG
pHPS9-sht-Pspac-luxI-lacI #9-S. aureus-2 mM IPTG
pHPS9-sht-Pspac-luxI-lacI #9-S. aureus-no IPTG
negative control
 
Figure 4-9 (B). Fluorescent OHHL detection from pHP-PL #9 (or pHPS9-sht-Pspac-luxI-
lacI #9) in S. aureus at 28oC with and without IPTG using the bioreporter E. coli MT102 
with pJBA132 and Wallac Victor2 1420 Multilabel Counter. Results represent the mean 









Table 4-3. Comparison of bioluminescence and fluorescence from pDG-L #28 in E. coli 
and pHP-PL #9 in B. subtilis. Bioluminescence was detected using the bioreporter E. coli 
OHHLux and Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Fluorescence 
was detected using the bioreporter E. coli MT102 harboring pJBA132 and Wallac 
Victor2 1420 Multilabel Counter. (MI = maximum induction; the highest amount of light 
from a sample divided by the negative control value at the same time point, T = Time 
period in h to obtain MI) 
 pDG-L #28 in E. coli pHP-PL #9 in B. subtilis  
 MI T MI T 
Bioluminescence 604X 7 3.12X 5.5 
Fluorescence 20X 16 1.74X 16 
 
The Pspac promoter of pHP-PL #9 was also evaluated using the Overnight 
Express Autoinduction System 1 (Novagen, Darmstadt, Germany) instead of IPTG. This 
system is a mixture of optimized media components which is used by combining with a 
glucose-free complex medium like LB. Lactose in the resulting medium induces protein 
expression after bacteria reach high densities. It replaces IPTG for protein expression 
induction in IPTG-inducible hosts. Escherichia coli, B. subtilis and S. aureus with pHP-
PL #9 were tested for OHHL production using this system. Bioluminescent and 
fluorescent bioreporters were E. coli OHHLux and E. coli MT102 carrying pJBA132, 
respectively, which were grown in LB. The negative control for the S. aureus sample was 
S. aureus RN4220 which was grown in the Novagen System medium. Its supernatant was 
combined with the bioreporter and tested. The negative control for E. coli and B. subtilis 
samples was the bioluminescent or fluorescent bioreporter combined with dH20 instead 




High levels of bioluminescence and fluorescence were obtained from E. coli and 
B. subtilis containing pHP-PL #9 (Figures 4-10 and 4-11) while there was no light 
produced by S. aureus carrying pHP-PL #9 (Figure 4-12) with the Overnight Express 
Autoinduction System 1 (Novagen, Darmstadt, Germany). Results were compared to 
those obtained from the previous experiment with the strains with no induction (Figures 
4-7 and 4-8, Table 4-4). Since E. coli harboring pHP-PL #9 was not tested for IPTG 
induction, results from IPTG induction of E. coli with pDG-L #28 were used for 
comparison. pHP-PL #9 and pDG-L #28 carry luxI CDS under the control of the same 
promoter and RBS and they both have Gram-negative pBR322 origin of replication, 
pMB1. The maximum bioluminescence and fluorescence from pHP-PL #9 in E. coli and 
B. subtilis with the Overnight Express Autoinduction System 1 (Novagen, Darmstadt, 
Germany) were not significantly different from those produced by pDG-L #28 in E. coli 
and pHP-PL #9 in B. subtilis under no induction (Table 4-4). Therefore, the Overnight 
Express Autoinduction System 1 (Novagen, Darmstadt, Germany) does not have an 



























pHPS9-sht-Pspac-luxI-lacI #9-E. coli-Novagen Medium
negative control
 
Figure 4-10 (A). Bioluminescent OHHL detection from pHP-PL #9 (or pHPS9-sht-
Pspac-luxI-lacI #9) in E. coli in Overnight Express Autoinduction System 1 (Novagen, 
Darmstadt, Germany) at 28oC using the bioreporter E. coli OHHLux and Wallac 1450 
Microbeta Plus Liquid Scintillation Counter. Results represent the mean bioluminescence 



































pHPS9-sht-Pspac-luxI-lacI #9-E. coli-Novagen Medium
negative control
 
Figure 4-10 (B). Fluorescent OHHL detection from pHP-PL #9 (or pHPS9-sht-Pspac-
luxI-lacI #9) in E. coli in Overnight Express Autoinduction System 1 (Novagen, 
Darmstadt, Germany) at 28oC using the bioreporter E. coli MT102 with pJBA132 and 
Wallac Victor2 1420 Multilabel Counter. Results represent the mean fluorescence values 



























pHPS9-sht-Pspac-luxI-lacI #9-B. subtilis-Novagen Medium
negative control
 
Figure 4-11 (A). Bioluminescent OHHL detection from pHP-PL #9 (or pHPS9-sht-
Pspac-luxI-lacI #9) in B. subtilis in Overnight Express Autoinduction System 1 
(Novagen, Darmstadt, Germany) at 28oC using the bioreporter E. coli OHHLux and 
Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Results represent the mean 
































pHPS9-sht-Pspac-luxI-lacI #9-B. subtilis-Novagen Medium
negative control
 
Figure 4-11 (B). Fluorescent OHHL detection from pHP-PL #9 (or pHPS9-sht-Pspac-
luxI-lacI #9) in B. subtilis in Overnight Express Autoinduction System 1 (Novagen, 
Darmstadt, Germany) at 28oC using the bioreporter E. coli MT102 with pJBA132 and 
Wallac Victor2 1420 Multilabel Counter. Results represent the mean fluorescence values 

























pHPS9-sht-Pspac-luxI-lacI #9-S. aureus-Novagen Medium
negative control
 
Figure 4-12 (A). Bioluminescent OHHL detection from pHP-PL #9 (or pHPS9-sht-
Pspac-luxI-lacI #9) in S. aureus in Overnight Express Autoinduction System 1 (Novagen, 
Darmstadt, Germany) at 28oC using the bioreporter E. coli OHHLux and Wallac 1450 
Microbeta Plus Liquid Scintillation Counter. Results represent the mean bioluminescence 































pHPS9-sht-Pspac-luxI-lacI #9-S. aureus-Novagen Medium
negative control
 
Figure 4-12 (B). Fluorescent OHHL detection from pHP-PL #9 (or pHPS9-sht-Pspac-
luxI-lacI #9) in S. aureus in Overnight Express Autoinduction System 1 (Novagen, 
Darmstadt, Germany) at 28oC using the bioreporter E. coli MT102 with pJBA132 and 
Wallac Victor2 1420 Multilabel Counter. Results represent the mean fluorescence values 








Table 4-4. Overnight Express Autoinduction System 1 (Novagen, Darmstadt, Germany) 
effect on bioluminescence and fluorescence from constructs using IPTG-inducible Pspac. 
Bioluminescence was detected using the bioreporter E. coli OHHLux and Wallac 1450 
Microbeta Plus Liquid Scintillation Counter. Fluorescence was detected using the 
bioreporter E. coli MT102 harboring pJBA132 and Wallac Victor2 1420 Multilabel 
Counter. (LB = in LB, OEAS = in Overnight Express Autoinduction System 1, MI = 
maximum induction-the highest amount of light from a sample divided by the negative 








pHP-PL #9 in 
B. subtilis-LB 
pHP-PL #9 in 
B. subtilis-
OEAS 
Bioluminescence 604X(7)* 114X(7.5)* 3.12X(5.5)* 2.4X(21.5)* 
Fluorescence 20X(16)* 14X(17.5)* 1.74X(16)* 2.83X(16)* 
 
The luxI transcript detection from pHP-PL #9 and pDG-L #28 using real-time 
quantitative reverse transcriptase PCR 
To determine the reason for generation of light by E. coli and B. subtilis which 
contained pHP-PL #9 but not by S. aureus carrying pHP-PL #9, efficiency of the 
promoter Pspac was controlled. Transcription of luxI from pHP-PL #9 in E. coli, B. 
subtilis and S. aureus and pDG-L #28 in E. coli was tested using real-time qRT-PCR. The 
wild type S. aureus RN4220 was the negative control for the experiment. RNAs extracted 
from mid-log phase cultures were subjected to real-time qRT-PCR with primers and a 
labeled probe which are specific to luxI. The same amount of RNA (125 ng) was used for 
each sample which was prepared in triplicate. An additional reverse transcriptase-free 
reaction was also tested for each sample to control DNA contamination. Opticon Monitor 
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Analysis Software Version 1.08 was used for data analysis. The baseline was measured 
between cycles 3 and 7. 
Figure 4-13 shows results as plots of fluorescence versus the number of cycles for 
each sample. The threshold cycle (CT) for each sample was determined by calculating the 
mean of triplicate measurements (Table 4-5). There was negligible level of DNA 
contamination from the samples as shown by the reverse transcriptase-free reaction 
results with the CT difference of ≥7 between the triplicate sample average and the control 
values (Figure 4-13 and Table 4-5). The aim of this experiment was to detect the presence 
or absence of luxI transcripts and to compare them with one another. Therefore, the 
amounts of transcripts were not determined. Figure 4-13 and Table 4-5 show that all 
samples except for the negative control produced the luxI transcript. Comparison of CT 
values show that the order of samples, starting with the one with the highest amount of 
transcript to the one with the lowest amount, is pHP-PL #9 in B. subtilis>pDG-L #28 in 
E. coli>pHP-PL #9 in S. aureus>pHP-PL #9 in E. coli. Although pHP-PL #9 in S. aureus 
can not generate light, it produces the transcript of luxI. All other samples which were 





Figure 4-13 (A). Real-time qRT-PCR plots for luxI transcription from wild-type S. aureus 
(negative control). Reverse transcriptase-free control (n=1, yellow) was included to check 
DNA contamination.The horizontal line shows the baseline. The point at which the plot 
crosses the baseline is CT. 
 
 
Figure 4-13 (B). Real-time qRT-PCR plots for luxI transcription from pDG-L #28 (or 
pDG148-Stu-luxI #28) in E. coli (n=3). Reverse transcriptase-free control (n=1, yellow) 
was included to check DNA contamination.The horizontal line shows the baseline. The 




Figure 4-13 (C). Real-time qRT-PCR plots for luxI transcription from pHP-PL #9 (or 
pHPS9-sht-Pspac-luxI-lacI #9) in E. coli (n=3). Reverse transcriptase-free control (n=1, 
yellow) was included to check DNA contamination.The horizontal line shows the 
baseline. The point at which the plot crosses the baseline is CT. 
 
 
Figure 4-13 (D). Real-time qRT-PCR plots for luxI transcription from pHP-PL #9 (or 
pHPS9-sht-Pspac-luxI-lacI #9) in B. subtilis (n=3). Reverse transcriptase-free control 
(n=1, yellow) was included to check DNA contamination.The horizontal line shows the 




Figure 4-13 (E). Real-time qRT-PCR plots for luxI transcription from pHP-PL #9 (or 
pHPS9-sht-Pspac-luxI-lacI #9) in S. aureus (n=3). Reverse transcriptase-free control 
(n=1, yellow) was included to check DNA contamination.The horizontal line shows the 
baseline. The point at which the plot crosses the baseline is CT. 
 
 
Table 4-5. Real-time qRT-PCR CT values for luxI transcription from pDG-L #28 in E. 
coli and pHP-PL #9 in E. coli, B. subtilis, and S. aureus. (CT(ave) = the average of 
triplicate CT measurements, control CT = the reverse transcriptase-free control for DNA 
contamination)  




S. aureus RN4220 (the negative control) None 39.3 No 
pDG-L #28 in E. coli 12.9 24.8 Yes 
pHP-PL #9 in E. coli 18.2 30.1 Yes 
pHP-PL #9 in B. subtilis 12.6 26.8 Yes 






luxI translation product detection from pHP-PL #9 and pDG-L #28 using SDS-
PAGE and Western Blotting 
To determine whether LuxI is produced, soluble and insoluble protein extracts 
from E. coli, B. subtilis and S. aureus with pHP-PL #9 and E. coli containing pDG-L #28 
were controlled with SDS-PAGE and Western Blotting. SDS-PAGE was used to 
determine protein yields. Western Blotting was performed using the LuxI antibody. The 
wild type S. aureus RN4220 was the negative control. 
The B. subtilis soluble and E. coli insoluble protein yields were very low after the 
first extraction (Figure 4-14 (A)). Since LuxI protein was detected in soluble fractions of 
E. coli strains, another extraction was not performed for insoluble fractions. However, 
there was no LuxI in B. subtilis samples (Figure 4-15 (A)). Therefore, another extraction 
was done with French Press to increase protein yield. After verification of the high yield 
with SDS-PAGE (Figure 4-14 (A)), the extract was used for Western Blotting. 
Protein yields from extractions were high enough to be visible on gels except for 
the E. coli insoluble fractions as shown by SDS-PAGE results (Figure 4-14). Western 
Blotting showed the presence of the LuxI protein only in soluble fractions of E. coli 
strains carrying pHP-PL #9 or pDG-L #28 (Figure 4-15). There was no LuxI detection in 





       
Figure 4-14. SDS-PAGE of total protein extracts from E. coli, B. subtilis and S. aureus 
with pHP-PL #9; and E. coli containing pDG-L #28. (A) First extraction proteins (B) 
First extraction EC1 protein and second extraction BS protein. (EC1 = E. coli containing 
pDG-L #28; EC2 = E. coli with pHP-PL #9; BS = B. subtilis harboring pHP-PL #9; SA = 








    
Figure 4-15. Western blotting for LuxI detection from E. coli, B. subtilis and S. aureus 
with pHP-PL #9; and E. coli containing pDG-L #28. (A) First extraction proteins (B) 
First extraction EC1 protein and second extraction BS protein. (EC1 = E. coli containing 
pDG-L #28; EC2 = E. coli with pHP-PL #9; BS = B. subtilis harboring pHP-PL #9; SA = 
S. aureus carrying pHP-PL #9; NC = wild-type S. aureus) 
 
Detection and analysis of kanamycin resistance provided by pHP-PK #31 in S. 
aureus 
Although both E. coli and B. subtilis containing pHP-PL #9 are capable of 
producing light, S. aureus carrying pHP-PL #9 is not. S. aureus with pHP-PL #9 was 
shown to produce the luxI transcript at a level which is close to that of B. subtilis 
containing pHP-PL #9 and higher than that of E. coli harboring pHP-PL #9. However, the 
LuxI protein could be detected only in E. coli with pHP-PL #9 but not in S. aureus and B. 
subtilis carrying pHP-PL #9 using the LuxI antibody. Therefore, RBS efficiency of pHP-





native gene of S. aureus. Utilization of a native gene eliminates the codon preference 
problem during the expression of transcript. 
Table 4-6 shows the comparison of kanamycin resistance patterns detected with 
pHP-PK #31 in S. aureus to those of the other plasmids and constructs which have the 
kanr gene under the control of various promoters and RBSs in S. aureus. Figure 4-16 
shows the plates with various kanamycin concentrations (10-70 µg/ml) which were 
streaked with S. aureus carrying pHP-PK #31 and S. aureus containing pUB110 for 
comparison.  
 
Table 4-6. Kanamycin resistance patterns provided by pHP-PK #31 in S. aureus. Patterns 
were compared to those of other constructs which contained kanr under the control of 
different promoters and RBSs in S. aureus. (R = Resistant, S = Sensitive.) 
 Kanamycin concentration (µg/ml) 
 2.5 5 10 15 20 25 30 35 45 50-70 
pHP-PK #31  R R R R R R R R R R 
Wild-type S. aureus 
RN4220 
R R S S S S S S S S 
pUB110 R R R R R R R R R S 





Figure 4-16. Kanamycin resistance patterns provided by pHP-PK #31 in S. aureus 
compared to those from pUB110 in S. aureus. Arrows point to colonies of S. aureus 
carrying pHP-PK #31. Other colonies are of S. aureus containing pUB110. 
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 Both Figure 4-16 and Table 4-6 show that pHP-PK #31 in S. aureus provided the 
highest level of kanamycin resistance among all plasmids in S. aureus. Plasmids used for 
comparison carry kanr CDS under the control of various RBS and promoters and in 
vectors with different copy numbers so the RBS efficiency is not the only reason for 
difference between patterns of kanamycin resistance. However, it was found previously 
that pHP-PK #31 in S. aureus produces RNA amounts which are the same as or higher 
than those of strains which can produce light using the same construct. Therefore, 
kanamycin resistance patterns provided by pHP-PK #31 in S. aureus provide evidence 
that the RNA produced can be translated to protein amounts which are even higher than 
those produced by pUB110 from which kanr CDS originates as long as a S. aureus-native 
gene is used. This at least shows that there is no problem with utilization of pHP-PK #31 
RBS in S. aureus. 
 
Bioluminescent and fluorescent detection of OHHL from pHP-POL #5 in E. coli, B. 
subtilis, and S. aureus using Wallac Victor2 1420 Multilabel and 1450 Microbeta 
Plus Liquid Scintillation Counters 
While the luxI transcript was obtained from pHP-PL #9 in S. aureus, LuxI protein 
was not detected. RBS of the construct was shown to work by exchanging luxI with a 
native S. aureus gene, kanr. To determine if the problem for luxI translation in S. aureus 
is codon preference, the codons of luxI CDS were adapted to the codon bias of S. aureus 
phage P68. Although S. aureus RN4220 was the strain used for pHP-PL #9 expression, it 
was not selected for codon adaptation since its genome sequence is not known. P68 is not 
only the phage which luxI was planned to clone into but was also demonstrated to carry 
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genes most of which have high translation efficiency (616). Therefore, P68-optimized 
luxI replaced original luxI in pHP-PL #9, resulting in the construction of pHP-POL #5. 
pHP-POL #5 was tested for OHHL production in E. coli, B. subtilis, and S. aureus 
using bioluminescent bioreporter E. coli OHHLux and fluorescent bioreporter E. coli 
MT102 with pJBA132. Staphylococcus aureus RN4220 was the negative control for S. 
aureus sample while the bioreporter combined with dH2O instead of supernatant was 
used as the negative control for E. coli and B. subtilis samples. All samples and controls 
were prepared in triplicate. Wallac Victor2 1420 Multilabel Counter performed 
fluorescence and absorbance measurements while Wallac 1450 Microbeta Plus Liquid 
Scintillation Counter detected only bioluminescence. The Wallac Victor2 1420 
Multilabel Counter measurements were normalized by dividing GFP data by OD450 
values. Bioluminescence or fluorescence values at each time point represent the mean 
value of triplicate measurements. All measurements were carried out at 28oC.  
Results are shown in Figures 4-17 through 4-19. Although bioluminescence and 
fluorescence were obtained from pHP-POL #5 in E. coli and B. subtilis, pHP-POL #5 in 
S. aureus did not produce any light. However, comparison of maximum induction values 
obtained from E. coli and B. subtilis samples to those from E. coli and B. subtilis carrying 
non-optimized luxI (Table 4-7) shows that optimization of luxI decreased the amount of 
light from E. coli significantly, while the increase in light from B. subtilis was not 
significant. Therefore, lack of light from S. aureus containing pHP-POL #5 can not be 
used to eliminate the possibility of codon preference problem since it is not certain 



























pHPS9-sht-Pspac-optluxI-lacI #5 in E. coli
negative control
 
Figure 4-17 (A). Bioluminescent OHHL detection of from pHP-POL #5 (or pHPS9-sht-
Pspac-optluxI-lacI #5) in E. coli at 28oC using the bioreporter E. coli OHHLux and 
Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Results represent the mean 
































pHPS9-sht-Pspac-optluxI-lacI #5 in E. coli
negative control
 
Figure 4-17 (B). Fluorescent OHHL detection from pHP-POL #5 (or pHPS9-sht-Pspac-
optluxI-lacI #5) in E. coli at 28oC using the bioreporter E. coli MT102 with pJBA132 and 
Wallac Victor2 1420 Multilabel Counter. Results represent the mean fluorescence values 
























pHPS9-sht-Pspac-optluxI-lacI #5 in B. subtilis
negative control
 
Figure 4-18 (A). Bioluminescent OHHL detection from pHP-POL #5 (or pHPS9-sht-
Pspac-optluxI-lacI #5) in B. subtilis at 28oC using the bioreporter E. coli OHHLux and 
Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Results represent the mean 






























0 ) pHPS9-sht-Pspac-optluxI-lacI #5 in B. subtilis
negative control
 
Figure 4-18 (B). Fluorescent OHHL detection from pHP-POL #5 (or pHPS9-sht-Pspac-
optluxI-lacI #5) in B. subtilis at 28oC using the bioreporter E. coli MT102 with pJBA132 
and Wallac Victor2 1420 Multilabel Counter. Results represent the mean fluorescence 
























pHPS9-sht-Pspac-optluxI-lacI #5 in S. aureus
negative control
 
Figure 4-19 (A). Bioluminescent OHHL detection from pHP-POL #5 (or pHPS9-sht-
Pspac-optluxI-lacI #5) in S. aureus at 28oC using the bioreporter E. coli OHHLux and 
Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Results represent the mean 































pHPS9-sht-Pspac-optluxI-lacI #5 in S. aureus
negative control
 
Figure 4-19 (B). Fluorescent OHHL detection from pHP-POL #5 (or pHPS9-sht-Pspac-
optluxI-lacI #5) in S. aureus at 28oC using the bioreporter E. coli MT102 with pJBA132 
and Wallac Victor2 1420 Multilabel Counter. Results represent the mean fluorescence 









Table 4-7. Comparison of bioluminescence and fluorescence from constructs that carry 
non-optimized or optimized luxI for adaptation to the codon bias of S. aureus phage P68. 
Bioluminescence was detected using the bioreporter E. coli OHHLux and Wallac 1450 
Microbeta Plus Liquid Scintillation Counter. Fluorescence was detected using the 
bioreporter E. coli MT102 harboring pJBA132 and Wallac Victor2 1420 Multilabel 
Counter. (MI = maximum induction-the highest amount of light from a sample divided 
by the negative control value at the same time point, * = Time period in h to obtain MI)  
 
pDG-L 
#28 in E. 
coli 
pHP-PL 
#9 in E. 
coli 
pHP-PL 
#9 in B. 
subtilis 
pHP-POL 
#5 in E. 
coli 
pHP-POL 
#5 in B. 
subtilis 
Bioluminescence 604X(7)* 114X(7.5)* 3.12X(5.5)* 2X(8)* 4X(8)* 
Fluorescence 20X(16)* 14X(17.5)* 1.74X(16)* 1.7X(16.5)* 2.8X(16.5)* 
 
 
Invitro packaging of S. aureus phage P68 genome 
Staphylococcus aureus phage P68 was selected for luxI cloning to construct the 
recombinant phage for the S. aureus monitoring system. An invitro packaging method 
was developed by using only the P68 genome. The genome purified was packaged using 
MaxPlax Lambda Packaging Extracts (Epicentre Biotechnologies, Madison, WI). The 
phage obtained tested positive for infection of the host strain S. aureus RN451. 
Staphylococcus aureus phage P68 genome can be packaged invitro using MaxPlax 







Summary of results obtained with plasmids used to determine the luxI expression 
efficiency in S. aureus; and in E. coli and B. subtilis as controls 
Table 4-8 shows a summary of results obtained with all constructs which were 
used to determine luxI expression efficiency in S. aureus and also in E. coli and B. 







Table 4-8. A summary of results from all constructs used to determine luxI expression 
efficiency in S. aureus; and in E. coli and B. subtilis as controls. (x = not tested) 
Plasmid in E. coli in B. subtilis in S. aureus 
pMO-L #7 no light production x x 
pMK-L #13.3 x x no light production 
pHP-L #7 light production x no light production 




RBS = x 
decrease in light 
when optimized 





LuxI not detected 
RBS = x 
no significant 
increase in light 
when optimized luxI 
exchanged with luxI  
no light production 
luxI transcript 
detected 
LuxI not detected 
RBS working 








DISCUSSION AND CONCLUSIONS 
CONSTRUCTION OF S. AUREUS BIOREPORTER 
 
 The expression of luxI gene in S. aureus was examined in this work. The gene 
was cloned into E. coli, B. subtilis, and S. aureus under the control of various RBSs and 
promoters specific to Gram-positive bacteria. After the trial of several constructs, 
significant light was generated with E. coli using the pDG148-Stu RBS and promoter. 
The same construct provided a moderate level of light in B. subtilis compared to that of 
E. coli. However, there was no light from S. aureus. The reason for this was investigated 
by measuring the luxI transcript and protein using real-time qRT-PCR and Western 
blotting, respectively. Although the presence of luxI transcript was shown in E. coli, B. 
subtilis, and S. aureus carrying the construct, the protein was detected only in E. coli. The 
adaptation of luxI codons for S. aureus phage P68 genome codon utilization to increase 
LuxI production in S. aureus was not successful in generating light from S. aureus 
harboring the construct. 
 First, luxI was cloned into EZ::TN pMOD-2<MCS> plasmid (Epicentre 
Biotechnologies, Madison, WI) between two MEs. MEs are EZ::TN transposase 
(Invitrogen, Carlsbad, CA) recognition sites for transposition of the region between MEs 
to occur. The original plan was to clone luxI into S. aureus phage Twort using 
transposition since its genome sequence was not known at this point. The RBS of luxI 
which is from Gram-negative V. fischeri was changed into a Gram-positive RBS (615). 
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The Gram-negative RBS is too weak for Gram-positive ribosomes since Gram-positive 
bacteria do not posses ribosomal protein S1 which is found in E. coli (615). S1 is thought 
to provide the positioning which is necessary for SD (Shine-Dalgarno) sequence of RBS 
to interact with the initiation codon signals on the 3′ end of the 16S rRNA, part of 
ribosomal 30S subunit, by binding to RNA non-specifically (617). Therefore, Gram-
positive SD sites need to be in more extensive complementarity with the 3′ end of the 16S 
rRNA compared to Gram-negative bacteria. This causes Gram-positive ribosomes to 
show RBS selectivity. The SD sequence was placed 7 bps upstream of the luxI CDS, 
which is typical for S. aureus (615). luxI with the Gram-positive RBS was placed under 
the control of S. aureus phage Ф85 X8 promoter (605) into pMOD-2<MCS> vector. The 
resulting construct, pMO-L #7, did not produce light in E. coli although X8 was found to 
be a promoter stronger than E. coli λ PTac and PL promoters (605).  
The X8 promoter-S. aureus RBS-luxI CDS  fragment was integrated into pMK4 
which is a Gram-positive and -negative shuttle vector and cloned into S. aureus to test the 
expression of luxI in S. aureus under the control of same RBS and promoter. There was 
no generation of light from S. aureus as well. The source of X8 promoter which was 
amplified from the phage Ф85 genome was the X8 sequence described by Carbonelli et 
al. (605). Although its sequence was different from Carbonelli et al. (605), the putative 
promoter region was conserved. Therefore, the fragment obtained was used as the 
promoter region for constructs. The genome of phage Ф85 was sequenced later in 2005 
(606). The X8 sequence from the Carbonelli et al. article (605) and the sequence used in 
this study were aligned with the phage genome sequence by using BLAST engine for 




Figure 5-1 (A). The aligning of phage Ф85 genome sequence (the sense strand) and the 
X8 promoter sequence (the sense strand) used in construction of pMO-L #7 using 
BLAST. Vertical lines show identical bases. (Query = phage genome sequence, subject = 





Figure 5-1 (B). The aligning of phage Ф85 genome sequence (the sense strand) and the 
X8 promoter sequence (the sense strand) described by Carbonelli et al. (605) using 
BLAST. Vertical lines show identical bases and horizontal lines show missing 










While the X8 promoter sequence used for constructs match the phage genome 
sequence completely, this is not the case for the X8 promoter sequence reported by 
Carbonelli et al. (605). Out of a total 366 bps of the promoter sequence, 1-104th, 100-
149th, and 175-355th bps match with different parts of the phage genome. The other sites 
of the promoter are extra regions which do not exist in the genome sequence. The X8 
promoter was found experimentally by Carbonelli et al. (605) by placing DNA fragments 
obtained from digestion of various S. aureus phage genomes in place of the ampicillin 
resistance gene promoter. It was determined to belong to phage Ф85 using hybridization. 
The authors stated that it provides high ampicillin resistance and contains putative 
promoter motifs such as -10 and -35 regions. Based on these, the authors claimed that X8 
possesses a real, strong promoter. However, the X8 sequence seems to be a combination 
of different regions some of which are not found in the phage Ф85 genome. Although the 
promoter motifs mentioned in the article are found in the X8 fragment of 175-355th bps 
which matches with the phage genome, these are putatively determined motifs. It is 
possible that the promoter sequence used for the constructs did not have the regions 
which acted as the promoter in the Carbonelli et al. study (605). 
Expression of luxI in E. coli and S. aureus was tested using another promoter, P59 
of pHPS9 plasmid. P59 is a Gram-positive promoter from L. lactis. luxI was cloned into 
pHPS9 in front of P59 under the control of same Gram-positive RBS used for previous 
constructs. With this construct, light was obtained from E. coli although there was no 
light from S. aureus. To determine if the lack of light from S. aureus is caused by a 
problem at the OHHL or LuxI production level, LCMS was used. OHHL production 
from E. coli and S. aureus harboring the construct was determined by LCMS. While E. 
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coli was found to produce it (however without certainty), there was no OHHL from S. 
aureus. The luxI CDS was replaced with S. aureus kanr CDS from pDG148-Stu (same as 
the kanr CDS from pUB110) to examine the efficiency of the construct for the insert 
production. It was named pHP-K #4. Kanamycin resistance provided by the insert under 
the control of same RBS and promoter and in the same plasmid used for luxI was 
determined. Results were compared to those of other constructs carrying kanr CDS from 
this study (Table 4-2). pHP-K #4 in S. aureus provided the lowest kanamycin resistance 
compared to the other plasmids in S. aureus. kanr CDS is under the control of various 
RBSs and promoters and in plasmids with different copy numbers with these constructs 
(Table 5-1). 
 
Table 5-1. Comparison of copy numbers, RBSs, and promoters of constructs used for 
determination of S. aureus kanamycin resistance patterns. 
Construct Kanr Plasmid copy no RBS used for 
kanr 
Promoter used for kanr 
pHP-K #4 15 
µg/ml 
unknown in S. 
aureus, 5 in B. 
subtilis (pTA1060 
ori) (610) 





P59 from pHPS9 
pUB110 35 
µg/ml 
10 in S. aureus, 50 









unknown in S. 






Pspac from pDG148-Stu, 
hybrid of the B. subtilis 
phage SPO-1 promoter 





Although pHP-K #4 copy number in S. aureus is not known, it is the same as the 
pHP-PK #31 copy number since both plasmids carry the same Gram-positive origin of 
replication. pHP-PK #31 provided much higher Kanr. The plasmid copy number does not 
seem to be the reason for weak Kanr level. Promoters and RBSs used for constructs are all 
different from one another. Therefore, the reason for the low efficiency of pHP-K #4 in S. 
aureus can be either one of these or a combination of them. pHP-K #4 in E. coli was 
found to produce the highest Kanr level compared to other constructs, unlike S. aureus 
(Table 4-2). Since all constructs has the same ori, pMB1, for E. coli, the copy number for 
all of them is the same (15-20/chromosome) (610, ATCC). The different responses of the 
constructs in E. coli may be originating from either the promoter or RBS, or both. This 
difference between Kanr from E. coli and S. aureus provided by the same construct was 
expected. E. coli ribosomes can use mRNA from a range of Gram-positive and -negative 
organisms while Gram-positive ribosomes show RBS selectivity as explained previously 
(617). Studies have shown that the same promoters show different transcription levels in 
E. coli and S. aureus (618-620). Also, constructs have higher copy numbers in E. coli. 
Other reasons may be mRNA or protein stability or codon utilization differences between 
two species. 
 luxI was cloned into a Gram-positive and -negative shuttle expression vector, 
pDG148-Stu in front of the Gram-positive promoter Pspac and RBS of the plasmid (611). 
Pspac is a hybrid promoter of the B. subtilis phage SPO-1 and the lac operator (611, 
622). The plasmid also carries E. coli lacI repressor CDS under the control of 
penicillinase RBS and promoter of B. licheniformis to be expressed in B. subtilis (622). 
Therefore, Pspac which is repressed by LacI is induced when IPTG is added since IPTG 
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represses lacI. The IPTG-inducible promoter of the plasmid allows utilization of only 
SDS-PAGE to detect LuxI production. The resulting plasmid, pDG-L #28, could not be 
electroporated into S. aureus. To decrease the size of the plasmid, lacI and luxI under the 
control of Pspac and RBS were integrated into a shortened version of pHPS9. This 
smaller construct, pHP-PL #9, could be transferred into S. aureus and B. subtilis. The 
expression obtained with this plasmid was constitutive. IPTG (or IPTG substitute, 
Overnight Express Autoinduction System 1 of Novagen (Darmstadt, Germany) had no 
inducing effect on the promoter for both E. coli and B. subtilis. Therefore, further 
experiments were performed without IPTG addition. For lac repressor-operator system to 
be functional, both lac repressor and operator need to work properly (622). The binding 
site of the repressor not only contains the lac operator but also a part of the lacZ. The 
replacement of this region with a foreign gene may decrease the affinity of the repressor 
for the operator. Inability of the lac repressor to work leads to constitutive expression 
(622, 623). When the lac operator does not function, IPTG can not induce the promoter 
(622). 
Light was obtained from E. coli and B. subtilis but not from S. aureus with pHP-
PL #9. pDG-L #28 in E. coli generated light as well. However, the amount of light 
produced by E. coli with both constructs was much higher than B. subtilis light levels, 
pointing to the fact that the constructs work more efficiently in E. coli.  
To determine the reason for the absence of light from S. aureus, luxI transcript 
and protein product were examined. luxI transcript was found in all strains with the 
constructs including S. aureus using the real time qRT-PCR (Table 4-5 and Figure 4-13). 
The amount of RNA (total) used for the experiment was the same (125 ng) for all strains. 
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All extractions were performed using the mid-log phase cultures. Since the aim was to 
detect only the presence or absence of luxI transcript, its amount was not determined.  
The transcript amounts from different constructs were compared with one another. The 
order of the strains from the one with the highest amount of transcript to the one with the 
lowest is B. subtilis with pHP-PL #9>E. coli with pDG-L #28>S. aureus with pHP-PL 
#9>E. coli with pHP-PL #9. Production of LuxI was checked by Western Blotting using 
an antibody which targeted a certain region of the LuxI sequence. The antibody detected 
LuxI in E. coli strains carrying pHP-PL #9 or pDG-L #28 but not in B. subtilis and S. 
aureus harboring pHP-PL #9 (Figure 4-15).  
 Since luxI transcript was detected from S. aureus but not LuxI, the efficiency of 
the construct for a native S. aureus gene CDS was tested to eliminate the codon 
preference problem. luxI CDS in pHP-PL #9 was replaced by the S. aureus kanr CDS. 
Resistance to kanamycin provided by this construct, pHP-PK #31, was compared to those 
by other constructs in S. aureus. pHP-PK #31 was resistant up to 70 µg/ml kanamycin 
while pHP-K #4 was kanr up to 15 µg/ml and pUB110 (the source of kanr CDS) up to 45 
µg/ml (Figure 4-16 and Table 4-6). pHP-PK #31 kanamycin resistance level was high 
unlike the other constructs (624-626). All constructs contained the same kanr CDS under 
the control of different RBSs and promoters with different copy numbers in S. aureus 
(Table 5-1), so differences between Kanr levels demonstrate efficiencies of all these 
features combined for the production of a native gene. Results show the capability of 
pHP-PK #31 to produce high amounts of the gene product in S. aureus, provided that the 
gene CDS is native to S. aureus. 
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 luxI CDS was adapted to the codon bias of S. aureus phage P68 to eliminate 
potential problems which may be caused by codon preference. Phage P68 was used 
because it was the phage which was selected to use for construction of the recombinant 
phage with luxI and its genes have high translation efficiency (616). Optimized luxI gene 
replaced luxI in pHP-PL #9. The new construct, pHP-POL #5, was tested for light 
generation. Escherichia coli and B. subtilis harboring the construct produced light while 
S. aureus did not (Figures 4-17 through 4-19). However, light generated by E. coli 
decreased significantly and light from B. subtilis was not increased significantly 
compared to non-optimized luxI light levels (Table 4-7), which may point to an 
unsuccessful optimization process. Therefore, optimization results can not be used to 
assess the effect of codon preference on luxI expression in S. aureus. 
 luxI transcript production from pHP-PL #9 showed that the promoter Pspac 
worked efficiently in all strains including S. aureus. LuxI was detected from E. coli 
carrying pHP-PL #9 or pDG-L #28 which produces light but not from S. aureus 
harboring pHP-PL #9 which is light negative. Although B. subtilis with pHP-PL #9 
generates light, there was no LuxI detection from this strain. This shows that there may 
be a problem with the protein detection method. Therefore, the absence of LuxI from S. 
aureus does not mean that it does not produce LuxI. The problem may be 
posttranslational modification of the protein in Gram-positive B. subtilis and S. aureus, 
which may be occurring in a different way or not be occurring at all in Gram-negative V. 
fischeri (source of luxI) and E. coli (627). The other possibility is an insufficient amount 
of protein from the strain to produce a band during Western blotting (628). Although B. 
subtilis produces light, its level is very low compared to E. coli strain light levels (~5-193 
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times lower) (Table 4-4) and there is no light detection from S. aureus. Therefore, the 
western blotting results are inconclusive for B. subtilis and S. aureus. The high-level of 
resistance obtained from kanr CDS in S. aureus which replaced luxI CDS in pHP-PL #9 
showed that this construct worked efficiently for genes which are not foreign to the host 
organism. However, this does not indicate that the RBS of the construct is strong since 
the promoter itself can be strong enough to cause such a Kanr level.  
In an attempt to increase translation, the luxI CDS codon preference was adapted 
to S. aureus codon usage. Determination of the codon usage for an organism to which a 
gene will be adapted is performed by using the organism’s genome sequence. This 
eliminated S. aureus RN4220 whose sequence is unknown as the organism to which luxI 
codons will be adapted. P68, the phage to be used for luxI cloning, was selected instead. 
Most of the P68 genes (70%) were found to have high translation efficiency (616). The 
codon usage of P68 was expected to be adapted to its host’s translation mechanism since 
it does not encode its own tRNAs (629). Indeed P68 codon usage was found to be 
positively correlated with the host, S. aureus Mu50, tRNA copy numbers (616). Although 
the S. aureus strain used in this study was different from the strain RN4220, the results 
should be applicable to all S. aureus strains. Genes within a species are very homogenous 
in codon usage (630). However, optimization did not increase light from B. subtilis 
significantly. Staphylococcus aureus and B. subtilis are phylogenetically very close (631-
633). Almost half of the S. aureus proteins, most of which are essential for vegetative 
growth, are very similar to those of B. subtilis and B. halodurans (634). Furthermore, S. 
aureus genes have been shown to be translated in B. subtilis efficiently (635). Therefore, 
it is possible that light levels from B. subtilis with the optimized luxI point to an 
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unsuccessful optimization which may or may not be caused by the use of P68 codon 
usage for the optimization. However, B. subtilis and S. aureus are different organisms 
and thus results may also mean that the problem is not at the translational level. 
 Results from all of the experiments suggest that the problem is either at the LuxI 
protein level, translational or post-translational, or at the level of LuxI product, OHHL. 
The stability of mRNA is one of the factors for translation efficiency (636, 637). mRNA 
stability changes depending on the half-life which can be in the range of seconds to 20 
min. After that, they are degraded by ribonucleases (RNases) (636, 637). mRNA with a 
short half life decreases the amount of translation. Factors affecting mRNA stability are 
folding, protection by ribosomes and polyadenylation (636, 637). Protein instability is 
also important in determining translational efficiency. Proteins are degraded by cellular 
proteases after translation (638, 639). Stability depends on the protein amino acid 
sequence. Certain amino acids located in certain places of the protein sequence affect 
stability (636). One example is the type of amino acid found in the N-terminus. Although 
the amino terminal amino acid is always methionine, it may be removed leaving another 
amino acid as the first one (636). There may be removals or additions of other amino 
acids as well. These post-translational modifications may place a particular amino acid in 
the amino terminus, which decreases protein half life (636). Arginine is such an example. 
If it is used as the first amino acid, the half life of protein is decreased to two minutes 
from hours. The third problem may be over-expression or incorrect folding of the protein 
which leads to aggregation and thus formation of inclusion bodies in the cell (636, 637). 
These are insoluble and not functional. There may also be some post-translational 
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modifications on the protein which is specific to S. aureus. These modifications may 
result in production of a nonfunctional LuxI protein.  
The cause for the lack of light from S. aureus with the non-optimized or 
optimized luxI may be related with OHHL production. There are different AHL-
inactivation mechanisms developed by various prokaryotic and eukaryotic organisms. 
Bacillus species including B. thuringiensis, B. cereus and B. mycoides were shown to 
produce AHL lactonases (475, 476, 640). AHL lactonases inactivate AHLs by 
hydrolyzing their lactone ring. AHL lactonase homologues were found in other species as 
well such as A. tumefaciens (641) and Arthrobacter sp. (642). Although AHL lactonase 
has not been reported from S. aureus so far, future studies may show otherwise. AHL 
antagonists which were detected in various Gram-negative bacteria are another AHL 
inactivation mechanism (131, 142, 227, 643-646). They compete with the AHL to bind to 
regulatory proteins, which blocks the quorum sensing response. The halogenated 
furanones from marine red algae Delisea pulchra have been documented to inhibit 
luminescence and virulence in V. harveyi by displacing OHHL from LuxR transcription 
factor (647-649). AHL was found to be metabolized by Variovorax paradoxus as the sole 
source of energy and nitrogen (650). Other possible mechanisms include AHL synthesis 
inhibition as a result of antimicrobial triclosan suppression of the reaction which is 
catalyzed by enoyl-acyl carrier protein reductase and autoinducer synthase targeting 
(651). Staphylococcus aureus may be found to posses one or more of these mechanisms 





MATERIALS AND METHODS 
CONSTRUCTION OF SALMONELLA BIOREPORTER 
 
Bacterial strains, plasmids, and bacteriophage 
Bacterial strains, plasmids, and bacteriophage used in this study are shown in 
Tables 6-1, 6-2, and 6-3, respectively. 
 
Growth and storage conditions 
 Escherichia coli, Salmonella, and Klebsiella strains were grown overnight in LB 
at 37oC at 220 rpm unless stated otherwise. Agrobacterium tumefaciens strains were 
grown overnight in LB at 30oC at 220 rpm unless stated otherwise. LB contains 10 g 
tryptone, 5 g yeast extract, 10 g NaCl (pH 7.5). Media were sterilized by autoclaving at 
121°C and 15 psi for 20 min. Agar plates were prepared by adding 15 g/L of agar into the 
medium before autoclaving. Overnight cultures of the bacterial strains were stored at -









Table 6-1. Bacterial strains used in this study. 
Species Strain Description and/or Genotype Reference 
and/or Source 
V. fischeri  NCMB 
1281 
Type strain ATCC 7744, 
602 
E. coli  DH5α General cloning , blue/white 
screening without IPTG; F- 
φ80lacZ∆M15 ∆(lacZYA-
argF)U169 recA1 endA1 
hsdR17(rk-, mk+) phoA  
supE44 thi-1 gyrA96 relA1 
Invitrogen, 
Carlsbad, CA  
E. coli  TOP10 Chemically competent, general 
cloning, blue/white screening 
without IPTG; F- mcrA ∆ (mrr-
hsdRMS-mcrBC) Ф80lacZ∆M15 
∆lacX74 recA1 araD139 ∆(ara-
leu)7697 galU galK rpsL (StrR) 
endA1 nupG  
Invitrogen, 
Carlsbad, CA  
E. coli  RoLux OHHL bioluminescent 
bioreporter, phage λ sensitive; 
STBL4 (EZ::TN luxRoCDABE) 
603 
E. coli  OHHLux OHHL bioluminescent 
bioreporter, phage λ resistant; 
EZ::TN pMOD (Epicentre 
Biotechnologies, Madison, WI)-V. 
fischeri luxR-PluxI-P. luminescens 
luxCDABE-rrnB T1T2, Kanr  
63 
E. coli carrying 
pJBA132 




S. choleraesuis VCS 275  Lab stock 




Wild-type prototroph ATCC 15380, 
652 
K. pneumoniae   Lab stock 
K. oxytoca M5a1 Wild-type prototroph, lacks the 
normal polysaccharide capsule so 










Table 6-1. Continued. 
Species Strain Description and/or Genotype Reference 
and/or Source 
K. oxytoca VJSK009 M5a1 mutant carrying a modified 








A136 AHL bioreporter.Ti plasmidless, 
traR overexpression plasmid 
(pCF218) and traI-lacZ (pCF372), 




KYC6 AHL overproducer. traM null 
mutant, traR overexpression 



















Table 6-2. Plasmids used in this study. 
Plasmid Description Function Reference 
and/or 
Source 
pCR2.1-TOPO 3931 bp, LacZα, MCS, 
pUC origin, Kanr, Ampr 






pCR2.1-PL #1  3982 bp, PL with 5′ SpeI 
and 3′ SalI sites 
Cloning of PL, Salmonella 





4539 bp, luxI CDS with 
the Gram-negative RBS 
carrying 5′ SalI and 3′ 
XhoI sites 
Cloning of luxI CDS 
under the control of the 
Gram-negative RBS for 




4369 bp, T1T2 with 5′ 
XhoI and 3′ XbaI sites 
Cloning of rRNB 




4541 bp, PL-luxI CDS 
with the Gram-negative 
RBS 
Cloning of luxI CDS with 
the Gram-negative RBS in 





(also referred to 
as pCR-L #3 in 
text and tables)* 
4964 bp, PL-luxI CDS 
with the Gram-negative 
RBS-T1T2, pUC origin, 
Kanr, Ampr 
Testing OHHL production 
from luxI under the 
control of Gram-negative 
RBS and Salmonella 
phage P22 promoter PL, 
early left promoter, inside 
S. choleraesuis  
This work 
pCR2.1-HA1 #2  4243 bp, the Salmonella 
phage P22 genome site 
between 22,406th and 
22,711th bps with 5′ 
KpnI and 3′ SpeI sites 
Cloning of homology arm 
#1, the Salmonella phage 
P22 genome region from 
22,406th to 22,711th 
nucleotide 
This work 
pCR2.1-HA2 #2 4262bp, P22 genome 
site from 22,712th to 
23,030th bps with 5′ 
XbaI and 3′ ApaI sites 
Cloning of the homology 
arm #2, the Salmonella 
phage P22 genome region 





5217 bp, the homology 
arm #1-PL-luxI CDS 
with the Gram-negative 
RBS-T1T2 
Cloning of the homology 
arm #1, Salmonella phage 
P22 genome region from 
22,406th to 22,711th 
nucleotide, into pCR2.1-





Table 6-2. Continued. 







(also referred to 
as pCR-HAL #5 
in text and 
tables)* 
5466 bp, the homology 
arm #1-PL-luxI CDS 
with the Gram-negative 
RBS-T1T2-the homology 
arm #2, pUC origin, 
Kanr, Ampr 
Cloning of the luxI CDS 
under the control of Gram-
negative RBS and 
Salmonella phage P22 
promoter PL, early left 
promoter, into the P22 
genome and the packaging 




(*See Table A in the appendix for a complete list of alternative names used for plasmids.) 
 
Table 6-3. Bacteriophage used in this study. 
Phage Host Description Reference 
and/or 
Source 
P22 Salmonella Podoviridae, 60 nm diameter, short/non-
contractile tail (20 nm), temperate (high 
multiplicity of infection leading to 
lysogenization; single infections leading to 
lysis), single linear ds DNA genome 
(41,724 bp), transducing phage for 




P22luxI #3 Salmonella Recombinant P22 carrying luxI under the 
control of Gram-negative RBS and 
Salmonella phage P22 promoter PL, early 
left promoter 
This work 
P22luxI #7 Salmonella Recombinant P22 carrying luxI under the 
control of Gram-negative RBS and 
Salmonella phage P22 promoter PL, 
This work 
P22luxI 10-4 Salmonella Recombinant P22 carrying luxI under the 
control of Gram-negative RBS and 
Salmonella phage P22 promoter PL 
This work 
P22luxI HR Salmonella Recombinant P22 carrying luxI under the 
control of Gram-negative RBS and 





Molecular biology techniques 
 All molecular biology techniques were carried out according to Molecular 
Cloning: A Laboratory Manual (612) unless stated otherwise. Manufacturer’s instructions 
were followed for kits. All restriction enzymes were from Promega (Madison, WI). 
Electrophoresis was done using TBE buffer (0.045 M Tris-Borate, 0.001 M EDTA, pH 
8.0). All PCR reactions were carried out using PCR Ready-To-Go beads (Amersham 
Biosciences, Buckinghamshire, England) according to manufacturer’s instructions with a 
PTC-225 DNA Engine Tetrad Peltier Thermal Cycler (MJ Research, Inc., Waltham, MA, 
Inc.). All primers were from Sigma Genosys (The Woodlands, TX) or Operon 
Biotechnologies, Inc. (Huntsville, AL). A list of primers is given in Table 6-4. 
Lyophilized primers were suspended in sterile dH2O to obtain a stock solution of 1 
nmol/µl. The stock solution was diluted with sterile dH2O to working solution of 5 
pmol/µl concentration. All PCR and sequencing reactions were performed using working 
solutions. DNA quantifications were done using a DyNA 200 Fluorometer (GE 
Healthcare, Buckinghamshire, UK).  
 
DNA sequencing 
Sequencing reactions were carried out by the Molecular Biology Resource 
Facility at The University of Tennessee, Knoxville with an ABI Prism 3100 Genetic 
Analyzer and a 3730 DNA Analyzer (Applied Biosystems, Foster City, CA). M13 
reverse and forward primers (Invitrogen, Carlsbad, CA) were used in sequencing 
reactions of genes which were cloned into pCR2.1-TOPO or pCR2.1 (Invitrogen, 
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Carlsbad, CA). Sequencing of genes cloned into other plasmids was performed with 
primers which were used for cloning. 
 
Electroporation of S. choleraesuis 
 The method of O’Callaghan and Charbit (658) was used for preparation of 
electrically competent cells and electroporation of S. choleraesuis. Briefly, mid-log phase 
cultures were washed with sterile ice-cold dH20 twice and sterile ice-cold 10% glycerol 
twice. Cells were resuspended in 10% glycerol in 40 µl aliquots and used for 
electroporation by mixing with 1 µl DNA in a 2-mm gap electroporation cuvette with a 
time constant of 5 ms, 200 ohms resistance, 25 µF capacitance, and 2.5 kV at 4oC.  
 
Table 6-4. List of primers used in this study. 
Name Sequence (5′-3′) References 
PLSpeI forward ACTAGTTTGACCATTTAATTAAGAA This work 








CTCGAGTTAATTTAAGACTGCTT This work 
T1T2XhoI 
forward 
CTCGAGAAGAGTTTGTAGAAACGCAAA This work 
T1T2XbaI 
reverse 
TCTAGATCTGTTTTGGCGGATGAG This work 
HRA1KpnI 
forward 
GGTACCTCTTCTCGATAATATCTTCA This work 
HRA1SpeI 
reverse 
ACTAGTCGATTCATGACAT This work 
HRA2XbaI 
forward 
TCTAGATGAGATAGTCCAGATGGGCGT This work 
HRA2ApaI 
reverse 




Electroporation of Klebsiella strains 
 The method of Fournet-Fayard et al. (659) was used for preparation of electrically 
competent cells and electroporation of Klebsiella strains. Briefly, the cultures were grown 
in LB and EDTA until OD600 of 0.2. Then these cultures were washed with sterile ice-
cold 10% glycerol once. Cells were resuspended in 10% glycerol in 40 µl aliquots and 
used for electroporation. Electroporation was performed by mixing 40 µl 
electrocompetent cells with 1 µl DNA in a 1-mm gap electroporation cuvette. Cells and 
DNA were electroporated at 4oC, 200 ohms resistance, 25 µF capacitance (optimum time 
constant of 4.5 ms), and 1.8 kV.  
 
Plasmid purification using rapid boiling mini-prep method 
 One ml of an overnight culture was centrifuged at 10,000 x g for 5 min at room 
temperature in a microcentrifuge. The pellet was resuspended in 40 µl of STET buffer 
(50 mM EDTA, 50 mM Tris pH 8.0, 5% Triton, 8% sucrose). Four µl of freshly prepared 
lysozyme solution (10 mg/ml in 20% sucrose, 50 mM Tris pH 8.0) were added to the 
suspension. The tube was placed in a boiling water bath for 1 min, and centrifuged at 
14,000 x g for 10 min at room temperature. The pellet was removed with a sterile 
toothpick and then 150 µl of 0.3 M KAc, pH 8.0 and 500 µl ice-cold ethanol were added 
to the supernatant. After mixing by inversion, the solution was stored on ice for 10 min, 
centrifuged at 14,000 x g for 15 min at 4°C, and supernatant was discarded. The DNA 
pellet was washed with 500 µl of 70% ethanol. The pellet was dried at room temperature, 




Construction of pCR2.1-PL-luxI-T1T2 #3 (or pCR-L #3) 
 The plasmid pCR2.1-PL-luxI-T1T2 #3 (or pCR-L #3) was constructed by placing 
luxI under the control of a Salmonella phage promoter to test luxI expression in 
Salmonella and to clone it into the phage. Since Salmonella phage P22 was selected to 
use to construct the recombinant phage carrying luxI, P22 early left promoter, PL, (655, 
656) was chosen as the promoter. A 10-bp spacer region was placed between the 
promoter and the RBS since transcription is started approximately 7 bp downstream of 
the promoter. Promoter and spacer sequences are shown below: 
TTGACCATTT AATTAAGAAG TCTTAAATTTTAGCCATCA 
 
  Promoter region                             Spacer region 
 
Promoter and spacer sequences were amplified using PLSpeI forward and PLSalI reverse 
primers following a PCR protocol which contained a step of 94oC for 5 min followed by 
40 cycles of 94oC for 30 sec, 45oC for 30 sec, and 72oC for 4 sec, and then a final step of 
72oC for 15 min. The PCR product was confirmed based on size by running it on a 0.5% 
agarose gel with EtBr in 0.5xTBE and UV illumination of the gel. The amplicon with the 
5′ SpeI and 3′ SalI sites was cloned into the TOPO TA cloning vector pCR2.1 and E. coli 
TOP10 cells (Invitrogen, Carlsbad, CA). Transformants were screened using EcoRI 
digestion and sequencing. The construct pCR2.1-PL #1 was selected. 
 The RBS of luxI was changed from the original to a Gram-negative consensus 
sequence after examination of various RBSs from Salmonella and phage P22 genes 





               AGGGAGGTTGGT           changed to            TAAGGAGGTCACCC 
 
          V. fischeri RBS  Spacer between                  Gram-negative RBS   Spacer between 
                                     RBS and CDS                                                        RBS and CDS 
 
The RBS change of luxI was carried out by amplification from pMO-L #7 using 
luxISalmSalI forward and luxISalmXhoI reverse primers. The PCR protocol consisted of 
a first step of 94oC for 5 min and then 35 cycles of 94oC for 30 sec, 42oC for 30 sec, and 
72oC for 38 sec, and finally a step of 72oC for 15 min. The product was run on a 0.5% 
agarose gel with EtBr in 0.5xTBE. UV light screening of the gel verified the amplicon, 
based on size. The PCR product carrying the changed RBS and the 5′ SalI and 3′ XhoI 
sites was cut out of the gel and purified using QIAquick Gel Extraction Kit (Qiagen Inc., 
Valencia, CA). The purified product was cloned into the TOPO TA cloning vector 
pCR2.1 into E. coli TOP10 cells (Invitrogen, Carlsbad, CA). After transformant 
screening with EcoRI analysis and sequencing, the construct picked was named pCR2.1-
luxISalm #2.8. 
rRNB ribosomal terminator T1T2 of pKK223-3 plasmid (Pharmacia, Uppsala, 
Sweden) was used as the transcription termination site for luxI expression in Salmonella. 
It was amplified from pMO-L #7 using T1T2XhoI forward and T1T2XbaI reverse 
primers. The PCR protocol was a step of 94oC for 5 min followed by 35 cycles of 94oC 
for 30 sec, 54oC for 30 sec, and 72oC for 28 sec, and a final step of 72oC for 15 min. 
Confirmation and cloning of the PCR product, and transformant screening were 
performed the same way as that of luxI described previously. The plasmid selected was 
called pCR2.1-T1T2 #2.5. 
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 pCR2.1-PL #1 and pCR2.1-luxISalm #2.8 were digested with SalI and XhoI in the 
presence of 1X buffer D (Promega, Madison, WI) at 37oC to place luxI under the PL 
control into pCR2.1-PL #1. Digests were run on a 0.5% agarose gel with EtBr in 
0.5xTBE. UV illumination was used to spot the luxI fragment from pCR2.1-luxISalm 
#2.8 and digested pCR2.1-PL #1 plasmid on the gel. The luxI fragment and pCR2.1-PL #1 
were cut out of the gel and purified using the QIAquick Gel Extraction Kit (Qiagen Inc., 
Valencia, CA). luxI was integrated into pCR2.1-PL #1 using the DNA Ligation 
Kit<Mighty Mix> (Takara Bio Inc., Shiga, Japan).  Reactions which contained 122 ng 
vector and 196 ng insert (1:10 ratio); and 94 ng vector and 220 ng insert (1:15 ratio) were 
incubated overnight at 16oC. Then, ligation reactions were transformed into chemically 
competent E. coli TOP10 cells (Invitrogen, Carlsbad, CA). Transformants were screened 
using EcoRI restriction analysis and sequencing. The construct pCR2.1-PL-luxI #2 was 
chosen to use for the future experiments. 
 To add a transcription termination site after the luxI gene, pCR2.1-T1T2 #2.5 and 
pCR2.1-PL-luxI #2 were cut with XhoI and XbaI using 1X buffer D (Promega, Madison, 
WI) at 37oC. The pCR2.1-T1T2 #2.5 digest was run on a 0.5% agarose gel with EtBr in 
0.5xTBE while the pCR2.1-PL-luxI #2 digest was purified directly from the reaction with 
the QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA). T1T2 fragment spotted on 
the gel based on size under UV light was cut and purified using the same kit. Ligation of 
165 ng T1T2 to 170 ng pCR2.1-PL-luxI #2 was performed with the DNA Ligation 
Kit<Mighty Mix> (Takara Bio Inc., Shiga, Japan) at 16oC overnight. SalI/XbaI digestion 
and sequencing were used to screen transformants. The construct with the correct insert 
was named pCR2.1-PL-luxI-T1T2 #3 (or pCR-L #3; see Table A in the appendix for a 
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complete list of alternative names used for plasmids). The construct diagram is shown in 
Figure 6-1. 
 
Transfer of pCR-L #3 into Salmonella 
pCR-L #3 was electroporated into electrically competent S. choleraesuis. 
Plasmids were purified from overnight cultures of transformants using the Wizard Plus 
Midi-Preps DNA Purification Systems (Promega, Madison, WI) according to 
manufacturer instructions, and screened by sequencing. The S. choleraesuis strain 




Figure 6-1. pCR2.1-PL-luxI-T1T2 #3 (or pCR-L #3) plasmid. luxI is under the control of 
a Gram-negative RBS and a Salmonella phage P22 promoter PL. (MCS=multiple cloning 
site of HindIII/KpnI/SacI/BamHI/SpeI/EcoRI) 
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Bioluminescent and fluorescent detection of OHHL from pCR-L #3 in S. 
choleraesuis using Wallac Victor2 1420 Multilabel and 1450 Microbeta Plus Liquid 
Scintillation Counters 
Overnight cultures of the bioluminescent bioreporter E. coli OHHLux, the 
fluorescent bioreporter E. coli MT102 with pJBA132, the negative control (wild type S. 
choleraesuis  strain), and S. choleraesuis harboring pCR-L #3 were prepared by growth 
of cells in LB with antibiotics at 37oC with 220 rpm. Cultures of S. choleraesuis strains 
were inoculated into fresh LB without antibiotics (100 µl into 10 ml LB) and grown at 
37oC until mid-log phase (OD600=0.9). Supernatants were collected, passed through 0.22 
µm filters and used for the assay. Overnight cultures of bioreporters were washed with 
LB, resuspended in LB with antibiotics to OD600=0.1 and used for the assay. Costar 96-
well black microtiter plates with a black or clear bottom (Corning Inc. Life Sciences, 
Lowell, MA) were used for measurements with a Wallac 1450 Microbeta Plus Liquid 
Scintillation or Victor2 1420 Multilabel Counter (PerkinElmer Life and Analytical 
Sciences, Waltham, MA), respectively. Samples and controls were prepared in triplicate. 
Each preparation contained 100 µl supernatant of the sample or control and 100 µl 
bioreporter solution. Also, measurements from bioreporters alone were performed to test 
background bioluminescence and fluorescence. These were in triplicate as well and each 
contained 100 µl bioreporter and 100 µl dH20. The assay methodology is summarized in 
Figure 3-2. The protocol followed by the Wallac Victor2 1420 Multilabel Counter was 
shaking for 10 sec, absorbance measurement at 450 nm, shaking for 10 sec, 
bioluminescence measurement (CPS), shaking for 10 sec, fluorescence measurement 
(GFP), and incubation for 20 min repeated overnight at 28oC. Measurements were 
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normalized by dividing CPS and GFP by OD450 values. The average of normalized values 
in triplicate was calculated. The Wallac 1450 Microbeta Plus Liquid Scintillation Counter 
protocol was bioluminescence measurement (CPS) followed by incubation for 20 min 
repeated overnight at 28oC. The mean of CPS values in triplicate was calculated for each 
sample. 
 
Construction of homologous recombination plasmid, pCR2.1-HA1-PL-luxI-T1T2-
HA2 #5 (or pCR-HAL #5) 
To integrate the PL-luxI-T1T2 fragment from pCR-L #3 into the phage P22 
genome and to package the resulting genome with luxI, homologous recombination 
method was used. The insertion site in the genome was between the 22,711th and 22,712th 
nucleotides; and ORF-201 and ORF-80 genes (phage genome PubMed No: AF217253; 
655). Homology regions selected from the genome were the 306-bp sequence before the 
insertion site (from 22,406th to 22,711th nucleotide) and the 319-bp sequence after the 
insertion site (from 22,712th to 23,030th nucleotide). The region before the insertion site 
was named homology arm #1 and the region after the insertion site was called homology 
arm #2. They are shown below: 












Homology arms were amplified from phage P22 genome which was extracted 
using Wizard Lambda Preps DNA Purification System (Promega, Madison, WI). 
HRA1KpnI forward and HRA1SpeI reverse primers were utilized for homology arm #1 
amplification with the PCR protocol of a first step of 94oC for 5 min followed by 40 
cycles of 94oC for 30 sec, 51oC for 30 sec, and 72oC for 20 sec, and then a step of 72oC 
for 15 min. Homology arm #2 was amplified using HRA2XbaI forward and HRA2ApaI 
reverse primers and the PCR protocol which contained a step of 94oC for 5 min and then 
40 cycles of 94oC for 30 sec, 62oC for 30 sec, and 72oC for 20 sec, and a final step of 
72oC for 15 min. Products were confirmed by running 15 µl of each reaction on a 0.5% 
agarose gel with EtBr in 0.5xTBE and screening the gel with UV light to control the 
product size. The remaining 10 µl of each PCR product was cloned into the TOPO TA 
cloning vector pCR2.1 and then into E. coli TOP10 cells (Invitrogen, Carlsbad, CA). 
Transformants were screened with EcoRI analysis and sequencing. The construct 
carrying homology arm #1 was called pCR2.1-HA1 #2 and the one containing homology 
arm #2 was named pCR2.1-HA2 #2. 
 Homology arms were inserted into pCR-L #3 to construct a plasmid to use for 
homologous recombination. Homology arm #1 was placed before the PL-luxI-T1T2 
fragment and homology arm #2 was placed after the fragment. First, homology arm #1 
was cloned into the plasmid at the KpnI and SpeI sites. For this, pCR2.1-HA1 #2 and 
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pCR-L #3 were digested with KpnI and SpeI with 1X multicore buffer (Promega, 
Madison, WI) at 37oC. Digestion products were run on a 0.5% agarose gel with EtBr in 
0.5xTBE and then screened with UV illumination. This spotted the homology arm #1 
fragment from pCR2.1-HA1 #2 and the digested pCR-L #3 on the gel based on size. 
Homology arm #1 and pCR-L #3 were cut out of the gel and purified using the QIAquick 
Gel Extraction Kit (Qiagen Inc., Valencia, CA). The DNA Ligation Kit<Mighty Mix> 
(Takara Bio Inc., Shiga, Japan) was used to integrate 69 ng homology arm into 111 ng 
pCR-L #3. The reaction was incubated at 16oC for 30 min and then transformed into 
chemically competent E. coli TOP10 cells (Invitrogen, Carlsbad, CA). Transformants 
were screened using XhoI/KpnI digestion and sequencing. Results showed that construct 
pCR2.1-HA1-PL-luxI-T1T2 #1 carried the correct insert.  
 To clone homology arm #2 into pCR2.1-HA1-PL-luxI-T1T2 #1 at the XbaI and 
ApaI sites, pCR2.1-HA2 #2 and pCR2.1-HA1-PL-luxI-T1T2 #1 were digested with these 
enzymes in the presence of 1X multicore buffer (Promega, Madison, WI) at 37oC. 
Digests were run on a 0.5% agarose gel with EtBr in 0.5xTBE. UV light screening 
showed homology arm #2 fragment from pCR2.1-HA2 #2 and the digested pCR2.1-
HA1-PL-luxI-T1T2 #1 on the gel based on size. Homology arm #2 and pCR2.1-HA1-PL-
luxI-T1T2 #1were cut out of the gel and purified using the QIAquick Gel Extraction Kit 
(Qiagen Inc., Valencia, CA). The homology arm fragment (96 ng) was ligated to pCR2.1-
HA1-PL-luxI-T1T2 #1 (160 ng) using the DNA Ligation Kit<Mighty Mix> (Takara Bio 
Inc., Shiga, Japan) at 16oC for 30 min. The reaction was chemically transformed into 
competent E. coli TOP10 cells (Invitrogen, Carlsbad, CA). Transformant screening was 
carried out with XhoI/ApaI restriction analysis and sequencing. The construct picked was 
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called pCR2.1-HA1-PL-luxI-T1T2-HA2 #5 (or pCR-HAL #5; see Table A in the 
appendix for a complete list of alternative names used for plasmids). A diagram of the 
plasmid is shown in Figure 6-2. 
 
Transfer of pCR-HAL #5 into S. choleraesuis 
pCR-HAL #5 was electroporated into electrically competent S. choleraesuis. 
Plasmids were purified from the overnight cultures of transformants using the Wizard 
Plus Midi-Preps DNA Purification Systems (Promega, Madison, WI) and run on a 0.5% 
agarose gel with EtBr in 0.5xTBE and sequenced. The S. choleraesuis strain determined 
to have pCR-HAL #5 was used for homologous recombination. 
 
 




Cloning of PL, luxI, and T1T2 into Salmonella phage P22 using homologous 
recombination 
 Salmonella choleraesuis strain carrying pCR-HAL #5 was used to clone PL, luxI, 
and T1T2 into phage P22. The homologous recombination method of Oda et al. (665) was 
used with some modifications. The overnight culture of S. choleraesuis with pCR-HAL 
#5 was diluted 10X in fresh LB with antibiotic and grown at 37oC with 220 rpm until 
reaching OD600=0.1. Then, 4 ml of the culture were infected with 1.4x107 plaque forming 
units (pfu) P22 in 640 µl. The infected culture was incubated for 5 h at 37oC with 220 
rpm. To lyse bacterial cells, 50 µl of chloroform were added to the culture and mixed, and 
then centrifuged at 8,000 x g for 10 min. The supernatant which contained the phage was 
collected and 50 µl of chloroform were added. The lysate was diluted with SM buffer (50 
mM Tris-HCL pH 7.5, 100 mM NaCl, 8 mM MgSO4, 0.01% gelatin) to obtain 10-1, 10-2, 
10-3, and 10-4 dilutions. Each dilution (100 µl) was mixed with the overnight culture of S. 
choleraesuis harboring pCR-HAL #5 (5 µl) and top agar (2.5 ml LB, 0.5% agar) and 
poured onto an LB plate. Plates were incubated overnight at 37oC. 
 
Propagation of phage from homologous recombination  
 Two plaques were picked from the 10-4 homologous recombination phage dilution 
plate. Each was placed into 250 µl SM buffer (50 mM Tris-HCL pH 7.5, 100 mM NaCl, 
8 mM MgSO4, 0.01% gelatin) containing 12 µl of chloroform. Suspensions were shaken 
gently at room temperature for 2 h. The remainder of plaques on the plate was collected 
by scraping the top agar off of the plate surface. The top agar containing plaques was 
suspended in 2 ml LB containing 40 µl of chloroform and shaken gently at room 
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temperature for 1.5 h. Supernatants of 2 plaques and the top agar collected after 
centrifugation at 8,000 x g for 10 min were added into 2 h-S. choleraesuis cultures (4 ml 
each) and a 2 h-S. choleraesuis with pCR-HAL #5 culture (4 ml), respectively. One ml of 
undiluted homologous recombination lysate was also added to a 2 h-S. choleraesuis with 
pCR-HAL #5 culture (4 ml). Cultures with phage were incubated overnight at 37oC with 
220 rpm. Lysates were centrifuged at 8,000 x g for 10 min. Supernatants containing the 
phage were stored at 4oC with chloroform. Lysates of 2 individual plaques picked from 
the 10-4 dilution plate were named P22luxI #3 and #7. The lysate obtained from the 10-4 
dilution plate was called P22luxI 10-4. The homologous recombination lysate was named 
P22luxI HR. 
 
Phage propagation for preparation of phage lysate stocks 
Routine propagation of phage to renew lysate stocks were performed in serial 
propagations using S. choleraesuis or S. choleraesuis harboring pCR-HAL #5 as the host. 
The host culture was prepared by inoculation of fresh LB with the overnight culture 
followed by incubation at 37oC at 220 rpm for 2-3 h. The phage lysate was mixed with 
this culture and incubated overnight at 37oC with 220 rpm. The lysate supernatant was 
subjected to the same protocol. This process was repeated 3 times in series. The final 





Bioluminescent detection of OHHL from P22luxI phage propagated with S. 
choleraesuis or S. choleraesuis with pCR-HAL #5 using Wallac Victor2 1420 
Multilabel and 1450 Microbeta Plus Liquid Scintillation Counters 
 Bioluminescent bioreporters E. coli OHHLux and S. choleraesuis were grown 
overnight in LB (with antibiotic for the bioreporter) at 37oC with 220 rpm. Salmonella 
choleraesuis was diluted 10 times in fresh LB and shaken at 37oC with 220 rpm until 
mid-log phase. The bioreporter overnight culture and the S. choleraesuis mid-log phase 
culture were washed with LB. The bioreporter culture was diluted to OD600=0.1 in LB 
without antibiotic. The S. choleraesuis culture was resuspended in the same volume of 
LB. The Costar 96-well black microtiter plates with a black bottom (Corning Inc. Life 
Sciences, Lowell, MA) were used for measurement of samples. Each sample contained 
50 µl bioreporter (~5x109 cfu), 50 µl S. choleraesuis (~4.3x108 cfu), and 100 µl P22luxI 
lysate. The P22luxI phage were #3, #7, 10-4, and HR. Two types of lysates were tested for 
each phage. One was the stock propagated using S. choleraesuis as the host and the other 
was the stock propagated using S. choleraesuis harboring pCR-HAL #5 as the host. The 
amount of each phage in a plate well is shown in Table 6-5. Each sample was prepared in 
triplicate. The methodology for the assay is shown in Figure 6-3. The protocol for Wallac 
Victor2 1420 Multilabel Counter measurements was shaking for 20 sec, bioluminescence 
measurement (CPS), shaking for 10 sec, and incubation for 20 min repeated overnight at 
28oC. The Wallac 1450 Microbeta Plus Liquid Scintillation Counter followed the 
protocol of bioluminescence measurement (CPS) and then incubation for 20 min repeated 




Table 6-5. P22luxI amounts (per each plate well) for bioluminescence detection from 
P22luxI propagated with S. choleraesuis or S. choleraesuis carrying pCR-HAL #5. Wells 
also included the bioreporter E. coli OHHLux and the host S. choleraesuis. 
 Propagated with S. 
choleraesuis    
Propagated with S. choleraesuis carrying 
pCR-HAL #5  
#3 ~7x108 pfu ~1.3x109 pfu 
#7 ~1.3x109 pfu ~8x108 pfu 
10-4 ~109 pfu ~109 pfu 











Screening of P22luxI #3 and #7 phage by PCR 
The presence of luxI in P22luxI #3 and #7 phage which were propagated using S. 
choleraesuis and S. choleraesuis carrying pCR-HAL #5 were checked by PCR. For this, 
plaques of each phage type were prepared by pouring a mixture of S. choleraesuis 
culture, the phage lysate which was filtered through 0.22 µm filters after the propagation 
(see above) and checked for bacterial contamination (see below), and top agar (2.5 ml 
LB, 0.5% agar) onto an LB plate. Plates were incubated overnight at 37oC. The tip of a 
sterile toothpick was touched to a plaque and then washed with sterile dH2O into a sterile 
tube. This was performed for a plaque of each phage type. Plaque suspensions in the 
tubes were heated for 2 min in a boiling water bath, cooled to room temperature, and used 
as templates for PCR reactions to amplify luxI with luxISalmSalI forward and 
luxISalmXhoI reverse primers. The PCR protocol consisted of a step of 94oC for 5 min 
followed by 35 cycles of 94oC for 30 sec, 42oC for 30 sec, and 72oC for 38 sec, and 
finally a step of 72oC for 15 min. PCR products were run on a 0.5% agarose gel with 
EtBr in 0.5xTBE. The gel was screened by UV illumination to detect luxI amplicons 
based on size.  
 
Testing bioluminescent bioreporter E. coli OHHLux for infection by P22 and 
P22luxI #3 and #7 phage on an LB plate 
 An overnight culture of bioluminescent bioreporter E. coli OHHLux and top agar 
(2.5 ml LB, 0.5% agar) were mixed and poured onto an LB plate. Drops of P22 and 
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P22luxI #3 and #7 phage stocks (a few µl each) were placed onto the plate and incubated 
overnight at 37oC.  
 
Detection of bioluminescence from the bioluminescent bioreporter E. coli OHHLux 
and P22luxI mixture using Wallac Victor2 1420 Multilabel and 1450 Microbeta Plus 
Liquid Scintillation Counters 
The bioluminescent bioreporter E. coli OHHLux overnight culture was washed in 
LB and then diluted to OD600=0.1 in LB without antibiotic to use for the assay. The 
overnight culture of S. choleraesuis (100 µl) was inoculated into fresh LB (10 ml) and 
grown at 37oC with 220 rpm until mid-log phase. The mid-log phase culture was 
resuspended in the same volume of SM buffer (50 mM Tris-HCL pH 7.5, 100 mM NaCl, 
8 mM MgSO4, 0.01% gelatin) after washing to use for P22luxI #3 assay. For the P22luxI 
#7 assay, the mid-log phase culture was washed with and resuspended in same volume of 
LB. Samples prepared in triplicate were placed into Costar 96-well black microtiter plates 
with a black bottom (Corning Inc. Life Sciences, Lowell, MA). Samples used for the 
P22luxI #7 and #3 assays and their amounts are shown in Tables 6-6 and 6-7. The assay 
methodology is shown in Figure 6-3. The Wallac Victor2 1420 Multilabel Counter 
measurement followed the protocol of shaking for 20 sec, bioluminescence measurement 
(CPS), shaking for 10 sec, and incubation for 20 min repeated overnight at 28oC. The 
Wallac 1450 Microbeta Plus Liquid Scintillation Counter measurements contained a 
bioluminescence measurement (CPS) and then incubation for 20 min repeated overnight 
at 28oC. The mean of CPS values in triplicate was calculated for each sample and used 





Table 6-6. Samples and amounts (per each plate well) used for bioluminescence detection 
from E. coli OHHLux and P22luxI #7. Each row represents a sample.  
P22luxI #7 S. choleraesuis  E. coli OHHLux bioreporter 
100 µl (~8.2x108 pfu) 50 µl (~109 cfu) 50 µl (~6x109 cfu) 
100 µl (~8.2x108 pfu) exchanged with 50 µl LB 50 µl (~6x109 cfu) 
 
 
Table 6-7. Samples and amounts (per each plate well) used for bioluminescence detection 
from E. coli OHHLux and P22luxI #3. Each row represents a sample.  
P22luxI #3 S. choleraesuis  E. coli OHHLux 
bioreporter 
 
100 µl (~1.3x109 pfu) 50 µl (~109 cfu) 50 µl (~6x109 cfu) +50 µl LB 
100 µl (~1.3x109 pfu) exchanged with 50 
µl SM buffer 
50 µl (~6x109 cfu) +50 µl LB 
100 µl (~1.3x109 pfu) 50 µl (~109 cfu) exchanged with 50 µl LB +50 µl LB 
exchanged with 100 µl 
SM buffer 
50 µl (~109 cfu) 50 µl (~6x109 cfu) +50 µl LB 
100 µl (~1.3x109 pfu) exchanged with 50 
µl SM buffer  
exchanged with 50 µl LB +50 µl LB 
exchanged with 100 µl 
SM buffer 
50 µl (~109 cfu) exchanged with 50 µl LB +50 µl LB 
exchanged with 100 µl 
SM buffer  
exchanged with 50 
µl SM buffer  











Control of phage stocks for contamination 
 Lysate stocks of P22luxI #3 and #7 phage were tested for bacterial contamination. 
One-hundred µl of each phage lysate (1.3x109 pfu P22luxI #3; 8.2x108 pfu P22luxI #7) 
were spreaded onto a sterile LB plate. Plates were incubated overnight at 37oC and 
checked for bacterial growth the next day. Furthermore, 520 µl of each phage stock 
(1.9x1010 pfu P22luxI #3; 1.4x1010 pfu P22luxI #7) were incubated with 10 ml sterile LB 
at 37oC with 220 rpm for 6 d. Suspensions were checked for bacterial growth after 
incubation. 
 
Measurements from mixtures of bioluminescent bioreporter E. coli OHHLux and 
P22luxI #3 phage to determine the source of bioluminescence using Wallac 1450 
Microbeta Plus Liquid Scintillation Counter 
The overnight culture of the bioluminescent bioreporter E. coli OHHLux which 
was washed with LB was diluted to OD600=0.1 in LB without antibiotic. Various 
dilutions of this culture were prepared using LB. The lysate stock of P22luxI #3 phage 
was diluted serially using SM buffer (50 mM Tris-HCL pH 7.5, 100 mM NaCl, 8 mM 
MgSO4, 0.01% gelatin). Samples containing different dilutions of the phage combined 
with a constant amount of bioreporter and samples of a constant amount of phage mixed 
with different dilutions of bioreporter were prepared. Control samples were a mixture of 
P22luxI #3 phage and bioreporter without dilution, P22luxI #3 phage alone, bioreporter 
alone, a mixture of wild type phage P22 and bioreporter, and P22 phage alone. Samples 
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and controls were prepared in triplicate and placed into Costar 96-well black microtiter 
plates with a black bottom (Corning Inc. Life Sciences, Lowell, MA). Samples and 
controls used and their amounts are shown in Tables 6-8 and 6-9. The Wallac 1450 
Microbeta Plus Liquid Scintillation Counter protocol consisted of a bioluminescence 
measurement (CPS) and then incubation for 20 min repeated overnight at 28oC. The 
mean CPS value was calculated for each sample prepared in triplicate. 
 
Test of pseudolysogeny 
This experiment was performed to determine whether a pseudolysogenic 
interaction existed between the bioluminescent bioreporter E. coli OHHLux and P22luxI 
phage. Two cultures with OD600 = 0.1 were prepared by diluting the bioreporter overnight 
culture in LB. One culture was infected with P22luxI #3 phage. The other culture was 
used as the negative control. The culture with the phage contained ~1011 cfu/ml 
bioreporter and ~6x109 pfu/ml phage and the negative control culture had ~1011 cfu/ml 
bioreporter. Cultures were incubated at 37oC with 220 rpm and measured for 
bioluminescence at certain time points using DeltaTox luminometer with ATP Mode 
Testing (Strategic Diagnostics Inc., Newark, DE). Bioluminescence from the bioreporter 
culture with the phage was compared to that of the negative control. When 
bioluminescence from the bioreporter-phage sample started to increase (~4 times higher 






Table 6-8. Samples and amounts (per each plate well) used to determine the source of 
bioluminescence from the E. coli OHHLux and P22luxI mixture. Each row represents a 
sample.  
P22luxI #3 E. coli OHHLux bioreporter  
100 µl (~1.9x109 pfu)-diluted 2x 50 µl (~6x109 cfu) +50 µl LB 
100 µl (~9.3x108 pfu)-diluted 4x 50 µl (~6x109 cfu) +50 µl LB 
100 µl (~4.6x108 pfu)-diluted 8x 50 µl (~6x109 cfu) +50 µl LB 
100 µl (~3.7x108 pfu)-diluted 10x 50 µl (~6x109 cfu) +50 µl LB 
100 µl (~1.2x108 pfu)-diluted 32x 50 µl (~6x109 cfu) +50 µl LB 
100 µl (~3.7x107 pfu)-diluted 100x 50 µl (~6x109 cfu) +50 µl LB 
100 µl (~3.7x109 pfu) 50 µl (~3x109 cfu)-diluted 2x +50 µl LB 
100 µl (~3.7x109 pfu) 50 µl (~1.5x109 cfu)-diluted 4x +50 µl LB 
100 µl (~3.7x109 pfu) 50 µl (~7.7x108 cfu)-diluted 8x +50 µl LB 
100 µl (~3.7x109 pfu) 50 µl (~2x108 cfu)-diluted 32x +50 µl LB 
 
Table 6-9. Controls and amounts (per each plate well) used to determine the source of 
bioluminescence from the E. coli OHHLux and P22luxI mixture. Each row represents a 
sample. 
P22luxI #3 = 100 µl (~3.7x109 pfu) Bioreporter = 50 µl (~6x109 cfu) +50 µl LB 
P22 = 100 µl (~4x109 pfu) Bioreporter = 50 µl (~6x109 cfu) +50 µl LB 
P22luxI #3 = 100 µl (~3.7x109 pfu) X +100 µl LB 
P22 = 100 µl (~4x109 pfu) X +100 µl LB 
100 µl SM buffer Bioreporter = 50 µl (~6x109 cfu) +50 µl LB 
 
Table 6-10. Bioluminescence detection from E. coli OHHLux during its incubation with 
P22luxI and negative control, E. coli OHHLux using DeltaTox luminometer (Strategic 
Diagnostics Inc., Newark, DE) 
 Bioluminescence in photon counts 
Time period (min) E. coli OHHLux E. coli OHHLux + P22luxI #3 
140 1,184,157 1,082,840 
200 1,125,739 1,712,733 
245 2,914,816 4,933,702 
300 2,654,806 11,130,231 
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The culture of bioreporter containing phage was divided into two. Both were 
centrifuged at 10,000 x g for 10 min. Supernatant was discarded to remove phage 
particles. Pellets which contained bacterial cells were resuspended in fresh LB and 
vortexed vigorously for 5 min to remove phage particles which may be adsorbed to 
bacterial cells. One of the suspensions was centrifuged at 10,000 x g for 10 min. The 
resulting pellet was subjected to plasmid purification using Wizard Midi-Prep Plasmid 
Purification Kit (Promega, Madison, WI). The other suspension was centrifuged at 
16,000 x g for 2 min and used for genomic DNA purification with Wizard Genomic DNA 
Purification Kit (Promega, Madison, WI). Plasmid and genomic DNA were used as 
templates in PCR reactions with luxISalmSalI forward and luxISalmXhoI reverse primers 
to detect luxI. The PCR protocol followed a step of 94oC for 5 min and then 35 cycles of 
94oC for 30 sec, 42oC for 30 sec, and 72oC for 38 sec, and a final step of 72oC for 15 min. 
The PCR products were run on a 0.5% agarose gel with EtBr in 0.5xTBE. The gel was 
screened with UV light to spot the luxI amplicons based on size.  
 
Qualitative detection of OHHL from P22luxI and S. choleraesuis mixture using 
AHL bioreporter A. tumefaciens A136 
 Since the bioluminescent bioreporter E. coli OHHLux produces bioluminescence 
in the presence of P22luxI without S. choleraesuis, it can not be used to test P22luxI for 
S. choleraesuis detection. Therefore, another AHL bioreporter, A. tumefaciens A136, was 
employed for this test. Although A. tumefaciens A136 can not quantify OHHL, it can 
detect the presence of it. Cultures of bacterial strains grown overnight were used for the 
assay. LB agars were spreaded with freshly prepared X-gal (40 mg/ml in dimethyl 
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formamide), 50 µl for each plate. One half of a plate was used for the test of each sample. 
Agrobacterium tumefaciens A136 was streaked across one half of an LB plate at two 
places, the top and the bottom. The culture or the culture-phage mixture to be tested was 
streaked onto the plate in between the two lines of bioreporter at exactly 0.5 cm distance 
vertically from each bioreporter line. Each A. tumefaciens A136 line consisted of 4 µl of 
an overnight culture of the strain. A diagram of the assay is shown in Figure 6-4. Samples 
and controls and their amounts are shown in Table 6-11.  
This experiment was used to determine the efficiency of P22luxI phage for 
detection of S. choleraesuis. Also, the bioluminescent bioreporter E. coli OHHLux and 
bioreporter A. tumefaciens A136 were tested for OHHL production in the presence of 
P22luxI without S. choleraesuis. Positive controls included A. tumefaciens KYC6 which 
is an AHL overproducer and S. choleraesuis containing pCR-HAL #5. Negative control 
was S. choleraesuis mixed with the wild type P22 phage. Plates were checked after 32 h 






Figure 6-4. Assay diagram for qualitative detection of OHHL using AHL bioreporter A. 
tumefaciens A136. 
 
Table 6-11. Samples, controls, and amounts (per each sample or control) used for OHHL 
detection from P22luxI and S. choleraesuis using AHL bioreporter A. tumefaciens A136. 
Each row represents a sample. 
S. choleraesuis = 2 µl (~6x1010 cfu) P22luxI #3 = 2 µl (~7.4x107 pfu) 
S. choleraesuis = 2 µl (~6x1010 cfu) P22luxI #7 = 2 µl (~5.4x107 pfu) 
E. coli OHHLux bioreporter = 2 µl (~4.8x109 cfu) P22luxI #3 = 2 µl (~7.4x107 pfu) 
E. coli OHHLux bioreporter = 2 µl (~4.8x109 cfu) P22luxI #7 = 2 µl (~5.4x107 pfu) 
A. tumefaciens A136 = 4 µl  P22luxI #3 = 2 µl (~7.4x107 pfu) 
A. tumefaciens A136 = 4 µl  P22luxI #7 = 2 µl (~5.4x107 pfu) 
A. tumefaciens KYC6 = 4 µl  X 
S. choleraesuis with pCR-HAL #5 = 4 µl  X 




Construction of Klebsiella bioluminescent bioreporters  
 The bioluminescent bioreporter E. coli OHHLux can not be used for monitoring 
Salmonella since it produces bioluminescence in the presence of P22luxI phage without 
S. choleraesuis. Agrobacterium tumefaciens A136 AHL bioreporter was used 
successfully to detect S. choleraesuis with the assistance of P22luxI. However, it 
provides a qualitative detection so it can not be used for optimization of the system. 
Therefore, to construct a new bioluminescent bioreporter, the plasmid carried by E. coli 
OHHLux was transferred into various Klebsiella strains. 
 The plasmid of E. coli OHHLux was constructed by placing a fusion of the 
luxCDABE genes from P. luminescens, the luxR gene and luxI promoter from V. fischeri, 
rrnB T1T2 transcriptional terminator, and a kanamycin resistance gene into an EZ::TN 
pMOD cloning vector (Epicentre Biotechnologies, Madison, WI) (63). The plasmid was 
purified from the strain using Wizard Plus Midi-Preps DNA Purification Systems 
(Promega, Madison, WI), and electroporated into electrically competent cells of K. 
oxytoca M5a1, K. oxytoca VJSK009, K. pneumoniae NCTC 418, and K. pneumoniae 
strains. Transformants were obtained from only K. oxytoca VJSK009 and K. pneumoniae 
NCTC 418. Plasmids of transformants were purified from overnight cultures with Wizard 
Plus Midi-Preps DNA Purification Systems (Promega, Madison, WI) and controlled by 
EcoRI (Promega, Madison, WI) digestion and sequencing for verification. One 
transformant carrying the plasmid was selected for each Klebsiella strain and used for 




Bioluminescent detection of OHHL from S. choleraesuis and P22luxI phage using 
Klebsiella bioluminescent bioreporters and a Wallac 1450 Microbeta Plus Liquid 
Scintillation Counter 
 Overnight cultures of K. oxytoca VJSK009 and K. pneumoniae NCTC 418 
harboring the plasmid from the bioluminescent bioreporter E. coli OHHLux and S. 
choleraesuis were prepared. Klebsiella cultures which were washed in LB were diluted to 
OD600=0.1 in LB without antibiotic. The S. choleraesuis culture was diluted 10X in fresh 
LB and grown at 37oC with 220 rpm until mid-log phase, and resuspended in the same 
volume LB. The Costar 96-well black microtiter plates with black bottom (Corning Inc. 
Life Sciences, Lowell, MA) were used for samples and controls, prepared in triplicate. 
Samples and controls, and their amounts are shown in Tables 6-12, 6-13, and 6-14. The 
assay methodology is shown in Figure 6-3. Wallac 1450 Microbeta Plus Liquid 
Scintillation Counter measurements included a bioluminescence measurement (CPS) and 
then incubation for 20 min repeated overnight at 28oC. Average CPS values in triplicate 
was calculated for each sample. 
 
Table 6-12. Samples and amounts (per each plate well) used for bioluminescence 
detection from P22luxI and its host S. choleraesuis using the K. pneumoniae bioreporter. 
Each row represents a sample. 
P22luxI S. choleraesuis  K. pneumoniae 
bioreporter 
(#3) 100 µl (~5x108-5x109 pfu) 50 µl (~7x108 cfu) 50 µl (~5x1010 cfu) 
(#7) 100 µl (~4x108 pfu) 50 µl (~7x108 cfu) 50 µl (~5x1010 cfu) 
(#3) 100 µl (~5x108-5x109 pfu) exchanged with 50 µl LB 50 µl (~5x1010 cfu) 




Table 6-13. Samples and amounts (per each plate well) used for bioluminescence 
detection from P22luxI and its host S. choleraesuis using the K. oxytoca bioreporter. Each 
row represents a sample. 
P22luxI S. choleraesuis K. oxytoca 
bioreporter 
(#3) 100 µl (~5x108-5x109 pfu) 50 µl (~7x108 cfu) 50 µl (~1.3x1010 cfu) 
(#7) 100 µl (~4x108 pfu) 50 µl (~7x108 cfu) 50 µl (~1.3x1010 cfu) 
(#3) 100 µl (~5x108-5x109 pfu) exchanged with 50 µl LB 50 µl (~1.3x1010 cfu) 
(#7) 100 µl (~4x108 pfu) exchanged with 50 µl LB 50 µl (~1.3x1010 cfu) 
 
 
Table 6-14. Negative controls and amounts (per each plate well) used for 
bioluminescence detection P22luxI and its host S. choleraesuis using Klebsiella 
bioreporters. Each row represents a sample. 
100 µl P22 (~4x109 pfu) 50 µl S. choleraesuis  
(~7x108 cfu) 
50 µl K. pneumoniae 
(~5x1010 cfu) 
100 µl P22 (~4x109 pfu) 50 µl S. choleraesuis  
(~7x108 cfu) 
50 µl K. oxytoca 
(~1.3x1010 cfu) 
100 µl SM buffer 50 µl S. choleraesuis  
(~7x108 cfu) 
50 µl K. pneumoniae 
(~5x1010 cfu) 
100 µl SM buffer 50 µl S. choleraesuis  
(~7x108 cfu) 
50 µl K. oxytoca 
(~1.3x1010 cfu) 
100 µl P22luxI #3 (~5x108-5x109 pfu) 50 µl S. choleraesuis  
(~7x108 cfu) 
50 µl LB 
100 µl P22luxI #7 (~4x108 pfu) 50 µl S. choleraesuis  
(~7x108 cfu) 
50 µl LB 
100 µl SM buffer 50 µl LB 50 µl K. pneumoniae 
(~5x1010 cfu) 
100 µl SM buffer 50 µl LB 50 µl K. oxytoca 
(~1.3x1010 cfu) 
100 µl SM buffer 50 µl S. choleraesuis  
(~7x108 cfu) 
50 µl LB 
100 µl P22luxI #3 (~5x108-5x109 pfu) 100 µl LB  





Bioluminescent detection of OHHL from P22luxI genome and bioluminescent 
bioreporters using a Wallac 1450 Microbeta Plus Liquid Scintillation Counter 
 Bioluminescence measurements were performed to test the possibility that the 
P22luxI genome is taken by the bioreporter cells without infection, leading to 
bioluminescence generation from bioreporter and phage mixtures. Overnight cultures of 
K. oxytoca VJSK009, K. pneumoniae NCTC 418, and E. coli OHHLux bioluminescent 
bioreporters were washed in LB, and diluted to OD600=0.1 in LB without antibiotic. 
Samples and controls were set up in triplicate. Costar 96-well black microtiter plates with 
black bottom (Corning Inc. Life Sciences, Lowell, MA) were used for the assay. Samples 
and controls, and their amounts are shown in Tables 6-15 and 6-16. Two different 
concentrations of the phage genome were used for each P22luxI with 4.6 ng 
corresponding to 108 pfu and 46 ng corresponding to 109 pfu. Phage genomes were 
extracted using Wizard Lambda Preps DNA Purification System (Promega, Madison, 
WI). Phage-bioreporter mixtures were used as positive controls. Also, bioreporters alone 
and bioreporter-P22 mixtures were used as negative controls in addition to those in Table 
6-16. A bioluminescence measurement (CPS) followed by incubation for 20 min which 
was repeated overnight to 52 h at 28oC was performed by Wallac 1450 Microbeta Plus 






Table 6-15. Samples and amounts (per each plate well) used for bioluminescence 
detection from P22luxI genome and K. oxytoca, K. pneumoniae, or E. coli OHHLux 
bioreporters. Each row represents a sample. 
P22luxI or P22 phage; or their genome Bioreporter   
#3 = 100 µl (~5x108-5x109 pfu) 50 µl (~5x1010 cfu) 50 µl LB
#3 genome = 4.6 ng in 100 µl SM buffer 50 µl (~5x1010 cfu) 50 µl LB
#3 genome = 46 ng in100 µl SM buffer 50 µl (~5x1010 cfu) 50 µl LB
#7 = 100 µl (~4x108 pfu) 50 µl (~5x1010 cfu) 50 µl LB
#7 genome = 4.6 ng in 100 µl SM buffer 50 µl (~5x1010 cfu) 50 µl LB
#7 genome = 46 ng in 100 µl SM buffer 50 µl (~5x1010 cfu) 50 µl LB
P22 = 100 µl (~4x109 pfu) 50 µl (~5x1010 cfu) 50 µl LB
exchanged with 100 µl SM buffer 50 µl (~5x1010 cfu) 50 µl LB
 
 
Table 6-16. Negative controls and amounts (per each plate well) used for 
bioluminescence detection from P22luxI genome and K. oxytoca, K. pneumoniae, or E. 
coli OHHLux bioreporters. Each row represents a sample. 
P22luxI or its genome  
#3 = 100 µl (~5x108-5x109 pfu)  + 100 µl LB 
#3 genome = 4.6 ng in 100 µl SM buffer  + 100 µl LB 
#3 genome = 46 ng in100 µl SM buffer  + 100 µl LB 
#7 = 100 µl (~4x108 pfu)  + 100 µl LB 
#7 genome = 4.6 ng in 100 µl SM buffer  + 100 µl LB 










Bioluminescence and fluorescence values were normalized by dividing the CPS 
and GFP values obtained, respectively, by absorbance values at OD450 of the bioreporter 
culture measured at the same time point where available. The average of triplicate 
measurements was calculated for each time point. Normalized values were used if the 
absorbance of the bioreporter culture was measured. Error bars were determined by 
calculating the standard deviation of triplicate bioluminescence or fluorescence values at 
each time point as follows: The average of triplicate measurements (normalized where 
available) for a time point was subtracted from each measurement (normalized where 
available) at that time point. The squares of the differences were calculated. The average 
of all three squared differences was determined. The square root of the value found was 
used as the standard deviation for the average value at each time point. Significance 
levels were determined by comparing average bioluminescence or fluorescence values of 
a sample to those of the negative control using Student’s t-test (P < 0.05). Maximum 
induction value of a sample for an assay was calculated by dividing the highest amount of 
light obtained from the sample during the assay by the amount of light from the negative 





CONSTRUCTION OF SALMONELLA BIOREPORTER 
 
Bioluminescent and fluorescent detection of OHHL from pCR-L #3 in S. 
choleraesuis using Wallac Victor2 1420 Multilabel and 1450 Microbeta Plus Liquid 
Scintillation Counters 
The plasmid pCR-L #3 was constructed and transferred to S. choleraesuis to test 
luxI expression in Salmonella with a Salmonella phage promoter to detect promoter 
efficiency. The aim was to finally clone the luxI into a Salmonella phage under this 
promoter. Therefore, S. choleraesuis harboring pCR-L #3 was tested for bioluminescence 
and fluorescence using the bioluminescent bioreporter E. coli OHHLux, the fluorescent 
bioreporter E. coli MT102 with pJBA132, and the wild type S. choleraesuis strain as the 
negative control. Also, measurements from bioreporters alone were done to determine 
background bioluminescence and fluorescence. Samples and controls were in triplicate. 
Wallac Victor2 1420 Multilabel Counter (PerkinElmer Life and Analytical Sciences, 
Waltham, MA) bioluminescence and fluorescence measurements were normalized by 
dividing CPS and GFP by OD450 values. The mean of triplicate values obtained was 
calculated for each sample. The mean of Wallac 1450 Microbeta Plus Liquid Scintillation 
Counter (PerkinElmer Life and Analytical Sciences, Waltham, MA) bioluminescence 
measurements in triplicate was calculated for each sample. Measurements were carried 
out at 28oC.  
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High levels of bioluminescence and fluorescence were obtained from pCR-L #3 
in S. choleraesuis (Figure 7-1). Table 7-1 shows the maximum inductions obtained from 
each assay. Bioluminescence and fluorescence levels obtained from the construct were 15 
to 33 times higher than those of the negative control. 
 
Cloning of PL, luxI, and T1T2 into Salmonella phage P22 using homologous 
recombination 
 luxI under the control of the Gram-negative RBS, and P22 promoter PL followed 
by transcription termination site T1T2 was cloned into phage P22 using the homologous 
recombination method (665) with some modifications. The integration site was after the 
22,711th nucleotide of the genome and between ORF-201 and ORF-80 genes (phage 
genome PubMed No: AF217253; 655). Homology regions of the genome which were 
used for homologous recombination were the 306-bp sequence before and the 319-bp 
sequence after the insertion site. Salmonella choleraesuis harboring pCR-HAL #5 which 
carries homology arms was infected with P22 for homologous recombination to take 
place. Resulting plaques were screened by plating dilutions of the lysate with the culture 
of S. choleraesuis containing pCR-HAL #5. Isolated plaques could be visualized only on 
the 10-4 phage dilution plate. The morphology of all ~200 plaques obtained on the plate 
differed from wild type P22 plaque morphology. A wild type plaque occupied a large 
area with a clear halo around the center where there was bacterial growth. The plaques 
obtained from the homologous recombination formed much smaller (~1 mm), clear areas 



























Figure 7-1 (A). Bioluminescent OHHL detection from pCR-L #3 (or pCR2.1-PL-luxI-
T1T2 #3) in S. choleraesuis at 28oC using the bioreporter E. coli OHHLux and Wallac 
1450 Microbeta Plus Liquid Scintillation Counter. Results represent the mean 








































Figure 7-1 (B). Bioluminescent OHHL detection from pCR-L #3 (or pCR2.1-PL-luxI-
T1T2 #3) in S. choleraesuis at 28oC using the bioreporter E. coli OHHLux and Wallac 
Victor2 1420 Multilabel Counter. Results represent the mean bioluminescence values 





































Figure 7-1 (C). Fluorescent OHHL detection from pCR-L #3 (or pCR2.1-PL-luxI-T1T2 
#3) in S. choleraesuis at 28oC using the bioreporter E. coli MT102 with pJBA132 and 
Wallac Victor2 1420 Multilabel Counter. Results represent the mean fluorescence values 









Table 7-1. Bioluminescence and fluorescence from pCR-L #3 in S. choleraesuis. 
Bioluminescence was detected using the bioreporter E. coli OHHLux and Wallac 1450 
Microbeta Plus Liquid Scintillation Counter. Fluorescence was detected using the 
bioreporter E. coli MT102 harboring pJBA132 and Wallac Victor2 1420 Multilabel 
Counter. (MI = maximum induction; the highest amount of light from a sample divided 
by the negative control value at the same time point, T = Time period in h to obtain MI) 
 pCR-L #3 in S. choleraesuis  
 MI T 
Bioluminescence-Wallac 1450  33.5X 10.5 
Bioluminescence-Wallac Victor2 16.4X 7 
Fluorescence-Wallac Victor2 15.2X 17 
 
Bioluminescent detection of OHHL from P22luxI phage propagated with S. 
choleraesuis or S. choleraesuis with pCR-HAL #5 using Wallac Victor2 1420 
Multilabel and 1450 Microbeta Plus Liquid Scintillation Counters 
 The P22luxI phage #3, #7, 10-4, and HR obtained from homologous 
recombination were tested for OHHL production using the bioluminescent bioreporter E. 
coli OHHLux and Wallac Victor2 1420 Multilabel and 1450 Microbeta Plus Liquid 
Scintillation Counters. Samples were prepared in triplicate. Each sample contained 
~5x109 cfu bioreporter, ~4.3x108 cfu S. choleraesuis, and P22luxI lysate. There were two 
varieties of each phage type: the one propagated with S. choleraesuis and the one 
propagated with S. choleraesuis carrying pCR-HAL #5 as the host. The amount of each 
phage in a plate well is shown in Table 6-5. Measurements were performed at 28oC.  
 High levels of bioluminescence from all phage propagated using S. choleraesuis 
with pCR-HAL #5 were detected (Figure 7-2). Maximum bioluminescence values 
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obtained from these phage compared with the background (time 0) are shown in Table 7-
2. There was no bioluminescence produced by any of the phage which were propagated 
with S. choleraesuis (Figure 7-2). Phage P22luxI #3 and #7 were selected for further 
experiments. They were propagated using S. choleraesuis harboring pCR-HAL #5 when 
needed since they lose the capability of bioluminescence production when propagated 
with the wild type S. choleraesuis. 
 
Screening of P22luxI #3 and #7 phage by PCR 
 The phage P22luxI #3 and #7 propagated with S. choleraesuis and S. choleraesuis 
harboring pCR-HAL #5 were controlled for the presence of luxI by PCR. Plaques of the 
phage suspended in sterile dH2O were boiled and used as the template for PCR with 
luxISalmSalI forward and luxISalmXhoI reverse primers. PCR products were screened 
by running on a gel. luxI was obtained only from phage that were propagated with S. 































P22luxI #3 propagated with recombinant S. choleraesuis
P22luxI #7 propagated with recombinant S. choleraesuis
P22luxI 10E-4 propagated with recombinant S. choleraesuis
P22luxI HR propagated with recombinant S. choleraesuis
P22luxI #3 propagated with wild type S. choleraesuis
P22luxI #7 propagated with wild type S. choleraesuis
P22luxI 10E-4 propagated with wild type S. choleraesuis
P22luxI HR propagated with wild type S. choleraesuis
 
Figure 7-2 (A). Bioluminescent OHHL detection from P22luxI #3, #7, 10-4, and HR using 
the bioreporter E. coli OHHLux, the host S. choleraesuis, and Wallac 1450 Microbeta 
Plus Liquid Scintillation Counter. Results represent the mean bioluminescence values 



























P22luxI #3 propagated with recombinant S. choleraesuis
P22luxI #7 propagated with recombinant S. choleraesuis
P22luxI 10E-4 propagated with recombinant S. choleraesuis
P22luxI HR propagated with recombinant S. choleraesuis
P22luxI #3 propagated with wild type S. choleraesuis
P22luxI #7 propagated with wild type S. choleraesuis
P22luxI 10E-4 propagated with wild type S. choleraesuis
P22luxI HR propagated with wild type S. choleraesuis
 
Figure 7-2 (B). Bioluminescent OHHL detection from P22luxI #3, #7, 10-4, and HR using 
the bioreporter E. coli OHHLux, the host S. choleraesuis, and Wallac Victor2 1420 
Multilabel Counter. Results represent the mean bioluminescence values (n=3) ± SD 









Table 7-2. Bioluminescence from P22luxI #3, #7, 10-4, and HR propagated using S. 
choleraesuis containing pCR-HAL #5. Detection was performed using E. coli OHHLux 
as the bioreporter and S. choleraesuis as the host. (MI = maximum induction-the highest 
amount of light from a sample divided by the time 0 value of the same sample, * = Time 
period in h to obtain MI, Wallac 1450 = Wallac 1450 Microbeta Plus Liquid Scintillation 
Counter, Wallac Victor2 = Wallac Victor2 1420 Multilabel Counter) 
 
MI by P22luxI phage propagated using S. choleraesuis 
carrying pCR-HAL #5 
 #3 #7 10-4 HR 
Bioluminescence-
Wallac 1450  
25X*(5) 33X*(6.5) 33X*(7) 33X*(6) 
Bioluminescence-
Wallac Victor2 




                            
Figure 7-3. Products from PCR to check the presence of luxI in P22luxI #3 and #7 
propagated using S. choleraesuis or S. choleraesuis carrying pCR-HAL #5. 
(7SC=P22luxI #7 propagated using S. choleraesuis, 7SCPL=P22luxI #7 propagated using 
S. choleraesuis with pCR-HAL #5, 3SC = P22luxI #3 propagated using S. choleraesuis, 




Testing the bioluminescent bioreporter E. coli OHHLux for infection by P22 and 
P22luxI #3 and #7 phage on an LB plate 
The P22 and P22luxI #3 and #7 phage stock drops were put on a bioluminescent 
bioreporter E. coli OHHLux LB plate to test the bioreporter infection by the phage. After 
overnight incubation at 37oC, no lysis was detected with any of the phage drops. 
 
Detection of bioluminescence from the bioluminescent bioreporter E. coli OHHLux 
and P22luxI mixture using Wallac Victor2 1420 Multilabel and 1450 Microbeta Plus 
Liquid Scintillation Counters 
Bioluminescence from the bioreporter E. coli OHHLux combined with P22luxI 
#3 or #7 was tested using Wallac Counters. Control samples were also prepared for 
comparison. The control for P22luxI #7 was a mixture of phage, bioreporter, and S. 
choleraesuis. P22luxI #3 controls consisted of a mixture of phage, bioreporter, and S. 
choleraesuis; a mixture of phage and S. choleraesuis; a mixture of bioreporter and S. 
choleraesuis; phage alone; bioreporter alone; and S. choleraesuis alone. Samples and 
their amounts for the P22luxI #7 and #3 assays are shown in Tables 6-6 and 6-7, 
respectively. Measurements were performed at 28oC.  
 Results of P22luxI #3 and #7 assays are shown in Figure 7-4. There was no 
bioluminescence from controls, phage-S. choleraesuis, bioreporter-S. choleraesuis, 
phage, bioreporter, and S. choleraesuis as expected. However, high levels of 
bioluminescence were produced by samples which contain the P22luxI #3 or #7 and the 
bioreporter. These were even higher than amounts obtained from control samples which 








































Figure 7-4 (A). Bioluminescent OHHL detection from P22luxI and the bioreporter E. coli 
OHHLux using Wallac 1450 Microbeta Plus Liquid Scintillation Counter. Results 



































Figure 7-4 (B). Bioluminescent OHHL detection from P22luxI and the bioreporter E. coli 
OHHLux using Wallac Victor2 1420 Multilabel Counter. Results represent the mean 











Control of phage stocks for contamination 
 Lysate stocks of P22luxI #3 and #7 phage were checked for bacterial 
contamination which may cause bioluminescence production from mixtures of 
bioreporter and phage. Each phage stock (100 µl; 1.3x109 pfu P22luxI #3; 8.2x108 pfu 
P22luxI #7) was spreaded onto a sterile LB plate. Plates were incubated overnight at 
37oC. Also, an aliquot from the lysate of each phage (520 µl-1.9x1010 pfu P22luxI #3; 
1.4x1010 pfu P22luxI #7) was incubated with 10 ml sterile LB at 37oC with 220 rpm for 6 
d. There was no growth in both media after incubation. 
 
Measurements from the mixtures of bioluminescent bioreporter E. coli OHHLux 
and P22luxI #3 phage to determine the source of bioluminescence using Wallac 1450 
Microbeta Plus Liquid Scintillation Counter 
To determine the source of bioluminescence from the mixture of bioluminescent 
bioreporter E. coli OHHLux  and phage P22luxI, samples of various phage P22luxI #3 
dilutions mixed with a constant amount of bioreporter and samples of a constant amount 
of phage P22luxI #3 combined with various dilutions of bioreporter were prepared. 
Bioluminescence from these samples was measured using Wallac 1450 Microbeta Plus 
Liquid Scintillation Counter. Bioreporter dilutions were prepared with LB and phage 
dilutions with SM buffer (50 mM Tris-HCL pH 7.5, 100 mM NaCl, 8 mM MgSO4, 
0.01% gelatin). Control samples consisted of a mixture of P22luxI #3 phage and 
bioreporter without dilution, P22luxI #3 phage alone, bioreporter alone, a mixture of wild 
type phage P22 and bioreporter, and P22 phage alone. Samples and controls were 
prepared in triplicate. Samples and controls including the amounts are shown in Tables 6-
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8 and 6-9, respectively. Measurements were performed overnight at 28oC. The average of 
CPS values from each sample prepared in triplicate was calculated. 
 Table 7-3 shows the comparison of the bioluminescence values reached at the end 
of the assay shown in Figure 7-5. Dilutions of the bioreporter did not affect the output of 
bioluminescence considerably. Bioluminescence with all bioreporter dilutions reached 
levels which were not significantly different from the level obtained with the undiluted 
bioreporter. However, dilutions in phage decreased the amount of bioluminescence 
significantly. The decrease bioluminescence was correlated with the increase in phage 
dilution. As expected, there was no bioluminescence from controls, P22-bioreporter, 
P22luxI #3, P22, and bioreporter. 
 
Table 7-3. Comparison of bioluminescence from P22luxI and E. coli OHHLux dilutions 
determined to find the source of light from the P22luxI and E. coli OHHLux mixture. A 
constant amount of E. coli OHHLux was used with P22luxI dilutions and a constant 
amount of P22luxI was used with E. coli OHHLux dilutions. The final induction was 
calculated by dividing the final value from a sample by the negative control value at the 
same time point. 
dilution 
Final induction by 
P22luxI #3 
dilutions 
Final induction by 
bioreporter dilutions
Final induction by 
P22luxI #3-bioreporter 
with no dilution 
2X 10.6X 19.3X 23.5X 
4X 6.6X 20.8X  
8X 4.6X 22.3X  
10X 2.2X --  
32X 1.1X 20.3X  













































Figure 7-5. Bioluminescence detection to find the source of light from the P22luxI and E. 
coli OHHLux mixture. A constant amount of E. coli OHHLux was used with P22luxI 
dilutions and a constant amount of P22luxI was used with E. coli OHHLux dilutions. 










Test of pseudolysogeny 
Bioluminescence obtained from the bioluminescent bioreporter E. coli OHHLux 
and P22luxI phage mixture decreased with dilutions of phage. Test of phage lysate for 
bacterial contamination detected no bacterial cells. It was also determined previously that 
there was no plaque formation on plates containing the bioreporter culture infected with 
the phage, implicating no lysis or lysogeny. Therefore, the possibility of a 
pseudolysogenic interaction between the bioreporter and phage was evaluated. A culture 
of bioreporter infected with P22luxI #3 was incubated until the detection of 
bioluminescence. Then, bacterial cells were separated from phage particles by collecting 
the pellet after centrifugation. The resuspended pellet was vortexed vigorously for 5 min 
to remove phage particles which may be found adsorbed to bacterial cell surfaces. After 
another centrifugation, bacterial cells were suspended in LB and used for separate 
plasmid and genomic DNA purifications. Purifications were controlled for the presence 
of luxI by PCR using luxISalmSalI forward and luxISalmXhoI reverse primers. PCR 
products were screened by running on a gel and followed by UV illumination. luxI was 
detected in both plasmid and genome purifications (Figure 7-6) and the amount was 





Figure 7-6. Products from PCR to check the presence of luxI in genome and plasmid 
purifications of E. coli OHHLux after incubation with P22luxI. (Negative control = P22 
genome, positive control = pCR-L #3, genome = genome from E. coli OHHLux after 
incubation with P22luxI, plasmid = plasmid from E. coli OHHLux after incubation with 
P22luxI) 
 
Qualitative detection of OHHL from P22luxI and S. choleraesuis mixture using 
AHL bioreporter A. tumefaciens A136 
 The bioluminescent bioreporter E. coli OHHLux was found to produce 
bioluminescence in the presence of P22luxI without S. choleraesuis. Therefore, to 
determine the efficiency of P22luxI for S. choleraesuis detection, another AHL 
bioreporter, A. tumefaciens A136, was used. Agrobacterium tumefaciens A136 can detect 
the presence of OHHL; however, it is not as sensitive as E. coli OHHLux for OHHL 
quantification.  
Overnight cultures of bacterial strains were used for the experiment. The sample 
to be tested was placed in between two lines of A. tumefaciens A136 on an LB plate 
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spread with X-gal. The line of sample was adjusted to be at exactly 0.5 cm distance 
vertically from each bioreporter line. Each line of bioreporter contained 4 µl overnight 
culture of the strain. A diagram of the assay is shown in Figure 6-4. Samples and 
controls, and their amounts are shown in Table 6-11. Agrobacterium tumefaciens KYC6 
which is an AHL overproducer and S. choleraesuis containing pCR-HAL #5 were used as 
positive controls. Salmonella choleraesuis mixed with the wild type P22 phage was the 
negative control. Plates were incubated for 32 h at room temperature and then 36 h at 
4oC. 
 Agrobacterium tumefaciens A136 carries a traI-lacZ fusion. When OHHL is 
produced by the sample, it diffuses across the plate and reaches the strain. This results in 
activation of the traI-lacZ fusion, causing expression of β-galactosidase activity. This 
expression converts the color of A. tumefaciens A136 colonies on the plate from white to 
blue. Therefore, no change in white color of A. tumefaciens A136 colonies demonstrates 
the absence of OHHL from the sample while a change to a blue color shows the release 
of OHHL from the sample.  
As expected, there was OHHL production by positive controls and no OHHL 
from the negative control (Figure 7-7). Agrobacterium tumefaciens A136 bioreporter did 
not generate OHHL in the presence of only P22luxI, making it a suitable bioreporter to 
determine P22luxI efficiency for S. choleraesuis detection. High amounts of OHHL were 
released from mixtures of S. choleraesuis and P22luxI #3 or #7 as demonstrated by the 
dense blue color of bioreporter colonies. This demonstrates that P22luxI #3 and #7 can be 






Figure 7-7. Qualitative OHHL detection using AHL bioreporter A. tumefaciens A136. Sample names are shown on top of 





However, there was no OHHL produced by the combination of the 
bioluminescent bioreporter E. coli OHHLux and P22luxI although the same combination 
was found to produce bioluminescence using Wallac Victor2 1420 Multilabel and 1450 
Microbeta Plus Liquid Scintillation Counters. This may suggest a possible 
pseudolysogenic interaction between E. coli OHHLux and P22luxI, which is discussed in 
more detail in the discussion section (see chapter 8). 
 
Bioluminescent detection of OHHL from S. choleraesuis and P22luxI phage using 
Klebsiella bioluminescent bioreporters and a Wallac 1450 Microbeta Plus Liquid 
Scintillation Counter 
The bioreporter E. coli OHHLux produces bioluminescence when combined with 
P22luxI phage and thus can not be used for Salmonella monitoring. Agrobacterium 
tumefaciens A136 AHL bioreporter can not replace E. coli OHHLux since it is not as 
sensitive as the bioluminescent E. coli OHHLux for OHHL quantification.  
To construct another OHHL bioreporter to use with P22luxI phage, E. coli 
OHHLux plasmid (63) was transferred into K. oxytoca VJSK009 and K. pneumoniae 
NCTC 418 strains. Klebsiella strains carrying the plasmid were tested for S. choleraesuis 
detection using P22luxI #3 and #7 phage and Wallac 1450 Microbeta Plus Liquid 
Scintillation Counter. They were also tested for infection by P22luxI phage. Costar 96-
well black microtiter plates with black bottom (Corning Inc. Life Sciences, Lowell, MA) 
were used for the assay. Samples and controls, prepared in triplicate, and their amounts 
 
 237
are shown in Tables 6-12 through 6-14. The experiment was performed at 28oC. The 
mean of CPS values in triplicate for each sample was calculated. 
 Results are shown in Figures 7-8 and 7-9. Both Klebsiella bioreporters produced 
bioluminescence in the presence of P22luxI #3 or #7 without S. choleraesuis like E. coli 
OHHLux bioreporter. Levels of bioluminescence were not significantly different from 
those which were obtained with the presence of S. choleraesuis. Also, background levels 
from the negative controls, the bioreporter, the bioreporter-S. choleraesuis mixture, and 
the bioreporter-S. choleraesuis-P22 mixture were very high. Bioluminescence from these 
controls reached amounts as high as those from the bioreporter-S. choleraesuis-P22luxI 
and bioreporter-P22luxI combinations in some cases. There was no bioluminescence 
from negative controls, S. choleraesuis, P22luxI, and S. choleraesuis-P22luxI mixture. 
Since light was obtained from the Klebsiella bioreporters in the presence of P22luxI 
without its host, these results may be pointing to the possible infection of Klebsiella 
strains by P22luxI like E. coli OHHLux bioreporter. This will be discussed in more detail 


































Figure 7-8 (A). Bioluminescent OHHL detection from P22luxI #3 using the host S. 
choleraesuis and the K. oxytoca bioreporter. Results represent the mean bioluminescence 

























K. oxytoca-S. choleraesuis-P22luxI #7 K. oxytoca-P22luxI #7
K. oxytoca-S. choleraesuis K. oxytoca-S. choleraesuis-P22
S. choleraesuis-P22luxI #7 K. oxytoca
S. choleraesuis P22luxI #7
 
Figure 7-8 (B). Bioluminescent OHHL detection from P22luxI #7 using the host S. 
choleraesuis and the K. oxytoca bioreporter. Results represent the mean bioluminescence 
























K. pneumoniae-S. choleraesuis-P22luxI #3 K. pneumoniae-P22luxI #3
K. pneumoniae-S. choleraesuis-P22 K. pneumoniae-S. choleraesuis
S. choleraesuis-P22luxI #3 K. pneumoniae
S. choleraesuis P22luxI #3
 
Figure 7-9 (A). Bioluminescent OHHL detection from P22luxI #3 using the host S. 
choleraesuis and the K. pneumoniae bioreporter. Results represent the mean 
































Figure 7-9 (B). Bioluminescent OHHL detection from P22luxI #7 using the host S. 
choleraesuis and the K. pneumoniae bioreporter. Results represent the mean 










Bioluminescent detection of OHHL from P22luxI genome and bioluminescent 
bioreporters using a Wallac 1450 Microbeta Plus Liquid Scintillation Counter 
 This test was carried out to determine if bioluminescence from the bioreporter and 
P22luxI mixtures is caused by the pick-up of the phage genome by the bioreporter cells 
instead of an infection. Klebsiella oxytoca VJSK009, K. pneumoniae NCTC 418, and E. 
coli OHHLux bioluminescent bioreporters were combined with the phage genome and 
then measured for bioluminescence. Samples and negative controls with their amounts 
are shown in Tables 6-15 and 6-16, respectively. The phage genome of 4.6 ng 
corresponds to 108 pfu and 46 ng corresponds to 109 pfu. The positive control was the 
phage-bioreporter mixture. Two more negative controls, the bioreporter alone and the 
bioreporter-P22 mixture were used in addition to those above. Costar 96-well black 
microtiter plates with black bottom (Corning Inc. Life Sciences, Lowell, MA) were 
employed for the assay performed at 28oC. Average CPS value for each sample in 
triplicate was calculated. 
 Results are presented in Figures 7-10 through 7-12. There was high amount of 
bioluminescence from the positive control and bioreporter-P22luxI, but no 
bioluminescence from negative controls, P22luxI alone and P22luxI genome alone, as 
expected. There was background bioluminescence from bioreporter-P22 samples. Their 
peak bioluminescence values were 4.5X, 4X, and 145X higher than those from the 
bioreporter samples for K. pneumoniae, K. oxytoca, and E. coli OHHLux, respectively. 
Bioluminescence from the bioreporter-phage genome was lower than the bioreporter-P22 
bioluminescence for all bioreporter types. It was also not significantly different from that 
of the bioreporter sample for Klebsiella strains. The same result was obtained for E. coli 
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OHHLux in the case of the P22luxI #3 genome and the P22luxI #7 genome of 4.6 ng. 
However, bioluminescence from E. coli OHHLux-P22luxI #7 genome of 46 ng was 12X 
higher than that of E. coli OHHLux at its peak value. Nevertheless, values from this 
sample never exceeded values from the bioreporter-P22 sample. Furthermore, 
bioluminescence from E. coli OHHLux-P22luxI #7 phage was much higher with a 































K. pneumoniae-P22luxI #3 genome; 46 ng




P22luxI #3 genome; 46 ng
P22luxI #3 genome; 4.6 ng
 
Figure 7-10 (A). Bioluminescent OHHL detection from P22luxI #3 genome using the K. 
pneumoniae bioreporter and Wallac 1450 Microbeta Plus Liquid Scintillation Counter. 


























K. pneumoniae-P22luxI #7 genome; 46 ng




P22luxI #7 genome; 46 ng
P22luxI #7 genome; 4.6 ng
 
Figure 7-10 (B). Bioluminescent OHHL detection from P22luxI #7 genome using the K. 
pneumoniae bioreporter and Wallac 1450 Microbeta Plus Liquid Scintillation Counter. 

























K. oxytoca-P22luxI #3 genome; 46 ng




P22luxI #3 genome; 46 ng
P22luxI #3 genome; 4.6 ng
 
Figure 7-11 (A). Bioluminescent OHHL detection from P22luxI #3 genome using the K. 
oxytoca bioreporter and Wallac 1450 Microbeta Plus Liquid Scintillation Counter. 

























K. oxytoca-P22luxI #7 genome; 46 ng




P22luxI #7 genome; 46 ng
P22luxI #7 genome; 4.6 ng
 
Figure 7-11 (B). Bioluminescent OHHL detection from P22luxI #7 genome using the K. 
oxytoca bioreporter and Wallac 1450 Microbeta Plus Liquid Scintillation Counter. 

























E. coli OHHLux-P22luxI #7
E. coli OHHLux-P22luxI #7 genome; 46 ng
E. coli OHHLux-P22luxI #7 genome; 4.6 ng
E. coli OHHLux-P22luxI #3 genome; 46 ng




P22luxI #7 genome; 46 ng
P22luxI #7 genome; 4.6 ng
P22luxI #3 genome; 46 ng
P22luxI #3 genome; 4.6 ng
 
Figure 7-12. Bioluminescent OHHL detection from P22luxI genome using the E. coli 
OHHLux bioreporter and Wallac 1450 Microbeta Plus Liquid Scintillation Counter. 





DISCUSSION AND CONCLUSIONS 
CONSTRUCTION OF SALMONELLA BIOREPORTER 
 
The luxI gene which was placed under the control of a Salmonella phage 
promoter and a Gram-negative RBS was cloned into S. choleraesuis. The promoter was 
phage P22 early left promoter, PL, (655, 656) since luxI was planned to clone into phage 
P22. RBS sequence was selected after examination of various RBSs from Salmonella and 
phage P22 genes. Also, the rRNB ribosomal terminator T1T2 of pKK223-3 plasmid 
(Pharmacia, Uppsala, Sweden) was used as the transcription termination site. The 
plasmid, pCR-L #3 produced high levels of bioluminescence and fluorescence in S. 
choleraesuis. luxI, under the control of same promoter and RBS, was integrated into the 
P22 genome between ORF-201 and ORF-80 using homologous recombination (phage 
genome PubMed No: AF217253; 655).  
 Bioluminescence and fluorescence tests showed that the recombinant phage 
produced light only when propagated using S. choleraesuis harboring pCR-HAL #5, the 
homologous recombination plasmid. When recombinant phage were propagated with the 
wild type S. choleraesuis as the host, they lost the capability of light production. luxI was 
detected by PCR in the recombinant phage propagated using S. choleraesuis carrying 
pCR-HAL #5 but not in those propagated using the wild type strain. The recombinant 
phage, P22luxI, may be genetically unstable. Although luxI was placed in between genes, 
its insertion place is in an important region related with head formation and lysis (656). 
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luxI presence may be creating a disadvantage for the phage, which may lead to takeover 
by the wild type phage or loss of the luxI insert when S. choleraesuis is used as the host. 
The reason for retaining luxI by the phage when S. choleraesuis with pCR-HAL #5 is 
used as the propagation host may be the replication mechanism of P22. Homologous 
recombination is an essential mechanism for replication of the P22 genome in the host 
cell (656). The linear P22 genome is circularized early after infection by homologous 
recombination between terminal repeats at the two genome ends. The circularized 
genome is replicated via a rolling circle mechanism. Also, replicated P22 DNA molecules 
need to be circularized by homologous recombination to be inserted into the host 
chromosome for the lysogenic cycle (656). Homologous recombination can be performed 
by host rec gene products but P22 also has its own genes to perform recombination (656). 
Therefore, when the phage genome is inserted into a host cell containing luxI between the 
phage genome homology arms, high homologous recombination activity which takes 
place in the cell and the recombination machinery of the phage may result in an elevated 
level of luxI integration into the genome. 
The bioluminescent bioreporter E. coli OHHLux and P22luxI phage produced 
light in the absence of S. choleraesuis. Tests performed with serial dilutions of the 
bioreporter mixed with a constant amount of P22luxI; and serial dilutions of P22luxI 
combined with a constant amount of the bioreporter showed P22luxI as the source of the 
problem. Previous tests did not detect plaque formation on bioreporter plates by P22luxI 
or the wild type P22, suggesting no lysis or lysogeny. Also, phage lysate stocks were 
determined to be contamination free. The possibility of the phage genome take-up by the 
bioreporter which may cause light production by bioreporter-P22luxI mixtures was 
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controlled. There was no light generated by the phage genome and the bioreporter 
combination.  
 Results above may be pointing to infection of the bioreporter by P22luxI although 
P22 is known to infect only Salmonella strains. The receptor site for P22 adsorption is a 
specific type of O antigen, a component of the outer membrane lipopolysaccharide. This 
O antigen type is found only in Salmonella serogroups A, B, and D1 (656, 666, 667). 
However, P22 is a “lambdoid” phage with the same genetic organization of the E. coli 
phage λ (656). P22 and λ contain homologous sequences and can recombine forming 
viable hybrids. This may suggest a possibility of E. coli bioreporter infection by P22luxI 
whose wild type is a close relative of an E. coli phage. Indeed, E. coli K-12 which was 
engineered to carry the Salmonella O-antigen-encoding rfb cluster was shown to be 
infected by P22 (667). This strain acted as a host for P22 infection and replication. 
Propagation of P22 on this strain resulted in phage concentrations which were close to 
those obtained using Salmonella as the host. Escherichia coli can be infected by P22 as 
long as it carries receptors for phage adsorption. 
 If the bioreporter E. coli OHHLux is infected by P22luxI, this is not a lytic or 
lysogenic infection since no lysis was obtained on bioreporter plates by P22luxI or P22. 
Also, if it was a lytic or lysogenic interaction, the high amount of light which was 
sustained for long periods of time would not be obtained from bioreporter-P22luxI 
mixtures. Since bioreporter cells would be lysed by the phage, light would not be 
generated. P22 is known to infect Salmonella by following one of three pathways: lytic, 
lysogenic, and pseudolysogenic (668). Pseudolysogeny is a state where the phage 
genome which does not integrate into the host chromosome replicates continuously 
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without lysing the host cell. It was suggested to be an environmental condition which 
occurs as a result of infection of starved bacterial cells (669, 670). The infecting phage 
does not enter a lytic or a lysogenic cycle since bacterial cells do not have enough 
resources to provide for the phage. The Wallac bioluminescence and fluorescence 
measurement conditions may leave bioreporter cells starved. Each well which was set up 
for these assays contained a very small volume of fresh LB (100 µl) which was used to 
suspend bioreporter cells and spent LB (100 µl) which came from the phage lysate. These 
are nutrient-poor conditions which may cause starvation of bioreporter cells. Starvation 
may be causing some changes in the E. coli cell membrane, which makes it susceptible to 
P22 infection. It was found that E. coli O157:H7 loses O antigenicity under starvation 
conditions (671). P22luxI may be infecting these starved susceptible bioreporter cells 
following a pseudolysogenic cycle under the particular conditions of light measurement 
assays.  
To test pseudolysogeny, the bioreporter was infected with P22luxI and incubated 
until light production started. Then, bioreporter cells were collected from the culture. The 
genome and the plasmid of bioreporter cells were purified separately and checked for the 
presence of luxI to determine the presence of P22luxI genome. luxI was expected to be 
found in plasmid purifications since a pseudolysogenic phage genome acts like a plasmid. 
It was detected in both preparations but the amount of the luxI PCR product from the 
plasmid purification was much higher than that of the PCR product from the genome 
preparation. luxI presence in the genome may be caused by a contamination of the 
preparation by plasmids which were not eliminated completely during the purification. 
Another possibility is integration of a small part of phage genome molecules into the host 
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cell chromosome. Results from this experiment suggest a pseudolysogenic interaction 
between P22luxI and the bioreporter. However, it is also possible that the phage which 
adsorbed to the bioreporter cell surface could not be removed totally and luxI was 
amplified from the genomes of these phage. 
 Another result which may be supporting a pseudolysogenic interaction between 
P22luxI and the bioreporter during Wallac light measurement assays is the one obtained 
using the AHL bioreporter A. tumefaciens A136. The same combination which generated 
light during Wallac measurements did not produce OHHL during A. tumefaciens A136 
experiments. Since these experiments were done on LB plates, conditions were not 
starving for the bioreporter. This supports a possible pseudolysogenic infection of the 
bioreporter by P22luxI which occurs only under nutrient-poor conditions. 
 The P22luxI-S. choleraesuis mixture was shown to produce OHHL which was 
detected by the AHL bioreporter, A. tumefaciens A136. Therefore, P22luxI can be used 
for Salmonella monitoring as long as the bioreporter itself does not produce light only in 
the presence of P22luxI. Agrobacterium tumefaciens A136 is not sensitive enough to be 
used to quantify the amount of OHHL produced, which makes it an unsuitable 
bioreporter for construction of a self-sustained, continuous, and real-time monitoring 
system. In an attempt to construct a new bioluminescent bioreporter to use with P22luxI, 
the plasmid of E. coli OHHLux bioreporter was transferred into K. oxytoca and K. 
pneumoniae strains. Since ColE1 which is the ori of the bioreporter plasmid works only 
in E. coli, Salmonella, and Klebsiella strains, Klebsiella strains were chosen to transfer 
the plasmid into. Klebsiella bioreporters produced bioluminescence in the presence of 
P22luxI without S. choleraesuis like E. coli OHHLux bioreporter. Salmonella, E. coli, 
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and Klebsiella all belong to Enterobacteriaceae. The outer membrane of 
Enterobacteriaceae is primarily composed of lipopolysaccharides (672) which contain 
the adsorption site, O-antigen, for P22 (656, 666, 667). P22luxI may be infecting all 
enterobacteria whose outer membrane composition may be affected by the starving 
conditions of the assays. A new bioluminescent bioreporter which does not produce light 
when mixed with P22luxI should be constructed to develop a Salmonella monitoring 
system using P22luxI. A bacterial strain other than enterobacteria such as A. tumefaciens 
which did not generate light in the presence of P22luxI needs to be employed for the 
construction of this bioreporter. This new bioreporter can be used for optimization and 
the sensitivity and specificity determination of the system. Tests which will be performed 
on artificially contaminated food should finalize the development of the Salmonella 
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Table A. Alternative names used for plasmids in this study. 
Plasmid Alternative Name 
pMOD-2-kanr-prom-luxI-T1T2 #7 pMO-L #7  
pMK4-prom-luxI #13.3 pMK-L #13.3 
pHPS9-luxI #7 pHP-L #7  
pHPS9-kanR #4 pHP-K #4  
pDG148-Stu-luxI #28 pDG-L #28  
pHPS9-sht-Pspac-luxI-lacI #9 pHP-PL #9  
pHPS9-sht-Pspac-kanR-lacI #31 pHP-PK #31  
pHPS9-sht-Pspac-optluxI-lacI #5 pHP-POL #5  
pCR2.1-PL-luxI-T1T2 #3 pCR-L #3  
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